"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. . "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. acetazolamide. this classification denotes a diuretic and carbonic anhydrase inhibitor with the molecular formula c4h6n4o3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o3fx965v0i, chemically known as 1,3,4-thiadiazole-2-sulfonamide, 5-acetamido- but generally known as acetazolamide, which bears us nih compound identifier 1986. acetazolamide comes in many forms, including adipate ethyl ester, methyl, sodium, and tri-methyl. european medicines agency schedules acetazolamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05219mig. the term acetazolamide is an international non-proprietary name. world health organization schedules acetazolamide in its anatomical therapeutic chemical (atc) classification. acetazolamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acetazolamide under hs 29350090 and sitc 51580. as of q4 2014, acetazolamide remains the us fda preferred term for this commodity. acetazolamide bears us nlm identifiers umls id c0000981 and nci concept code c28809. smiles: cc(=o)nc1nnc(s1)s(=o)(=o)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. felbamate. this classification denotes an anticonvulsant agent with the molecular formula c11h14n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x72rbb02n8, chemically known as 1,3-propanediol, 2-phenyl-, dicarbamate but generally known as felbamate, which bears us nih compound identifier 3331. european medicines agency schedules felbamate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07526mig. the term felbamate is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules felbamate in its anatomical therapeutic chemical (atc) classification. felbamate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule felbamate under hs 29242995 and sitc 51479. as of q4 2014, felbamate remains the us fda preferred term for this commodity. felbamate bears us nlm identifiers umls id c0060135 and nci concept code c47530. smiles: c1=cc=c(c=c1)c(coc(=o)n)coc(=o)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. lamotrigine. this classification denotes an anticonvulsant agent with the molecular formula c9h7cl2n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u3h27498ks, chemically known as 1,2,4-triazine-3,5-diamine, 6-(2,3-dichlorophenyl)- but generally known as lamotrigine, which bears us nih compound identifier 3878. european medicines agency schedules lamotrigine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08393mig. the term lamotrigine is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules lamotrigine in its anatomical therapeutic chemical (atc) classification. lamotrigine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lamotrigine under hs 29336980 and sitc 51576. as of q4 2014, lamotrigine remains the us fda preferred term for this commodity. lamotrigine bears us nlm identifiers umls id c0678180 and nci concept code c38703. smiles: clc1c(c2nnc(nc2n)n)cccc1cl.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. phenytoin. this classification denotes a cation channel blocker and anticonvulsant agent with the molecular formula c15h12n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6158tkw0c5, chemically known as 5,5-dwufenylohydantoina but generally known as phenytoin, which bears us nih compound identifier 1775. european medicines agency schedules phenytoin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12211mig. the term phenytoin is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules phenytoin in its anatomical therapeutic chemical (atc) classification. phenytoin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phenytoin under hs 29332100 and sitc 51572. as of q4 2014, phenytoin remains the us fda preferred term for this commodity. phenytoin bears us nlm identifiers umls id c0031507 and nci concept code c741. smiles: o=c1nc(=o)nc1(c1ccccc1)c1ccccc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ethosuximide. this classification denotes an anticonvulsant agent with the molecular formula c7h11no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5seh9x1d1d, chemically known as 2,5-pyrrolidinedione, 3-ethyl-3-methyl- but generally known as ethosuximide, which bears us nih compound identifier 3291. european medicines agency schedules ethosuximide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07282mig. the term ethosuximide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules ethosuximide in its anatomical therapeutic chemical (atc) classification. ethosuximide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ethosuximide under hs 29251995 and sitc 51482. as of q4 2014, ethosuximide remains the us fda preferred term for this commodity. ethosuximide bears us nlm identifiers umls id c0015043 and nci concept code c47523. smiles: o=c1nc(=o)cc1(cc)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. vigabatrin. this classification denotes an anticonvulsant agent with the molecular formula c6h11no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gr120krt6k, chemically known as 5-hexenoic acid, 4-amino- but generally known as vigabatrin, which bears us nih compound identifier 5665. european medicines agency schedules vigabatrin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00048mig. the term vigabatrin is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules vigabatrin in its anatomical therapeutic chemical (atc) classification. vigabatrin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vigabatrin under hs 29224995 and sitc 51465. as of q4 2014, vigabatrin remains the us fda preferred term for this commodity. vigabatrin bears us nlm identifiers umls id c0048044 and nci concept code c87611. smiles: oc(=o)ccc(n)c=c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. carbamazepine. this classification denotes an anticonvulsant agent with the molecular formula c15h12n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 33cm23913m, chemically known as 5h-dibenz(b,f)azepine-5-carboxamide but generally known as carbamazepine, which bears us nih compound identifier 2554. carbamazepine most often comes in base, dihydrate, epoxide, and glucuronide forms. european medicines agency schedules carbamazepine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06113mig. the term carbamazepine is an international non-proprietary name. world health organization schedules carbamazepine in its anatomical therapeutic chemical (atc) classification. carbamazepine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carbamazepine under hs 29339930 and sitc 51577. as of q4 2014, carbamazepine remains the us fda preferred term for this commodity. carbamazepine bears us nlm identifiers umls id c0006949 and nci concept code c341. smiles: o=c(n1c2c(c=cc3c1cccc3)cccc2)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. zonisamide. this classification denotes an anticonvulsant agent with the molecular formula c8h8n2o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 459384h98v, chemically known as 1,2-benzisoxazole-3-methanesulfonamide but generally known as zonisamide, which bears us nih compound identifier 5734. european medicines agency schedules zonisamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00187mig. the term zonisamide is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). world health organization schedules zonisamide in its anatomical therapeutic chemical (atc) classification. zonisamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zonisamide under hs 29350090 and sitc 51580. as of q4 2014, zonisamide remains the us fda preferred term for this commodity. zonisamide bears us nlm identifiers umls id c0078844 and nci concept code c47790. smiles: s(=o)(=o)(n)cc1noc2c1cccc2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ethotoin. this classification denotes an anticonvulsant agent with the molecular formula c11h12n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 46qg38nc4u, chemically known as 2,4-imidazolidinedione, 3-ethyl-5-phenyl- but generally known as ethotoin, which bears us nih compound identifier 3292. european medicines agency schedules ethotoin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07283mig. the term ethotoin is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules ethotoin in its anatomical therapeutic chemical (atc) classification. ethotoin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ethotoin under hs 29332100 and sitc 51572. as of q4 2014, ethotoin remains the us fda preferred term for this commodity. ethotoin bears us nlm identifiers umls id c0015046 and nci concept code c47524. smiles: ccn1c(=o)c(nc1=o)c2=cc=cc=c2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. fosphenytoin. this classification denotes an anticonvulsant agent with the molecular formula c16h13n2o6p.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7vlr55452z, chemically known as 2,4-imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, disodium salt but generally known as fosphenytoin sodium, which bears us nih compound identifier 56338. european medicines agency schedules fosphenytoin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13919mig. most nations schedule fosphenytoin under hs 29332100 and sitc 51572. as of q4 2014, fosphenytoin remains the us fda preferred term for this commodity. fosphenytoin bears us nlm identifiers umls id c0244656 and nci concept code c65766. smiles: p(=o)(ocn1c(=o)c(nc1=o)(c1ccccc1)c1ccccc1)(o)o.[na].[na].. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. levetiracetam. this classification denotes a neuroprotective agent and anticonvulsant agent with the molecular formula c8h14n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 44yrr34555, chemically known as 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-, (s)- but generally known as levetiracetam, which bears us nih compound identifier 59708. european medicines agency schedules levetiracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08459mig. the term levetiracetam is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules levetiracetam in its anatomical therapeutic chemical (atc) classification. most nations schedule levetiracetam under hs 29337900 and sitc 51561. as of q4 2014, levetiracetam remains the us fda preferred term for this commodity. levetiracetam bears us nlm identifiers umls id c0377265 and nci concept code c47581. smiles: o=c1n(ccc1)c(cc)c(=o)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. mephenytoin. this classification denotes an anticonvulsant agent with the molecular formula c12h14n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r420kw629u, chemically known as 2,4-imidazolidinedione, 5-ethyl-3-methyl-5-phenyl- but generally known as mephenytoin, which bears us nih compound identifier 4060. european medicines agency schedules mephenytoin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08749mig. the term mephenytoin is an international non-proprietary name or inn (see who inn reference publication, volume 16, no. 3 1962, list 4). world health organization schedules mephenytoin in its anatomical therapeutic chemical (atc) classification. mephenytoin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mephenytoin under hs 29332100 and sitc 51572. as of q4 2014, mephenytoin remains the us fda preferred term for this commodity. mephenytoin bears us nlm identifiers umls id c0025381 and nci concept code c66091. smiles: ccc1(c(=o)n(c(=o)n1)c)c2=cc=cc=c2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. mephobarbital or methylphenobarbital. this classification denotes a barbiturate with the molecular formula c13h14n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5nc67nu76b, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-1-methyl-5-phenyl- but generally known as mephobarbital, which bears us nih compound identifier 8271. european medicines agency schedules mephobarbital in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08871mig. the term mephobarbital is an international non-proprietary name. world health organization schedules mephobarbital in its anatomical therapeutic chemical (atc) classification. mephobarbital or methylphenobarbital bears us nlm identifiers umls id c0025382 and nci concept code c76528. smiles: o=c1n(c(=o)nc(=o)c1(cc)c1ccccc1)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. mesuximide or methsuximide. this classification denotes an anticonvulsant agent with the molecular formula c12h13no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 0g76k8x6c0, chemically known as 2,5-pyrrolidinedione,1,3-dimethyl-3-phenyl- but more generally known as mesuximide, which bears us nih compound identifier 6476. european medicines agency schedules mesuximide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08797mig. the term mesuximide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules mesuximide in its anatomical therapeutic chemical (atc) classification. methsuximide bears us nlm identifiers umls id c0109002 and nci concept code c47613. mesuximide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc1(cc(=o)n(c1=o)c)c2=cc=cc=c2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. oxcarbazepine. this classification denotes an anticonvulsant agent with the molecular formula c15h12n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vzi5b1w380, chemically known as 10,11-dihydro-10-oxo-5h-dibenz(b,f)azepine-5-carboxamide but generally known as oxcarbazepine, which bears us nih compound identifier 34312. european medicines agency schedules oxcarbazepine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09510mig. the term oxcarbazepine is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules oxcarbazepine in its anatomical therapeutic chemical (atc) classification. oxcarbazepine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxcarbazepine under hs 29339930 and sitc 51577. as of q4 2014, oxcarbazepine remains the us fda preferred term for this commodity. oxcarbazepine bears us nlm identifiers umls id c0876196 and nci concept code c47643. smiles: o=c1cc2c(n(c3c1cccc3)c(=o)n)cccc2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. paramethadione. this classification denotes an anticonvulsant agent with the molecular formula c7h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z615frw64n, chemically known as 3,5-dimethyl-5-ethyloxazolidine-2,4-dione but generally known as paramethadione, which bears us nih compound identifier 8280. european medicines agency schedules paramethadione in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09613mig. the term paramethadione is an international non-proprietary name. world health organization schedules paramethadione in its anatomical therapeutic chemical (atc) classification. paramethadione is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule paramethadione under hs 29349990 and sitc 51579. as of q4 2014, paramethadione remains the us fda preferred term for this commodity. paramethadione bears us nlm identifiers umls id c0070072 and nci concept code c66308. smiles: o1c(cc)(c(=o)n(c1=o)c)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. phenacemide. this classification denotes an anticonvulsant agent with the molecular formula c9h10n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pai7j52v09, chemically known as urea, (phenylacetyl)- but generally known as phenacemide, which bears us nih compound identifier 4753. european medicines agency schedules phenacemide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09744mig. the term phenacemide is an international non-proprietary name. world health organization schedules phenacemide in its anatomical therapeutic chemical (atc) classification. phenacemide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phenacemide under hs 29242995 and sitc 51479. as of q4 2014, phenacemide remains the us fda preferred term for this commodity. phenacemide bears us nlm identifiers umls id c0070525 and nci concept code c66363. smiles: o=c(nc(=o)n)cc1ccccc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. primidone. this classification denotes a barbiturate and anticonvulsant agent with the molecular formula c12h14n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 13afd7670q, chemically known as 4,6(1h,5h)-pyrimidinedione, 5-ethyldihydro-5-phenyl- but generally known as primidone, which bears us nih compound identifier 4909. european medicines agency schedules primidone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10045mig. the term primidone is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules primidone in its anatomical therapeutic chemical (atc) classification. primidone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule primidone under hs 29337900 and sitc 51561. as of q4 2014, primidone remains the us fda preferred term for this commodity. primidone bears us nlm identifiers umls id c0033148 and nci concept code c47686. smiles: ccc1(c(=o)ncnc1=o)c2=cc=cc=c2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. topiramate. this classification denotes an anticonvulsant agent with the molecular formula c12h21no8s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0h73wjj391, chemically known as 2,3:4,5-bis-o-isopropylidene-.beta.-d-fructopyranose sulfamate but generally known as topiramate, which bears us nih compound identifier 5514. european medicines agency schedules topiramate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11190mig. the term topiramate is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). world health organization schedules topiramate in its anatomical therapeutic chemical (atc) classification. topiramate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule topiramate under hs 29329970 and sitc 51569. as of q4 2014, topiramate remains the us fda preferred term for this commodity. topiramate bears us nlm identifiers umls id c0076829 and nci concept code c47764. smiles: s(=o)(=o)(occ12occ3oc(oc3c2oc(o1)(c)c)(c)c)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. trimethadione. this classification denotes an anticonvulsant agent with the molecular formula c6h9no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r7gv3h6fq4, chemically known as 3,5,5,-trimethyloxazolidine-2,4-dione but generally known as trimethadione, which bears us nih compound identifier 5576. european medicines agency schedules trimethadione in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11307mig. the term trimethadione is an international non-proprietary name. world health organization schedules trimethadione in its anatomical therapeutic chemical (atc) classification. trimethadione is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule trimethadione under hs 29349990 and sitc 51579. as of q4 2014, trimethadione remains the us fda preferred term for this commodity. trimethadione bears us nlm identifiers umls id c0041038 and nci concept code c47772. smiles: o1c(c(=o)n(c1=o)c)(c)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. valproic acid. this classification denotes an anticonvulsant agent with the molecular formula c8h16o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 614oi1z5wi, chemically known as 4-pentanoic acid, 2-propyl-, (s)- but generally known as valproic acid, which bears us nih compound identifier 3121. european medicines agency schedules valproic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00015mig. the term valproic acid is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules valproic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule valproic acid under hs 29159080 and sitc 51377. as of q4 2014, valproic acid remains the us fda preferred term for this commodity. valproic acid bears us nlm identifiers umls id c0042291 and nci concept code c29536. smiles: oc(=o)c(ccc)ccc.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. divalproex. this classification denotes an anticonvulsant agent with the molecular formula 2c8h15o2.h+.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 644vl95ao6, chemically known as pentanoic acid, 2-propyl-, sodium salt (2:1) but generally known as divalproex sodium, which bears us nih compound identifier 53519. european medicines agency schedules divalproex sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20309. the term valproate semisodium is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). smiles: cccc(ccc)c(=o)o.cccc(ccc)c(=o)[o-].[na+].. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. cabergoline. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula c26h37n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ll60k9j05t, chemically known as ergoline-8-carboxamide, n-(3-(dimethylamino)propyl)-n-((ethylamino)carbonyl)-6-(2-propenyl)-, (8-beta)- but generally known as cabergoline, which bears us nih compound identifier 54746. cabergoline most often comes in base and diphosphate forms. european medicines agency schedules cabergoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06041mig. the term cabergoline is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). world health organization schedules cabergoline in its anatomical therapeutic chemical (atc) classification. cabergoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule cabergoline under hs 29396900 and sitc 54146. as of q4 2014, cabergoline remains the us fda preferred term for this commodity. cabergoline bears us nlm identifiers umls id c0107994 and nci concept code c47428. smiles: o=c(n(cccn(c)c)c(=o)ncc)c1cc2c(n(c1)cc=c)cc1c3c2cccc3[nh]c1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. donepezil. this classification denotes an acetylcholinesterase inhibitor with the molecular formula c24h29no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8ssc91326p, chemically known as 1h-inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)- but generally known as donepezil, which bears us nih compound identifier 3152. european medicines agency schedules donepezil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06362mig. the term donepezil is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 11997, list 37). world health organization schedules donepezil in its anatomical therapeutic chemical (atc) classification. donepezil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule donepezil under hs 29333999 and sitc 51574. as of q4 2014, donepezil remains the us fda preferred term for this commodity. donepezil bears us nlm identifiers umls id c0527316 and nci concept code c66874. smiles: o=c1c(cc2ccn(cc2)cc2ccccc2)cc2c1cc(oc)c(oc)c2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. decimemide. this classification denotes an anticonvulsant agent with the molecular formula c19h31no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gaf9gj18j5, chemically known as 4-n-decyloxy-3,5-dimethoxybenzoic acid amide but generally known as decimemide, which bears us nih compound identifier 26929. european medicines agency schedules decimemide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06931mig. the term decimemide is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). decimemide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule decimemide under hs 29242995 and sitc 51479. as of q4 2014, decimemide remains the us fda preferred term for this commodity. decimemide bears us nlm identifiers umls id c2699569 and nci concept code c75162. smiles: o(cccccccccc)c1c(oc)cc(cc1oc)c(=o)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. albutoin. this classification denotes an anticonvulsant agent with the molecular formula c10h16n2os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 475ngr2dc1, chemically known as 4-imidazolidinone, 5-(2-methylpropyl)-3-(2-propenyl)-2-thioxo- but generally known as albutoin, which bears us nih compound identifier 3032361. european medicines agency schedules albutoin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05298mig. the term albutoin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). albutoin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule albutoin under hs 29332990 and sitc 51573. as of q4 2014, albutoin remains the us fda preferred term for this commodity. albutoin bears us nlm identifiers umls id c0051108 and nci concept code c90706. smiles: cc(c)cc1c(=o)n(c(=s)n1)cc=c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ameltolide. this classification denotes an anticonvulsant agent with the molecular formula c15h16n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f83240zove, chemically known as 4-amino-n-(2,6-dimethylphenyl)benzamide but generally known as ameltolide, which bears us nih compound identifier 13086. european medicines agency schedules ameltolide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05408mig. the term ameltolide is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). ameltolide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ameltolide under hs 29242995 and sitc 51479. as of q4 2014, ameltolide remains the us fda preferred term for this commodity. ameltolide bears us nlm identifiers umls id c0065310 and nci concept code c81472. smiles: o=c(nc1c(cccc1c)c)c1ccc(n)cc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. aminobutyric acid. this classification denotes a neurotransmitter, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2acz6ipc6i. european medicines agency schedules gamma-aminobutyric acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13946mig. gamma-aminobutyric acid generally arises in the molecular formula c4h9no2. the term gamma-aminobutyric acid is an international nomenclature of cosmetic ingredients designation. smiles: oc(=o)cccn.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. atolide. this classification denotes an anticonvulsant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier obn5i4b08w. european medicines agency schedules atolide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05599mig. atolide generally arises in the molecular formula c18h23n3o. the term atolide is an international non-proprietary name or inn (see who inn reference publication, volume 22, no. 10, 1968, list 8.) atolide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule atolide under hs 29242995 and sitc 51479. as of q4 2014, atolide remains the us fda preferred term for this commodity. atolide bears us nlm identifiers umls id c2698194 and nci concept code c77997. smiles: o=c(nc1c(cc(n(cc)cc)cc1)c)c1c(n)cccc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. beclamide. this classification denotes an anticonvulsant agent with the molecular formula c10h12clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f5n0ali65v, chemically known as propionamide, n-benzyl-3-chloro- but generally known as beclamide, which bears us nih compound identifier 10391. european medicines agency schedules beclamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05675mig. the term beclamide is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). world health organization schedules beclamide in its anatomical therapeutic chemical (atc) classification. beclamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule beclamide under hs 29242995 and sitc 51479. as of q4 2014, beclamide remains the us fda preferred term for this commodity. beclamide bears us nlm identifiers umls id c0053067 and nci concept code c75160. smiles: c1=cc=c(c=c1)cnc(=o)cccl.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. carisbamate. this classification denotes an anticonvulsant agent with the molecular formula c9h10clno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p7725i9v3z. the term carisbamate is an international non-proprietary name or inn (see who inn reference publication, volume 21, no. 3, 2007, list 58. ). as of q4 2014, carisbamate remains the us fda preferred term for this commodity. carisbamate bears us nlm identifiers umls id c1871983 and nci concept code c75161. smiles: c1=cc=c(c(=c1)c(coc(=o)n)o)cl. .. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ciprazafone. this classification denotes an anticonvulsant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8rsd11181g. european medicines agency schedules ciprazafone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07466mig. ciprazafone generally arises in the molecular formula c19h18cl2n2o2. the term ciprazafone is an international non-proprietary name or inn. ciprazafone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ciprazafone under hs 29242995 and sitc 51479. as of q4 2014, ciprazafone remains the us fda preferred term for this commodity. ciprazafone bears us nlm identifiers umls id c2699233 and nci concept code c78000. smiles: clc1cc(c(n(c(=o)cnc2cc2)c)cc1)c(=o)c1c(cl)cccc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ethylphenacemide or pheneturide. this classification denotes an anticonvulsant agent with the molecular formula c11h14n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 878cej4hgx, chemically known as urea, (2-phenylbutyryl)- but generally known as ethylphenacemide, which bears us nih compound identifier 72060. european medicines agency schedules pheneturide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09760mig. the term pheneturide is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules ethylphenacemide in its anatomical therapeutic chemical (atc) classification. ethylphenacemide or pheneturide bears us nlm identifiers umls id c0059837 and nci concept code c72826. smiles: ccc(c1=cc=cc=c1)c(=o)nc(=o)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. denzimol. this classification denotes an anticonvulsant agent with the molecular formula c19h20n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9c78o7jath, chemically known as 1h-imidazole-1-ethanol, alpha-(4-(2-phenylethyl)phenyl)- but generally known as denzimol, which bears us nih compound identifier 53626. european medicines agency schedules denzimol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06980mig. the term denzimol is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). denzimol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule denzimol under hs 29332990 and sitc 51573. as of q4 2014, denzimol remains the us fda preferred term for this commodity. denzimol bears us nlm identifiers umls id c0057398 and nci concept code c78001. smiles: oc(c1ccc(ccc2ccccc2)cc1)cn1ccnc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. dinazafone. this classification denotes an anticonvulsant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 411og24qou. european medicines agency schedules dinazafone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07191mig. dinazafone generally arises in the molecular formula c20h21cln2o2. the term dinazafone is an international non-proprietary name or inn. dinazafone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dinazafone under hs 29242995 and sitc 51479. as of q4 2014, dinazafone remains the us fda preferred term for this commodity. dinazafone bears us nlm identifiers umls id c1880337 and nci concept code c65411. smiles: clc1cc(c(n(c(=o)cncc(=c)c)c)cc1)c(=o)c1ccccc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. dulozafone. this classification denotes an anticonvulsant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bk2633656q. european medicines agency schedules dulozafone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06425mig. dulozafone generally arises in the molecular formula c20h22cl2n2o4. the term dulozafone is an international non-proprietary name or inn. dulozafone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dulozafone under hs 29242995 and sitc 51479. as of q4 2014, dulozafone remains the us fda preferred term for this commodity. dulozafone bears us nlm identifiers umls id c0642769 and nci concept code c65497. smiles: clc1cc(c(n(c(=o)cn(cco)cco)c)cc1)c(=o)c1c(cl)cccc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. eslicarbazepine. this classification denotes an anticonvulsant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier s5vxa428r4. european medicines agency schedules eslicarbazepine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub27751. eslicarbazepine generally arises in the molecular formula c15h14n2o2. the term eslicarbazepine is an international non-proprietary name or inn (see who inn reference publication, volume 19, no. 1, 2005, list 53.) most nations schedule eslicarbazepine under hs 29339930 and sitc 51577. as of q4 2014, eslicarbazepine remains the us fda preferred term for this commodity. eslicarbazepine bears us nlm identifiers umls id c2725260 and nci concept code c81473. smiles: c1ccc2c(c1)c[c@@h](c3ccccc3n2c(=o)n)o.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. eterobarb. this classification denotes a barbiturate with the molecular formula c16h20n2o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 432si047ga, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-ethyl-1,3-bis(methoxymethyl)-5-phenyl- but generally known as eterobarb, which bears us nih compound identifier 33925. european medicines agency schedules eterobarb in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07269mig. the term eterobarb is an international non-proprietary name. eterobarb is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eterobarb under hs 29335400 and sitc kg. as of q4 2014, eterobarb remains the us fda preferred term for this commodity. eterobarb bears us nlm identifiers umls id c0059686 and nci concept code c77629. smiles: o=c1n(c(=o)n(c(=o)c1(cc)c1ccccc1)coc)coc.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ethadione. this classification denotes an oxazole with the molecular formula c7h11no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i0f8o700bb, chemically known as 2,4-oxazolidinedione, 3-ethyl-5,5-dimethyl- (8ci)(9ci) but generally known as ethadione, which bears us nih compound identifier 10630. european medicines agency schedules ethadione in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13728mig. world health organization schedules ethadione in its anatomical therapeutic chemical (atc) classification. as of q4 2014, ethadione remains the us fda preferred term for this commodity. smiles: o1c(c(=o)n(cc)c1=o)(c)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. loreclezole. this classification denotes an anticonvulsant agent with the molecular formula c10h6cl3n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6dj32stz5w, chemically known as 1h-1,2,4-triazole, 1-(2-chloro-2-(2,4-dichlorophenyl)ethenyl)-, (z)- but generally known as loreclezole, which bears us nih compound identifier 3034012. european medicines agency schedules loreclezole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08586mig. the term loreclezole is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). loreclezole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule loreclezole under hs 29339990 and sitc 51577. as of q4 2014, loreclezole remains the us fda preferred term for this commodity. loreclezole bears us nlm identifiers umls id c0083257 and nci concept code c66036. smiles: c1=cc(=c(c=c1cl)cl)/c(=c/n2c=nc=n2)/cl.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. etiracetam. this classification denotes an anticonvulsant agent with the molecular formula c8h14n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 230447l0gl, chemically known as 1-pyrrolidineacetamide, alpha-ethyl-2-oxo-, (s)- but generally known as etiracetam, which bears us nih compound identifier 59708. european medicines agency schedules etiracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07308mig. the term etiracetam is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19). etiracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule etiracetam under hs 29337900 and sitc 51561. as of q4 2014, etiracetam remains the us fda preferred term for this commodity. etiracetam bears us nlm identifiers umls id c0059859 and nci concept code c78002. smiles: o=c1n(ccc1)c(cc)c(=o)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ezogabine or retigabine. this classification denotes an anticonvulsant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 12g01i6bbu. european medicines agency schedules retigabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10291mig. ezogabine generally arises in the molecular formula c16h18fn3o2. the term ezogabine is a european medicines agency european public assessment report system designation. ezogabine or retigabine bears us nlm identifiers umls id c0530684 and nci concept code c72839. smiles: fc1ccc(cnc2cc(n)c(nc(=o)occ)cc2)cc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ilepcimide. this classification denotes an anticonvulsant agent with the molecular formula c15h17no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5ml58o200f, chemically known as 1-(3-(1,3-benzodioxol-5-yl)-1-oxo-2-propenyl)piperidine but generally known as ilepcimide, which bears us nih compound identifier 54930. european medicines agency schedules ilepcimide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08130mig. the term ilepcimide is an international non-proprietary name. ilepcimide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ilepcimide under hs 29349990 and sitc 51579. as of q4 2014, ilepcimide remains the us fda preferred term for this commodity. ilepcimide bears us nlm identifiers umls id c0284581 and nci concept code c72810. smiles: o=c(n1ccccc1)/c=c/c1cc2ococ2cc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. lacosamide. this classification denotes an anticonvulsant agent with the molecular formula c13h18n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 563ks2pqy5, chemically known as 2-(acetylamino)-3-methoxy-n-(phenylmethyl)propanamide, (2r)- but generally known as lacosamide, which bears us nih compound identifier 219078. european medicines agency schedules lacosamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25407. the term lacosamide is an international non-proprietary name or inn (see who inn reference publication, volume 18, no. 3, 2004, list 52). world health organization schedules lacosamide in its anatomical therapeutic chemical (atc) classification. most nations schedule lacosamide under hs 29242995 and sitc 51479. as of q4 2014, lacosamide remains the us fda preferred term for this commodity. lacosamide bears us nlm identifiers umls id c1311230 and nci concept code c83859. smiles: o(cc(nc(=o)c)c(=o)ncc1ccccc1)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. nonapyrimine. this classification denotes an anticonvulsant agent with the molecular formula c15h24n4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 322d5y3q0g, chemically known as 7h-pyrrolo(2,3-d)pyrimidine, 4-(nonylamino)- but generally known as nonapyrimine, which bears us nih compound identifier 3047795. european medicines agency schedules nonapyrimine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09350mig. the term nonapyrimine is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). nonapyrimine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nonapyrimine under hs 29335995 and sitc 51576. as of q4 2014, nonapyrimine remains the us fda preferred term for this commodity. nonapyrimine bears us nlm identifiers umls id c2698489 and nci concept code c75164. smiles: n(ccccccccc)c1ncnc2[nh]ccc12.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. losigamone. this classification denotes an anticonvulsant agent with the molecular formula c12h11clo4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 84r8o3qm2g, chemically known as 2(5h)-furanone, 5-((2-chlorophenyl)hydroxymethyl)-4-methoxy-, (r*,s*)- but generally known as losigamone, which bears us nih compound identifier 60572. european medicines agency schedules losigamone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08594mig. the term losigamone is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). losigamone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, losigamone remains the us fda preferred term for this commodity. losigamone bears us nlm identifiers umls id c0083259 and nci concept code c90707. smiles: coc1=cc(=o)oc1c(c2=cc=cc=c2cl)o.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. epsom salt or magnesium sulfate. this classification denotes an industrial aid, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier de08037sab. european medicines agency schedules magnesium sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14448mig. magnesium sulfate generally arises in the molecular formula mgo4s. the term magnesium sulfate is a u.s. pharmacopeial convention designation. epsom salt or magnesium sulfate bears us nlm identifiers umls id c0024480 and nci concept code c623. smiles: [o-]s(=o)(=o)[o-].[mg+2].. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. milacemide. this classification denotes an anticonvulsant agent with the molecular formula c7h16n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0hxt24recu, chemically known as acetamide, 2-(pentylamino)- but generally known as milacemide, which bears us nih compound identifier 53569. european medicines agency schedules milacemide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08960mig. the term milacemide is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). milacemide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule milacemide under hs 29241900 and sitc 51471. as of q4 2014, milacemide remains the us fda preferred term for this commodity. milacemide bears us nlm identifiers umls id c0066545 and nci concept code c81467. smiles: o=c(n)cnccccc.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. morsuximide. this classification denotes an anticonvulsant agent with the molecular formula c16h20n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 57g776p4ej, chemically known as 2,5-pyrrolidinedione, 3-methyl-1-(4-morpholinylmethyl)-3-phenyl- (9ci) but generally known as morsuximide, which bears us nih compound identifier 71165. european medicines agency schedules morsuximide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09072mig. the term morsuximide is an international non-proprietary name or inn (see who inn reference publication, volume 26, no. 10 1972, list 12). morsuximide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule morsuximide under hs 29349990 and sitc 51579. as of q4 2014, morsuximide remains the us fda preferred term for this commodity. morsuximide bears us nlm identifiers umls id c1881904 and nci concept code c66202. smiles: o1ccn(cn2c(=o)c(cc2=o)(c2ccccc2)c)cc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. nafimidone. this classification denotes an anticonvulsant agent with the molecular formula c15h12n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hzu3iq1eww, chemically known as 2-imidazol-1-yl-1-naphthalen-2-ylethanone but generally known as nafimidone, which bears us nih compound identifier 51200. european medicines agency schedules nafimidone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09122mig. the term nafimidone is an international non-proprietary name or inn. most nations schedule nafimidone under hs 29332990 and sitc 51573. as of q4 2014, nafimidone remains the us fda preferred term for this commodity. smiles: c1=cc=c2c=c(c=cc2=c1)c(=o)cn3c=cn=c3.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. riluzole. this classification denotes an anticonvulsant agent with the molecular formula c8h5f3n2os, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7lj087rs6f, chemically known as 2-benzothiazolamine, 6-(trifluoromethoxy)- but generally known as riluzole, which bears us nih compound identifier 5070. european medicines agency schedules riluzole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10319mig. the term riluzole is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules riluzole in its anatomical therapeutic chemical (atc) classification. riluzole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule riluzole under hs 29341000 and sitc 51579. as of q4 2014, riluzole remains the us fda preferred term for this commodity. riluzole bears us nlm identifiers umls id c0073379 and nci concept code c47704. smiles: s1c2c(nc1n)ccc(oc(f)(f)f)c2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. phensuximide. this classification denotes an anticonvulsant agent with the molecular formula c11h11no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6wvl9c355g, chemically known as 2,5-pyrrolidinedione, 1-methyl-3-phenyl- but generally known as phensuximide, which bears us nih compound identifier 6839. european medicines agency schedules phensuximide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09783mig. the term phensuximide is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules phensuximide in its anatomical therapeutic chemical (atc) classification. phensuximide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phensuximide under hs 29251995 and sitc 51482. as of q4 2014, phensuximide remains the us fda preferred term for this commodity. phensuximide bears us nlm identifiers umls id c0070592 and nci concept code c66375. smiles: cn1c(=o)cc(c1=o)c2=cc=cc=c2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. pivagabine. this classification denotes an anticonvulsant agent with the molecular formula c9h17no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c53sv0wo4v, chemically known as 4-((2,2-dimethylpropionyl)amino)butyric acid but generally known as pivagabine, which bears us nih compound identifier 68888. european medicines agency schedules pivagabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09948mig. the term pivagabine is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules pivagabine in its anatomical therapeutic chemical (atc) classification. pivagabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pivagabine under hs 29241900 and sitc 51471. as of q4 2014, pivagabine remains the us fda preferred term for this commodity. pivagabine bears us nlm identifiers umls id c0619323 and nci concept code c66440. smiles: o=c(ncccc(=o)o)c(c)(c)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. potassium bromide. this classification denotes an industrial aid with the molecular formula br.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier osd78555zm. european medicines agency schedules potassium bromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14970mig. the term potassium bromide is a u.s. pharmacopeial convention designation. most nations schedule potassium bromide under hs 28275100 and sitc 52329. as of q4 2014, potassium bromide remains the us fda preferred term for this commodity. potassium bromide bears us nlm identifiers umls id c0071754 and nci concept code c76725. smiles: [k+].[br-].. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. progabide. this classification denotes an anticonvulsant, antidepressive agent, antiparkinson agent, and gaba agonist with the molecular formula c17h16clfn2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 38c836j57z, chemically known as butyramide, 4-(alpha-(p-chlorophenyl)-5-fluoro-2-hydroxybenzylideneamino)- but generally known as progabide, which bears us nih compound identifier 5361323. european medicines agency schedules progabide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10075mig. world health organization schedules progabide in its anatomical therapeutic chemical (atc) classification. progabide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule progabide under hs 29242995 and sitc 51479. as of q4 2014, progabide remains the us fda preferred term for this commodity. smiles: clc1ccc(c(=c2\\c=c(f)c=cc2=o)\\ncccc(=o)n)cc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ralitoline. this classification denotes an anticonvulsant agent with the molecular formula c13h13cln2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q4mw9rm93a, chemically known as (z)-6-chloro-3-methyl-4-oxo-delta(sup 2,alpha)-thiazolidineaceto-o-toludide but generally known as ralitoline, which bears us nih compound identifier 6436118. european medicines agency schedules ralitoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10242mig. the term ralitoline is an international non-proprietary name. ralitoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ralitoline under hs 29341000 and sitc 51579. as of q4 2014, ralitoline remains the us fda preferred term for this commodity. ralitoline bears us nlm identifiers umls id c0072968 and nci concept code c75165. smiles: clc1c(nc(=o)/c=c2\\scc(=o)n2c)c(ccc1)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. valproate pivoxil. this classification denotes an anticonvulsant agent with the molecular formula c14h26o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9f5a05a29t, chemically known as hydroxymethyl 2-propylvalerate, pivalate but generally known as valproate pivoxil, which bears us nih compound identifier 71160. european medicines agency schedules valproate pivoxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00013mig. the term valproate pivoxil is an international non-proprietary name. most nations schedule valproate pivoxil under hs 29159080 and sitc 51377. as of q4 2014, valproate pivoxil remains the us fda preferred term for this commodity. valproate pivoxil bears us nlm identifiers umls id c2349103 and nci concept code c72875. smiles: o(c(=o)c(ccc)ccc)coc(=o)c(c)(c)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. ropizine. this classification denotes an anticonvulsant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q5128gw9d4. european medicines agency schedules ropizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10383mig. ropizine generally arises in the molecular formula c24h26n4. the term ropizine is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40.) ropizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ropizine under hs 29335995 and sitc 51576. as of q4 2014, ropizine remains the us fda preferred term for this commodity. ropizine bears us nlm identifiers umls id c0073572 and nci concept code c75166. smiles: n1(c(c2ccccc2)c2ccccc2)ccn(/n=c/c2nc(ccc2)c)cc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. rufinamide. this classification denotes an anticonvulsant agent with the molecular formula c10h8f2n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wfw942pr79, chemically known as 1h-1,2,3-triazole-4-carboxamide, 1-((2,6-difluorophenyl)methyl)- but generally known as rufinamide, which bears us nih compound identifier 129228. european medicines agency schedules rufinamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10403mig. the term rufinamide is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules rufinamide in its anatomical therapeutic chemical (atc) classification. rufinamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rufinamide under hs 29339990 and sitc 51577. as of q4 2014, rufinamide remains the us fda preferred term for this commodity. rufinamide bears us nlm identifiers umls id c0213404 and nci concept code c75167. smiles: c1=cc(=c(c(=c1)f)cn2c=c(n=n2)c(=o)n)f.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. stiripentol. this classification denotes an anticonvulsant with the molecular formula c14h18o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r02xot8v8i, chemically known as 4,4-dimethyl-1-((3,4-methylenedioxy)phenyl)-1-penten-3-ol but generally known as stiripentol, which bears us nih compound identifier 5311454. european medicines agency schedules stiripentol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10654mig. world health organization schedules stiripentol in its anatomical therapeutic chemical (atc) classification. stiripentol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule stiripentol under hs 29329970 and sitc 51569. as of q4 2014, stiripentol remains the us fda preferred term for this commodity. smiles: oc(c(c)(c)c)/c=c/c1cc2ococ2cc1.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. sultiame. this classification denotes an anticonvulsant and thiazine with the molecular formula c10h14n2o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i00q766cz2, chemically known as 2-(p-sulfamoylphenyl)-tetrahydro-2h-1,2-thiazine 1,1-dioxide but generally known as sultiame, which bears us nih compound identifier 5356. european medicines agency schedules sultiame in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10762mig. world health organization schedules sultiame in its anatomical therapeutic chemical (atc) classification. sultiame is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sultiame under hs 29350090 and sitc 51580. smiles: c1ccs(=o)(=o)n(c1)c2=cc=c(c=c2)s(=o)(=o)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. taltrimide. this classification denotes an anticonvulsant agent with the molecular formula c13h16n2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nq74u9qr5d, chemically known as 2h-isoindole-2-ethanesulfonamide, 1,3-dihydro-n-(1-methylethyl)-1,3-dioxo- but generally known as taltrimide, which bears us nih compound identifier 71248. european medicines agency schedules taltrimide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10817mig. the term taltrimide is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). taltrimide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule taltrimide under hs 29350090 and sitc 51580. as of q4 2014, taltrimide remains the us fda preferred term for this commodity. taltrimide bears us nlm identifiers umls id c0075788 and nci concept code c72857. smiles: s(=o)(=o)(nc(c)c)ccn1c(=o)c2c(c1=o)cccc2.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. tiagabine. this classification denotes an anticonvulsant agent with the molecular formula c20h25no2s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z80i64hmnp, chemically known as 3-piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, (r)- but generally known as tiagabine, which bears us nih compound identifier 60648. european medicines agency schedules tiagabine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11000mig. the term tiagabine is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). world health organization schedules tiagabine in its anatomical therapeutic chemical (atc) classification. tiagabine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tiagabine under hs 29349990 and sitc 51579. as of q4 2014, tiagabine remains the us fda preferred term for this commodity. tiagabine bears us nlm identifiers umls id c0068897 and nci concept code c66602. smiles: s1c(/c(=c/ccn2cc(ccc2)c(=o)o)c2sccc2c)c(cc1)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. tolgabide. this classification denotes an anticonvulsant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0l55qf645f. european medicines agency schedules tolgabide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11156mig. tolgabide generally arises in the molecular formula c18h18cl2n2o2. the term tolgabide is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25.) tolgabide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tolgabide under hs 29252900 and sitc 51482. as of q4 2014, tolgabide remains the us fda preferred term for this commodity. tolgabide bears us nlm identifiers umls id c2348800 and nci concept code c72871. smiles: clc1=cc(=c(\\ncccc(=o)n)c2ccc(cl)cc2)\\c(=o)c(=c1)c.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. valpromide. this classification denotes an anticonvulsant and valproic acid analog with the molecular formula c8h17no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rua6cwu76g, chemically known as valeramide, 2-propyl- but generally known as valpromide, which bears us nih compound identifier 71113. european medicines agency schedules valpromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00016mig. world health organization schedules valpromide in its anatomical therapeutic chemical (atc) classification. valpromide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule valpromide under hs 29241900 and sitc 51471. as of q4 2014, valpromide remains the us fda preferred term for this commodity. smiles: o=c(n)c(ccc)ccc.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. vinpocetine. this classification denotes an anticonvulsant, antihypertensive agent, and calcium channel blocker with the molecular formula c22h26n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 543512obtc, chemically known as 3-alpha,16-alpha-apovincaminic acid ethyl ester but generally known as vinpocetine, which bears us nih compound identifier 5673. european medicines agency schedules vinpocetine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00070mig. world health organization schedules vinpocetine in its anatomical therapeutic chemical (atc) classification. vinpocetine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vinpocetine under hs 29399900 and sitc 54149. as of q4 2014, vinpocetine remains the us fda preferred term for this commodity. smiles: o(c(=o)c1=cc2(c3n(ccc2)ccc2c3n1c1c2cccc1)cc)cc.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. zoniclezole. this classification denotes an anticonvulsant agent with the molecular formula c12h10cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h1c5f0k79e, chemically known as 1,2-benzisoxazole, 5-chloro-3-(1-(1h-imidazol-1-yl)ethyl)- but generally known as zoniclezole, which bears us nih compound identifier 60745. european medicines agency schedules zoniclezole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00186mig. the term zoniclezole is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). zoniclezole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zoniclezole under hs 29349990 and sitc 51579. as of q4 2014, zoniclezole remains the us fda preferred term for this commodity. zoniclezole bears us nlm identifiers umls id c0656178 and nci concept code c82235. smiles: cc(c1=noc2=c1c=c(c=c2)cl)n3c=cn=c3.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. acetazolamide sodium. this classification denotes a diuretic and carbonic anhydrase inhibitor with the molecular formula c4h5n4o3s2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 429zt169uh, chemically known as 1,3,4-thiadiazole-2-sulfonamide, 5-acetamido- but more generally known as acetazolamide sodium, which bears us nih compound identifier 1986. the base compound, acetazolamide, also comes in forms adipate ethyl ester, methyl, and tri-methyl. european medicines agency schedules acetazolamide sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00251mig. most nations, for tariff and trade purposes, schedule acetazolamide sodium under hs 29350090 and sitc 51580. as of q4 2014, acetazolamide sodium remains us fdas preferred term for this commodity. acetazolamide sodium bears us nlm identifiers umls id c0304713 and nci concept code c61622. smiles: cc(=o)nc1nnc(s1)s(=o)(=o)[nh-].[na+].. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. cabergoline diphosphate. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula c26h37n5o2.2h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 477m7sa9n9, chemically known as ergoline-8-carboxamide, n-(3-(dimethylamino)propyl)-n-((ethylamino)carbonyl)-6-(2-propenyl)-, (8.beta.)-, phosphate (1:2), but more generally known as cabergoline diphosphate, which bears us nih compound identifier 83879. european medicines agency schedules cabergoline diphosphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06041mig. most nations, for tariff purposes, schedule cabergoline diphosphate under hs 29396900. smiles: ccnc(=o)n(cccn(c)c)c(=o)[c@@h]1c[c@@h]2c3cccc4c3c(c[nh]4)c[c@h]2n(c1)cc=c.op(=o)(o)o.op(=o)(o)o.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. carbamazepine dihydrate. this classification denotes an anticonvulsant agent with the molecular formula c15h12n2o.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 78m1rmw7q8, chemically known as 5h-dibenz(b,f)azepine-5-carboxamide, hydrate (1:2), but more generally known as carbamazepine dihydrate, which bears us nih compound identifier 158856. european medicines agency schedules carbamazepine dihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06113mig. most nations, for tariff purposes, schedule carbamazepine dihydrate under hs 29339930. smiles: c1ccc2c(c1)c=cc3ccccc3n2c(=o)n.o.o.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. donepezil hydrochloride. this classification denotes a cholinesterase inhibitor and nootropic agent with the molecular formula c24h29no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3o2t2pj89d, chemically known as 1h-inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-, hydrochloride but more generally known as donepezil hydrochloride, which bears us nih compound identifier 5741. european medicines agency schedules donepezil hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13647mig. most nations, for tariff and trade purposes, schedule donepezil hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, donepezil hydrochloride remains us fdas preferred term for this commodity. donepezil hydrochloride bears us nlm identifiers umls id c0771848 and nci concept code c2603. smiles: coc1cc2c(cc1oc)c(=o)c(c2)cc3ccn(cc3)cc4ccccc4.cl.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. donepezil oxalate. this classification denotes an acetylcholinesterase inhibitor c24h29no3.c2h2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier slf7m28si5, chemically known as 1h-inden-1-one, 2,3-dihydro-5,6-dimethoxyl-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-, ethanedoioate (1:1), but more generally known as donepezil oxalate, which bears us nih compound identifier 11397232. most nations, for tariff and trade purposes, schedule donepezil oxalate under hs 29333999 and sitc 51574. as of q4 2014, donepezil oxalate remains us fdas preferred term for this commodity. donepezil oxalate bears us nlm identifiers umls id c2828323 and nci concept code c87489. smiles: coc1cc2c(cc1oc)c(=o)c(c2)cc3ccn(cc3)cc4ccccc4.c(=o)(c(=o)o)o.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. eslicarbazepine acetate. this classification denotes an anticonvulsant agent c17h16n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bea68zvb2k, chemically known as (10s)-5-carbamoyl-10,11-dihydro-5h-dibenzo(b,f)azepin-10-yl acetate, but more generally known as eslicarbazepine acetate, which bears us nih compound identifier 179344. european medicines agency schedules eslicarbazepine acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub30424. most nations, for tariff and trade purposes, schedule eslicarbazepine acetate under hs 29339930 and sitc 51577. as of q4 2014, eslicarbazepine acetate remains us fdas preferred term for this commodity. eslicarbazepine acetate bears us nlm identifiers umls id c2725262 and nci concept code c83697. smiles: cc(=o)o[c@h]1cc2ccccc2n(c3c1cccc3)c(=o)n.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. fosphenytoin sodium. this classification denotes an anticonvulsant agent with the molecular formula c16h13n2o6p.2na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7vlr55452z, chemically known as 2,4-imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, disodium salt but more generally known as fosphenytoin sodium, which bears us nih compound identifier 56338. european medicines agency schedules fosphenytoin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13919mig. most nations, for tariff and trade purposes, schedule fosphenytoin sodium under hs 29332100 and sitc 51572. as of q4 2014, fosphenytoin sodium remains us fdas preferred term for this commodity. fosphenytoin sodium bears us nlm identifiers umls id c0284906 and nci concept code c47543. smiles: c1ccc(cc1)c2(c(=o)n(c(=o)n2)cop(=o)([o-])[o-])c3ccccc3.[na+].[na+].. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. milacemide hydrochloride. this classification denotes an anticonvulsant agent with the molecular formula c7h16n2o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6xk4g40f6w, chemically known as acetamide, 2-(pentylamino)-, monohydrochloride but more generally known as milacemide hydrochloride, which bears us nih compound identifier 53568. most nations, for tariff and trade purposes, schedule milacemide hydrochloride under hs 29241900 and sitc 51471. as of q4 2014, milacemide hydrochloride remains us fdas preferred term for this commodity. milacemide hydrochloride bears us nlm identifiers umls id c2825649 and nci concept code c81470. smiles: cccccncc(=o)n.cl.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. nafimidone hydrochloride. this classification denotes an anticonvulsant agent with the molecular formula c15h12n2o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lu0a7hd640, chemically known as 2-acetonaphthone, 2-(1-imidazolyl)-, hydrochloride but more generally known as nafimidone hydrochloride, which bears us nih compound identifier 51199. most nations, for tariff and trade purposes, schedule nafimidone hydrochloride under hs 29332990 and sitc 51573. as of q4 2014, nafimidone hydrochloride remains us fdas preferred term for this commodity. nafimidone hydrochloride bears us nlm identifiers umls id c2983843 and nci concept code c90708. smiles: c1ccc2cc(ccc2c1)c(=o)cn3ccnc3.cl.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. phenytoin sodium. this classification denotes a cation channel blocker and anticonvulsant agent with the molecular formula c15h11n2o2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4182431bjh, chemically known as 5,5-diphenylhydantoin sodium salt but more generally known as diphenylhydantoin sodium, which bears us nih compound identifier 12425. european medicines agency schedules phenytoin sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03787mig. most nations, for tariff and trade purposes, schedule phenytoin sodium under hs 29332100 and sitc 51572. as of q4 2014, phenytoin sodium remains us fdas preferred term for this commodity. phenytoin sodium bears us nlm identifiers umls id c0237417 and nci concept code c48011. smiles: c1ccc(cc1)c2(c(=o)[n-]c(=o)n2)c3ccccc3.[na+].. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. tiagabine hydrochloride. this classification denotes an anticonvulsant agent with the molecular formula c20h25no2s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier dqh6t6d8oy, chemically known as 3-piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-yl)-, hydrochloride, (r)- but more generally known as tiagabine hydrochloride, which bears us nih compound identifier 91274. european medicines agency schedules tiagabine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15566mig. most nations, for tariff and trade purposes, schedule tiagabine hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, tiagabine hydrochloride remains us fdas preferred term for this commodity. tiagabine hydrochloride bears us nlm identifiers umls id c0772200 and nci concept code c47755. smiles: cc1ccsc1c(=cccn2ccc[c@h](c2)c(=o)o)c3c(ccs3)c.cl.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. zoniclezole hydrochloride. this classification denotes an anticonvulsant agent with the molecular formula c12h10cln3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0vm256hnom, chemically known as 1,2-benzisoxazole, 5-chloro-3-(1-(1h-imidazol-1-yl)ethyl)- but more generally known as zoniclezole hydrochloride, which bears us nih compound identifier 60745. most nations, for tariff and trade purposes, schedule zoniclezole hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, zoniclezole hydrochloride remains us fdas preferred term for this commodity. zoniclezole hydrochloride bears us nlm identifiers umls id c0959127 and nci concept code c82236. smiles: cc(c1c2cc(ccc2on1)cl)n3ccnc3.cl.. "
"anticonvulsants. this classification denotes drugs used to prevent seizures or reduce their severity.. cannabidiol cbd. fda approved schedule v hemp or cannabis derivative. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. . "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. methyl butetisalicylate. this classification denotes an analgesic.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. metamizol or metamizole. this classification denotes an anti-inflammatory agents, non-steroidal, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier vsu62z74on. european medicines agency schedules metamizole sodium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08810mig. metamizole sodium generally arises in the molecular formula c13h16n3o4s.na. the term metamizole sodium is an international non-proprietary name or inn. smiles: cc1=c(c(=o)n(n1c)c2=cc=cc=c2)n(c)cs(=o)(=o)o.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. sodium thiosalicylate. this classification denotes a nonsteroidal antiinflammatory drug with the molecular formula c7h5o2s.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c2d9itw04b, chemically known as 2-mercapto-benzoic acid, monosodium salt but generally known as sodium thiosalicylate, which bears us nih compound identifier 8636. european medicines agency schedules sodium thiosalicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15331mig. as of q4 2014, sodium thiosalicylate remains the us fda preferred term for this commodity. sodium thiosalicylate bears us nlm identifiers umls id c0304347 and nci concept code c87326. smiles: sc1c(cccc1)c(=o)o.[na].. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. dehydrated alcohol injection. this classification denotes a fluid used to produce degeneration of nerve function (neurolysis) for control of chronic pain, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3k9958v90m. european medicines agency schedules alcohol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15995mig. dehydrated alcohol injection generally arises in the molecular formula c2h6o. the term dehydrated alcohol injection is an fda designation. smiles: cco.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. filantor or filenadol. this classification denotes an analgesic agent with the molecular formula c14h19no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yft8t83cf9, chemically known as 4-morpholineethanol, beta-1,3-benzodioxol-5-yl-alpha-methyl-, (r*,s*)-(+-)- but generally known as filenadol, which bears us nih compound identifier 71224. european medicines agency schedules filenadol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07626mig. the term filenadol is an international non-proprietary name. filenadol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. filantor or filenadol bears us nlm identifiers umls id c0381655 and nci concept code c65683. smiles: o1ccn(c(c(o)c)c2cc3ococ3cc2)cc1.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. acetaminosalol. this classification denotes an analgesic and antipyretic with the molecular formula c15h13no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o3j7h54kmd, chemically known as 2-hydroxybenzoic acid, 4-(acetylamino)phenyl-, ester but generally known as acetaminosalol, which bears us nih compound identifier 1984. european medicines agency schedules acetaminosalol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05217mig. the term acetaminosalol is an international non-proprietary name. acetaminosalol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acetaminosalol under hs 29242995 and sitc 51479. as of q4 2014, acetaminosalol remains the us fda preferred term for this commodity. acetaminosalol bears us nlm identifiers umls id c2346946 and nci concept code c72101. smiles: o(c1ccc(nc(=o)c)cc1)c(=o)c1c(o)cccc1.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. bicifadine. this classification denotes an analgesic agent with the molecular formula c12h15n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b0sv3n7j3h, chemically known as 3-azabicyclo(3.1.0)hexane, 1-(4-methylphenyl)-, (+-)- but generally known as bicifadine, which bears us nih compound identifier 47953. bicifadine most often comes in base and hydrochloride forms. european medicines agency schedules bicifadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05818mig. the term bicifadine is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 1, 2000, list 43). bicifadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bicifadine under hs 29339990 and sitc 51577. as of q4 2014, bicifadine remains the us fda preferred term for this commodity. bicifadine bears us nlm identifiers umls id c0053551 and nci concept code c79930. smiles: cc1=cc=c(c=c1)c23cc2cnc3.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. dibupyrone. this classification denotes an analgesic and antipyretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t99m8x4t54. european medicines agency schedules dibupyrone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07079mig. dibupyrone generally arises in the molecular formula c16h22n3o4s.na. the term dibupyrone is an international non-proprietary name or inn. dibupyrone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dibupyrone under hs 29331190 and sitc 51571. as of q4 2014, dibupyrone remains the us fda preferred term for this commodity. dibupyrone bears us nlm identifiers umls id c2699626 and nci concept code c77319. smiles: s(=o)(=o)(o)cn(cc(c)c)c1c(n(n(c1=o)c1ccccc1)c)c.[na].. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. dixyrazine. this classification denotes a non-narcotic analgesic, antiemetic, and antipsychotic agent with the molecular formula c24h33n3o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7h368w3ayc, chemically known as ethanol, 2-(2-(4-(2-methyl-3-phenothiazin-10-ylpropyl)-1-piperazinyl)ethoxy)- but generally known as dixyrazine, which bears us nih compound identifier 17182. european medicines agency schedules dixyrazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13640mig. world health organization schedules dixyrazine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, dixyrazine remains the us fda preferred term for this commodity. smiles: s1c2c(n(cc(cn3ccn(cc3)ccocco)c)c3c1cccc3)cccc2. .. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. dronabinol. this classification denotes an antiemetic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7j8897w37s. european medicines agency schedules dronabinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06407mig. dronabinol generally arises in the molecular formula c21h30o2. the term dronabinol is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24.) dronabinol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dronabinol under hs 29329985 and sitc 51569. as of q4 2014, dronabinol remains the us fda preferred term for this commodity. dronabinol bears us nlm identifiers umls id c0039663 and nci concept code c867. smiles: o1c(c2c(c3c1cc(cc3o)ccccc)c=c(cc2)c)(c)c.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. ethoheptazine. this classification denotes an opioid receptor agonist with the molecular formula c16h23no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3a4g3a848u, chemically known as 1h-azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester but generally known as ethoheptazine, which bears us nih compound identifier 6469. european medicines agency schedules ethoheptazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07280mig. most nations schedule ethoheptazine under hs 29339930 and sitc 51577. as of q4 2014, ethoheptazine remains the us fda preferred term for this commodity. ethoheptazine bears us nlm identifiers umls id c0059725 and nci concept code c76840. smiles: ccoc(=o)c1(cccn(cc1)c)c2=cc=cc=c2.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. flucarbril. this classification denotes an analgesic agent with the molecular formula c11h8f3no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5xjk6u3h0p, chemically known as carbostyril, n-methyl-6-(trifluoromethyl)- but generally known as flucarbril, which bears us nih compound identifier 16751. european medicines agency schedules flucarbril in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07668mig. the term flucarbril is an international non-proprietary name. flucarbril is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flucarbril under hs 29337900 and sitc 51561. as of q4 2014, flucarbril remains the us fda preferred term for this commodity. flucarbril bears us nlm identifiers umls id c2825603 and nci concept code c81382. smiles: cn1c2=c(c=cc1=o)c=c(c=c2)c(f)(f)f.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. flupirtine. this classification denotes an analgesic agent with the molecular formula c15h17fn4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier moh3et196h, chemically known as carbamic acid, (2-amino-6-(((4-fluorophenyl)methyl)amino)-3-pyridinyl)-, ethyl ester but generally known as flupirtine, which bears us nih compound identifier 53276. european medicines agency schedules flupirtine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07732mig. the term flupirtine is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules flupirtine in its anatomical therapeutic chemical (atc) classification. flupirtine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule flupirtine under hs 29333999 and sitc 51574. as of q4 2014, flupirtine remains the us fda preferred term for this commodity. flupirtine bears us nlm identifiers umls id c0060583 and nci concept code c72116. smiles: fc1ccc(cnc2nc(n)c(nc(=o)occ)cc2)cc1.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. phenacetin or phenacetinum. this classification denotes an organo-nitrogen carcinogen, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier er0cth01h9. european medicines agency schedules phenacetin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09745mig. phenacetin generally arises in the molecular formula c10h13no2. the term phenacetin is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3.) phenacetin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. phenacetin or phenacetinum bears us nlm identifiers umls id c0031364 and nci concept code c44432. smiles: ccoc1=cc=c(c=c1)nc(=o)c.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. phenicarbazide. this classification denotes an analgesic and antipyretic with the molecular formula c7h9n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1lr2578324, chemically known as 2-phenylhydrazide, carbamic acid but generally known as phenicarbazide, which bears us nih compound identifier 61002. european medicines agency schedules phenicarbazide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09763mig. the term phenicarbazide is an international non-proprietary name. phenicarbazide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phenicarbazide under hs 29280090 and sitc 51486. as of q4 2014, phenicarbazide remains the us fda preferred term for this commodity. phenicarbazide bears us nlm identifiers umls id c0770986 and nci concept code c72931. smiles: o=c(nnc1ccccc1)n.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. phenyl salicylate or salol. this classification denotes an analgesic and antipyretic with the molecular formula c13h10o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 28a37t47qo, chemically known as 2-hydroxybenzoic acid, phenyl ester but generally known as phenyl salicylate, which bears us nih compound identifier 8361. european medicines agency schedules phenyl salicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14839mig. world health organization schedules phenyl salicylate in its anatomical therapeutic chemical (atc) classification. smiles: c1=cc=c(c=c1)oc(=o)c2=cc=cc=c2o. smiles: c1=cc=c(c=c1)oc(=o)c2=cc=cc=c2o.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. pidolacetamol. this classification denotes an analgesic and antipyretic with the molecular formula c13h14n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 693sra99oh, chemically known as 5-oxo-l-proline, ester with 4-hydroxyacetanilide but generally known as pidolacetamol, which bears us nih compound identifier 65920. european medicines agency schedules pidolacetamol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09824mig. the term pidolacetamol is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). pidolacetamol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pidolacetamol under hs 29337900 and sitc 51561. as of q4 2014, pidolacetamol remains the us fda preferred term for this commodity. pidolacetamol bears us nlm identifiers umls id c2698807 and nci concept code c75080. smiles: o(c(=o)c1nc(=o)cc1)c1ccc(nc(=o)c)cc1.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. prednazate. this classification denotes an analgesic and antipyretic, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 71099p640p. european medicines agency schedules prednazate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10013mig. prednazate generally arises in the molecular formula c25h32o8.c21h26cln3os. the term prednazate is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7.) prednazate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule prednazate under hs 29372900 and sitc 54153. as of q4 2014, prednazate remains the us fda preferred term for this commodity. prednazate bears us nlm identifiers umls id c2826062 and nci concept code c82228. smiles: clc1cc2n(cccn3ccn(cc3)cco)c3c(sc2cc1)cccc3.oc1(c2(c(c3c(c(o)c2)c2(c(=cc(=o)c=c2)cc3)c)cc1)c)c(=o)coc(=o)ccc(=o)o.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. propacetamol. this classification denotes an analgesic and antipyretic with the molecular formula c14h20n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5chw4jmr82, chemically known as n,n-diethylglycine, ester with 4-hydroxyacetanilide but generally known as propacetamol, which bears us nih compound identifier 68865. european medicines agency schedules propacetamol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10093mig. the term propacetamol is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules propacetamol in its anatomical therapeutic chemical (atc) classification. propacetamol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule propacetamol under hs 29242995 and sitc 51479. as of q4 2014, propacetamol remains the us fda preferred term for this commodity. propacetamol bears us nlm identifiers umls id c0084186 and nci concept code c75081. smiles: o(c(=o)cn(cc)cc)c1ccc(nc(=o)c)cc1.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. xylazine. this classification denotes an alpha-adrenergic agonist with the molecular formula c12h16n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2kfg9tp5v8, chemically known as 5,6-dihydro-2-(2,6-xylidino)-4h-1,3-thiazine but generally known as xylazine, which bears us nih compound identifier 5707. european medicines agency schedules xylazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00120mig. the term xylazine is an international non-proprietary name. xylazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule xylazine under hs 29349990 and sitc 51579. as of q4 2014, xylazine remains the us fda preferred term for this commodity. xylazine bears us nlm identifiers umls id c0043366 and nci concept code c75049. smiles: cc1=c(c(=cc=c1)c)nc2=ncccs2.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. ziconotide. this classification denotes a nonnarcotic analgesic with the molecular formula c102h172n36o32s7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7i64c51o16, chemically known as omega-conotoxin m viia (reduced), cyclic (1-16),(8-20),(15-25)-tris(disulfide) but generally known as ziconotide, which bears us nih compound identifier 16129690. european medicines agency schedules ziconotide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00150mig. the term ziconotide is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules ziconotide in its anatomical therapeutic chemical (atc) classification. most nations schedule ziconotide under hs 29349990 and sitc 51579. as of q4 2014, ziconotide remains the us fda preferred term for this commodity. ziconotide bears us nlm identifiers umls id c0211011 and nci concept code c1475. smiles: cc1c(=o)nc(c(=o)nc2csscc3c(=o)nc(c(=o)nc(c(=o)ncc(=o)nc(c(=o)nc(csscc(c(=o)nc(csscc(c(=o)nc(c(=o)ncc(=o)nc(c(=o)ncc(=o)n1)ccccn)ccccn)n)c(=o)nc(c(=o)ncc(=o)nc(c(=o)n3)co)c(c)o)nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc(=o)c(nc2=o)co)cccnc(=n)n)cc(c)c)ccsc.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. nicoboxil. this classification denotes an analgesic agent with the molecular formula c12h17no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier gsd5b9us0w, chemically known as 3-pyridinecarboxylic acid, butoxyethyl ester but generally known as nicoboxil, which bears us nih compound identifier 14866. european medicines agency schedules nicoboxil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09231mig. the term nicoboxil is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). nicoboxil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nicoboxil under hs 29333999 and sitc 51574. as of q4 2014, nicoboxil remains the us fda preferred term for this commodity. nicoboxil bears us nlm identifiers umls id c0770962 and nci concept code c84007. smiles: ccccoccoc(=o)c1=cn=cc=c1.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. bucetin. this classification denotes an analgesic agent with the molecular formula c12h17no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6m7cvq8pf8, chemically known as p-butyrophenetidide, 3-hydroxy- but generally known as bucetin, which bears us nih compound identifier 14130. european medicines agency schedules bucetin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05942mig. the term bucetin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules bucetin in its anatomical therapeutic chemical (atc) classification. bucetin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bucetin under hs 29242995 and sitc 51479. as of q4 2014, bucetin remains the us fda preferred term for this commodity. bucetin bears us nlm identifiers umls id c0054195 and nci concept code c72112. smiles: ccoc1=cc=c(c=c1)nc(=o)cc(c)o.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. bicifadine hydrochloride. this classification denotes a neuroprotective agent with the molecular formula c12h15n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier oe6g20p68t, chemically known as 3-azabicyclo(3.1.0)hexane, 1-(4-methylphenyl)-, hydrochloride, (+-)- but more generally known as bicifadine hydrochloride, which bears us nih compound identifier 47952. european medicines agency schedules bicifadine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32896. most nations, for tariff and trade purposes, schedule bicifadine hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, bicifadine hydrochloride remains us fdas preferred term for this commodity. bicifadine hydrochloride bears us nlm identifiers umls id c0106275 and nci concept code c81047. smiles: cc1ccc(cc1)[c@@]23c[c@@h]2cnc3.cl.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. ethoheptazine citrate. this classification denotes an opioid receptor agonist with the molecular formula c16h23no2.c6h8o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lxk8ee245d, chemically known as ethyl hexahydro-1-methyl-4-phenyl-1h-azepine-4-carboxylate, compound with citric acid (1:1) but more generally known as ethoheptazine citrate, which bears us nih compound identifier 23165. european medicines agency schedules ethoheptazine citrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02001mig. most nations, for tariff and trade purposes, schedule ethoheptazine citrate under hs 29339930 and sitc 51577. as of q4 2014, ethoheptazine citrate remains us fdas preferred term for this commodity. ethoheptazine citrate bears us nlm identifiers umls id c0770435 and nci concept code c76841. smiles: ccoc(=o)c1(cccn(cc1)c)c2ccccc2.c(c(=o)o)c(cc(=o)o)(c(=o)o)o.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. ethoheptazine hydrochloride. this classification denotes an opioid receptor agonist with the molecular formula c16h23no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8kyo8o8jno, chemically known as 1h-azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester, hydrochloride (1:1), but more generally known as ethoheptazine hydrochloride, which bears us nih compound identifier 6469. european medicines agency schedules ethoheptazine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07280mig. most nations, for tariff purposes, schedule ethoheptazine hydrochloride under hs 29339930. smiles: ccoc(=o)c1(cccn(cc1)c)c2ccccc2.cl.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. flupirtine gluconate. this classification denotes an analgesic agent c15h17fn4o2.c6h12o7, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d7np6cr89m, chemically known as d-gluconic acid, compd. with ethyl (2-amino-6-(((4-fluorophenyl)methyl)amino)-3-pyridinyl)carbamate, but more generally known as flupirtine gluconate, which bears us nih compound identifier 18608234. european medicines agency schedules flupirtine gluconate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02233mig. most nations, for tariff and trade purposes, schedule flupirtine gluconate under hs 29333999 and sitc 51574. as of q4 2014, flupirtine gluconate remains us fdas preferred term for this commodity. smiles: ccoc(=o)nc1ccc(nc1n)ncc2ccc(cc2)f.c([c@h]([c@h]([c@@h]([c@h](c(=o)o)o)o)o)o)o.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. flupirtine maleate. this classification denotes an analgesic agent with the molecular structure c15h17fn4o2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 0vci53pk4a chemically known as carbamic acid, (2-amino-6-(((4-fluorophenyl)methyl)amino)-3-pyridinyl)-, ethyl ester, (z)-2-butenedioate (1:1), but more commonly known as flupirtine maleate, which bears us nih compound identifier 6435335. european medicines agency schedules flupirtine maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02234mig. most nations, for tariff and trade purposes, schedule flupirtine maleate under hs 29333999 and sitc 51574. as of q4 2014, flupirtine maleate remains us fdas preferred term for this commodity. flupirtine maleate bears us nlm identifiers umls id c0772084 and nci concept code c72785. smiles: ccoc(=o)nc1ccc(nc1n)ncc2ccc(cc2)f.c(=c\\c(=o)o)\\c(=o)o.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. propacetamol hydrochloride. this classification denotes an analgesic and antipyretic with the molecular formula c14h20n2o3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sh41qyh8e5, chemically known as 4-acetamidophenyl n,n-diethylaminoacetate monohydrochloride but more generally known as propacetamol hydrochloride, which bears us nih compound identifier 108082. european medicines agency schedules propacetamol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04076mig. most nations, for tariff and trade purposes, schedule propacetamol hydrochloride under hs 29242995 and sitc 51479. as of q4 2014, propacetamol hydrochloride remains us fdas preferred term for this commodity. smiles: ccn(cc)cc(=o)oc1ccc(cc1)nc(=o)c.cl.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. xylazine hydrochloride. this classification denotes an alpha-adrenergic agonist with the molecular formula c12h16n2s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ngc3s0882s, chemically known as 4h-1,3-thiazin-2-amine, n-(2,6-dimethylphenyl)-5,6-dihydro-, monohydrochloride, but more generally known as xylazine hydrochloride, which bears us nih compound identifier 68554. european medicines agency schedules xylazine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00120mig. most nations, for tariff purposes, schedule xylazine hydrochloride under hs 29349990. xylazine hydrochloride bears us nlm identifiers umls id c0242544 and nci concept code c75050. smiles: cc1cccc(c1nc2=ncccs2)c.cl.. "
"non narcotic analgesics and antipyretics. this classification denotes compounds which do not contain opium, morphine, or other opiods, but that relieve pain and lower body temperture without loss of consciousness.. ziconotide acetate. this classification denotes a nonnarcotic analgesic with the molecular formula c102h172n36o32s7.c2h4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t2i226k69m. european medicines agency schedules ziconotide acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25201. the term ziconotide acetate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule ziconotide acetate under hs 29349990 and sitc 51579. ziconotide acetate bears us nlm identifiers umls id c1577317 and nci concept code c95275. smiles: as of q4 2014, ziconotide acetate remains us fdas preferred term for this commodity.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. . "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. nalmefene. this classification denotes an opiate antagonist with the molecular formula c21h25no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tov02tdp9i, chemically known as morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5.alpha.)- but generally known as nalmefene, which bears us nih compound identifier 4422. european medicines agency schedules nalmefene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09139mig. the term nalmefene is an international non-proprietary name or inn (see who inn reference publication, volume 37, no. 6, 1983, list 23). nalmefene is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nalmefene under hs 29391900 and sitc 54141. as of q4 2014, nalmefene remains the us fda preferred term for this commodity. nalmefene bears us nlm identifiers umls id c0068377 and nci concept code c61855. smiles: o1c2c34c(o)(c(n(cc3)cc3cc3)cc3c4c1c(o)cc3)ccc2=c.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. naloxone. this classification denotes an opiate antagonist with the molecular formula c19h21no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 36b82amq7n, chemically known as 17-allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one but generally known as naloxone, which bears us nih compound identifier 5284596. european medicines agency schedules naloxone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09142mig. the term naloxone is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5). world health organization schedules naloxone in its anatomical therapeutic chemical (atc) classification. naloxone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule naloxone under hs 29391900 and sitc 54141. as of q4 2014, naloxone remains the us fda preferred term for this commodity. naloxone bears us nlm identifiers umls id c0027358 and nci concept code c62054. smiles: o1c2c34c(o)(c(n(cc3)cc=c)cc3c4c1c(o)cc3)ccc2=o.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. naltrexone. this classification denotes an opiate antagonist with the molecular formula c20h23no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5s6w795cqm, chemically known as morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5.alpha.)- but generally known as naltrexone, which bears us nih compound identifier 4428. european medicines agency schedules naltrexone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09143mig. the term naltrexone is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules naltrexone in its anatomical therapeutic chemical (atc) classification. naltrexone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule naltrexone under hs 29391900 and sitc 54141. as of q4 2014, naltrexone remains the us fda preferred term for this commodity. naltrexone bears us nlm identifiers umls id c0027360 and nci concept code c62055. smiles: o1c2c34c(o)(c(n(cc3)cc3cc3)cc3c4c1c(o)cc3)ccc2=o.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. levallorphan. this classification denotes an opiate antagonist with the molecular formula c19h25no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 353613bu4u, chemically known as morphinan-3-ol, 17-(2-propenyl)- but generally known as levallorphan, which bears us nih compound identifier 3912. european medicines agency schedules levallorphan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08452mig. the term levallorphan is an international non-proprietary name. levallorphan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule levallorphan under hs 29334990 and sitc 51575. as of q4 2014, levallorphan remains the us fda preferred term for this commodity. levallorphan bears us nlm identifiers umls id c0023554 and nci concept code c66004. smiles: oc1cc2c34c(c(n(cc3)cc=c)cc2cc1)cccc4.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. nalorphine. this classification denotes a narcotic antagonist with the molecular formula c19h21no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u59wb2wry2, chemically known as 7,8-didehydro-4,5-epoxy-17-(2-propenyl)morphinan-3,6-diol but generally known as nalorphine, which bears us nih compound identifier 5284595. european medicines agency schedules nalorphine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09141mig. world health organization schedules nalorphine in its anatomical therapeutic chemical (atc) classification. nalorphine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nalorphine under hs 29391900 and sitc 54141. as of q4 2014, nalorphine remains the us fda preferred term for this commodity. smiles: o1c2c34c(c(n(cc3)cc=c)cc3c4c1c(o)cc3)c=cc2o.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. levallorphan tartrate. this classification denotes an opiate antagonist with the molecular formula c19h25no.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u0vsf7htn0, chemically known as 2h-10,4a-iminoethanophenanthren-6-ol, 11-allyl-1,3,4,9,10,10a-hexahydro-, tartrate but more generally known as levallorphan tartrate, which bears us nih compound identifier 5464111. european medicines agency schedules levallorphan tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02901mig. most nations, for tariff and trade purposes, schedule levallorphan tartrate under hs 29334990 and sitc 51575. as of q4 2014, levallorphan tartrate remains us fdas preferred term for this commodity. levallorphan tartrate bears us nlm identifiers umls id c0770439 and nci concept code c66005. smiles: c=ccn1cc[c@]23cccc[c@h]2[c@h]1cc4c3cc(cc4)o.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. nalmefene hydrochloride. this classification denotes an opiate antagonist with the molecular formula c21h25no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier k7k69qc05x, chemically known as 17-(cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol, , hydrochloride but more generally known as nalmefene hydrochloride, which bears us nih compound identifier 5388881. european medicines agency schedules nalmefene hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14628mig. most nations, for tariff and trade purposes, schedule nalmefene hydrochloride under hs 29391900 and sitc 54141. as of q4 2014, nalmefene hydrochloride remains us fdas preferred term for this commodity. nalmefene hydrochloride bears us nlm identifiers umls id c0771297 and nci concept code c47631. smiles: c=c1cc[c@]2([c@h]3cc4ccc(c5c4[c@]2([c@h]1o5)ccn3cc6cc6)o)o.cl.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. nalmefene hydrochloride dihydrate. this classification denotes an opiate antagonist c21h25no3.clh.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 52z0g7qvjx, chemically known as morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, hydrochloride, hydrate (1:1:2), (5.alpha.)-, but more generally known as nalmefene hydrochloride dihydrate, which bears us nih compound identifier 46209574. most nations, for tariff and trade purposes, schedule nalmefene hydrochloride dihydrate under hs 29391900 and sitc 54141. as of q4 2014, nalmefene hydrochloride dihydrate remains us fdas preferred term for this commodity. smiles: c=c1cc[c@]2([c@h]3cc4ccc(c5c4[c@]2([c@h]1o5)ccn3cc6cc6)o)o.o.o.cl.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. nalorphine bromide. this classification denotes a narcotic antagonist with the molecular formula c20h23no3.brh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1olb66508a, chemically known as morphinan-3,6-.alpha.-diol, 17-allyl-7,8-didehydro-4,5-.alpha.-epoxy-, hydrobromide, but more generally known as nalorphine bromide, which bears us nih compound identifier 5486631. european medicines agency schedules nalorphine bromide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09141mig. most nations, for tariff purposes, schedule nalorphine bromide under hs 29391900. smiles: coc1ccc2c3c1o[c@@h]4[c@]35ccn([c@h](c2)[c@@h]5c=c[c@@h]4o)cc=c.br.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. nalorphine hydrobromide. this classification denotes a narcotic antagonist c20h23no3.brh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1olb66508a, chemically known as morphinan-3,6-.alpha.-diol, 17-allyl-7,8-didehydro-4,5-.alpha.-epoxy-, hydrobromide, but more generally known as nalorphine hydrobromide, which bears us nih compound identifier 5486631. most nations, for tariff and trade purposes, schedule nalorphine hydrobromide under hs 29391900 and sitc 54141. as of q4 2014, nalorphine hydrobromide remains us fdas preferred term for this commodity. smiles: coc1ccc2c3c1o[c@@h]4[c@]35ccn([c@h](c2)[c@@h]5c=c[c@@h]4o)cc=c.br.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. nalorphine hydrochloride. this classification denotes an opioid receptor agonist with the molecular formula c19h21no3.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9fpe56z2tw, chemically known as 17-allyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol hydrochloride but more generally known as nalorphine hydrochloride, which bears us nih compound identifier 5484366. european medicines agency schedules nalorphine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03381mig. most nations, for tariff and trade purposes, schedule nalorphine hydrochloride under hs 29391900 and sitc 54141. as of q4 2014, nalorphine hydrochloride remains us fdas preferred term for this commodity. nalorphine hydrochloride bears us nlm identifiers umls id c0086547 and nci concept code c76849. smiles: c=ccn1cc[c@]23c4c5ccc(c4o[c@h]2[c@h](c=c[c@h]3[c@h]1c5)o)o.cl.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. naloxone hydrochloride. this classification denotes a narcotic antagonist with the molecular formula c19h21no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f850569pqr, chemically known as 17-allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one hydrochloride but more generally known as naloxone hydrochloride, which bears us nih compound identifier 5464092. european medicines agency schedules naloxone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03382mig. most nations, for tariff and trade purposes, schedule naloxone hydrochloride under hs 29391900 and sitc 54141. as of q4 2014, naloxone hydrochloride remains us fdas preferred term for this commodity. naloxone hydrochloride bears us nlm identifiers umls id c0684237 and nci concept code c678. smiles: c=ccn1cc[c@]23c4c5ccc(c4o[c@h]2c(=o)cc[c@]3([c@h]1c5)o)o.cl.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. naloxone hydrochloride dihydrate. this classification denotes an opiate antagonist with the molecular formula c19h21no4.clh.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5q187997ee, chemically known as (-)-n-allyl-14-hydroxynordihydromorphinone hydrochloride dihydrate, but more generally known as naloxone hydrochloride dihydrate, which bears us nih compound identifier 5464092. european medicines agency schedules naloxone hydrochloride dihydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09142mig. most nations, for tariff purposes, schedule naloxone hydrochloride dihydrate under hs 29391900. smiles: c=ccn1cc[c@]23c4c5ccc(c4o[c@h]2c(=o)cc[c@]3([c@h]1c5)o)o.o.o.cl.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. naltrexone hydrochloride. this classification denotes an opiate antagonist with the molecular formula c20h23no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z6375yw9sf, chemically known as 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-morphinan-6-one hydrochloride but more generally known as naltrexone hydrochloride, which bears us nih compound identifier 5485201. european medicines agency schedules naltrexone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14629mig. most nations, for tariff and trade purposes, schedule naltrexone hydrochloride under hs 29391900 and sitc 54141. as of q4 2014, naltrexone hydrochloride remains us fdas preferred term for this commodity. naltrexone hydrochloride bears us nlm identifiers umls id c0355800 and nci concept code c679. smiles: c1cc(c2c3c1c[c@@h]4[c@]5([c@]3(ccn4cc6cc6)[c@@h](o2)c(=o)cc5)o)o.cl.. "
"narcotic antagonists. this classification denotes agents inhibiting the effect of narcotics, such as opiates and opiods, on the central nervous system.. naltrexone methobromide. this classification denotes an opiate antagonist with the molecular formula c21h26no4.br, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rfo6il3d3m, chemically known as morphinanium, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxo-, bromide, (5.alpha.)-, but more generally known as naltrexone methobromide, which bears us nih compound identifier 5361917. european medicines agency schedules naltrexone methobromide or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09143mig. most nations, for tariff purposes, schedule naltrexone methobromide under hs 29391900. smiles: c[n+]1(cc[c@]23c4c5ccc(c4o[c@h]2c(=o)cc[c@]3([c@h]1c5)o)o)cc6cc6.[br-].. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. . "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. methysergide. this classification denotes a serotonin agonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xza9hy6z98. european medicines agency schedules methysergide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08880mig. methysergide generally arises in the molecular formula c21h27n3o2. the term methysergide is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.) methysergide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule methysergide under hs 29396900 and sitc 54146. as of q4 2014, methysergide remains the us fda preferred term for this commodity. methysergide bears us nlm identifiers umls id c0025842 and nci concept code c66123. smiles: o=c(nc(cc)co)c1cn(c2c(=c1)c1c3c(c2)cn(c3ccc1)c)c.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. dihydroergotamine. this classification denotes a nonnarcotic analgesic and dopamine agonist with the molecular formula c33h37n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 436o5hm03c, chemically known as ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5.alpha.,10.alpha.)-, monomethanesulfonate but generally known as dihydroergotamine, which bears us nih compound identifier 3066. european medicines agency schedules dihydroergotamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07139mig. the term dihydroergotamine is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules dihydroergotamine in its anatomical therapeutic chemical (atc) classification. dihydroergotamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dihydroergotamine under hs 29396900 and sitc 54146. as of q4 2014, dihydroergotamine remains the us fda preferred term for this commodity. dihydroergotamine bears us nlm identifiers umls id c0012291 and nci concept code c65387. smiles: o1c2(o)n(c(c(=o)n3c2ccc3)cc2ccccc2)c(=o)c1(nc(=o)c1cc2c(n(c1)c)cc1c3c2cccc3[nh]c1)c.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. combination acetaminophen acetylsalicylic acid. this classification denotes a combination drug that treats migraines. the first component of this drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but generally known as acetaminophen (or paracetamol), which bears us nih compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. smiles: oc1ccc(nc(=o)c)cc1. the second component of this combination drug is a cyclooxygenase inhibitor with the molecular formula c9h8o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r16co5y76e, chemically known as salicylic acid, acetyl- but generally known as acetylsalicylic acid, which bears us nih compound identifier 2244. european medicines agency schedules acetylsalicylic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12730mig. world health organization schedules acetylsalicylic acid in its anatomical therapeutic chemical (atc) classification. smiles: o(c1c(cccc1)c(=o)o)c(=o)c.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. frovatriptan. this classification denotes a serotonin agonist with the molecular formula c14h17n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h82q2d5wa7, chemically known as 6-methylamino-6,7,8,9-tetrahydro-5h-carbazole-3-carboxamide but generally known as frovatriptan, which bears us nih compound identifier 77992. european medicines agency schedules frovatriptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07817mig. the term frovatriptan is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). world health organization schedules frovatriptan in its anatomical therapeutic chemical (atc) classification. frovatriptan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule frovatriptan under hs 29339990 and sitc 51577. as of q4 2014, frovatriptan remains the us fda preferred term for this commodity. frovatriptan bears us nlm identifiers umls id c0754647 and nci concept code c65772. smiles: o=c(n)c1cc2c3cc(nc)ccc3[nh]c2cc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. rizatriptan. this classification denotes a serotonin agonist with the molecular formula c15h19n5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 51086hbw8g, chemically known as 1h-indole-3-ethanamine, n,n-dimethyl-5-(1h-1,2,4-triazol-1-ylmethyl)- but generally known as rizatriptan, which bears us nih compound identifier 5078. european medicines agency schedules rizatriptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10346mig. world health organization schedules rizatriptan in its anatomical therapeutic chemical (atc) classification. rizatriptan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rizatriptan under hs 29339990 and sitc 51577. as of q4 2014, rizatriptan remains the us fda preferred term for this commodity. rizatriptan bears us nlm identifiers umls id c0297635 and nci concept code c61930. smiles: [nh]1c2c(c(ccn(c)c)c1)cc(cc2)cn1ncnc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. eletriptan. this classification denotes a serotonin agonist with the molecular formula c22h26n2o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 22qoo9b8ki, chemically known as 1h-indole, 3-(((2r)-1-methyl-2-pyrrolidinyl)methyl)-5-(2-(phenylsulfonyl)ethyl)ethyl)- but generally known as eletriptan, which bears us nih compound identifier 77993. european medicines agency schedules eletriptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06482mig. the term eletriptan is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules eletriptan in its anatomical therapeutic chemical (atc) classification. eletriptan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule eletriptan under hs 29339990 and sitc 51577. as of q4 2014, eletriptan remains the us fda preferred term for this commodity. eletriptan bears us nlm identifiers umls id c0759933 and nci concept code c65509. smiles: s(=o)(=o)(ccc1cc2c(cc3n(ccc3)c)c[nh]c2cc1)c1ccccc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. zolmitriptan. this classification denotes a serotonin agonist with the molecular formula c16h21n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2fs66th3yw, chemically known as 2-oxazolidinone, 4-((3-(2-(dimethylamino)ethyl)-1h-indol-5-yl)methyl)-, (s)- but generally known as zolmitriptan, which bears us nih compound identifier 60857. european medicines agency schedules zolmitriptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00181mig. the term zolmitriptan is an international non-proprietary name or inn (see who inn reference publication, volume 10, no. 3, 1996, list 36). world health organization schedules zolmitriptan in its anatomical therapeutic chemical (atc) classification. zolmitriptan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule zolmitriptan under hs 29349990 and sitc 51579. as of q4 2014, zolmitriptan remains the us fda preferred term for this commodity. zolmitriptan bears us nlm identifiers umls id c0528166 and nci concept code c47789. smiles: o1cc(nc1=o)cc1cc2c(ccn(c)c)c[nh]c2cc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. sumatriptan. this classification denotes a serotonin agonist with the molecular formula c14h21n3o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8r78f6l9vo, chemically known as 1h-indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-n-methyl- but generally known as sumatriptan, which bears us nih compound identifier 5358. european medicines agency schedules sumatriptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10770mig. the term sumatriptan is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). world health organization schedules sumatriptan in its anatomical therapeutic chemical (atc) classification. sumatriptan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sumatriptan under hs 29350090 and sitc 51580. as of q4 2014, sumatriptan remains the us fda preferred term for this commodity. sumatriptan bears us nlm identifiers umls id c0075632 and nci concept code c1240. smiles: s(=o)(=o)(nc)cc1cc2c(ccn(c)c)c[nh]c2cc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. combination acetaminophen butalbital. this classification denotes a combination drug that treats migraines. the first component of this drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but generally known as acetaminophen (or paracetamol), which bears us nih compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. smiles: oc1ccc(nc(=o)c)cc1. the second component of this combination drug is a barbiturate with the molecular formula c11h16n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier khs0az4jvk, chemically known as 2,4,6(1h,3h,5h)-pyrimidinetrione, 5-(2-methylpropyl)-5-(2-propenyl)- but generally known as butalbital, which bears us nih compound identifier 2481. butalbital most often comes in base and sodium forms. european medicines agency schedules butalbital in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05999mig. the term butalbital is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). butalbital is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc(c)cc1(c(=o)nc(=o)nc1=o)cc=c.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. iprazochrome. this classification denotes a serotonin antagonist with the molecular formula c12h16n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 903a9k181p, chemically known as 5,6-indolinedione, 3-hydroxy-1-isopropyl-, 5-semicarbazone (8ci) but generally known as iprazochrome, which bears us nih compound identifier 6381821. european medicines agency schedules iprazochrome in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08277mig. the term iprazochrome is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). world health organization schedules iprazochrome in its anatomical therapeutic chemical (atc) classification. iprazochrome is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule iprazochrome under hs 29339990 and sitc 51577. as of q4 2014, iprazochrome remains the us fda preferred term for this commodity. iprazochrome bears us nlm identifiers umls id c0123902 and nci concept code c83834. smiles: cc(c)n1cc(c2=c/c(=n/nc(=o)n)/c(=o)c=c21)o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. almotriptan. this classification denotes a serotonin agonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1o4xl5sn61. european medicines agency schedules almotriptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05350mig. almotriptan generally arises in the molecular formula c17h25n3o2s. the term almotriptan is an international non-proprietary name or inn. almotriptan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule almotriptan under hs 29350090 and sitc 51580. as of q4 2014, almotriptan remains the us fda preferred term for this commodity. almotriptan bears us nlm identifiers umls id c0914729 and nci concept code c65224. smiles: s(=o)(=o)(n1cccc1)cc1cc2c(ccn(c)c)c[nh]c2cc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. donitriptan. this classification denotes a serotonin agonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 70968bvh2j. european medicines agency schedules donitriptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01817mig. donitriptan generally arises in the molecular formula c23h25n5o2. the term donitriptan is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44.) most nations schedule donitriptan under hs 29335995 and sitc 51576. as of q4 2014, donitriptan remains the us fda preferred term for this commodity. donitriptan bears us nlm identifiers umls id c0769585 and nci concept code c65466. smiles: o(cc(=o)n1ccn(cc1)c1ccc(cc1)c#n)c1cc2c(ccn)c[nh]c2cc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. dotarizine. this classification denotes a serotonin antagonist and calcium channel blocker with the molecular formula c29h34n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier io7663s6d3, chemically known as 1-(diphenylmethyl)-4-(3-(2-phenyl-1,3-dioxolan-2-yl)propyl)piperazine but generally known as dotarizine, which bears us nih compound identifier 55285. european medicines agency schedules dotarizine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06378mig. the term dotarizine is an international non-proprietary name or inn (see who inn reference publication, volume 38, no. 6, 1984, list 24). dotarizine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule dotarizine under hs 29349990 and sitc 51579. as of q4 2014, dotarizine remains the us fda preferred term for this commodity. dotarizine bears us nlm identifiers umls id c0248284 and nci concept code c77827. smiles: o1c(occ1)(cccn1ccn(cc1)c(c1ccccc1)c1ccccc1)c1ccccc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. ergotamine. this classification denotes a serotonin agonist with the molecular formula c33h35n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pr834q503t, chemically known as 5-benzyl-12-hydroxy-2-methyl-3,6,18-trioxoergotaman but generally known as ergotamine, which bears us nih compound identifier 3251. european medicines agency schedules ergotamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06598mig. the term ergotamine is an international non-proprietary name or inn (see who inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules ergotamine in its anatomical therapeutic chemical (atc) classification. ergotamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ergotamine under hs 29396200 and sitc 54146. as of q4 2014, ergotamine remains the us fda preferred term for this commodity. ergotamine bears us nlm identifiers umls id c0014710 and nci concept code c61751. smiles: o1c2(o)n(c(c(=o)n3c2ccc3)cc2ccccc2)c(=o)c1(nc(=o)c1cn(c2c(=c1)c1c3c(c2)c[nh]c3ccc1)c)c.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. naratriptan. this classification denotes a serotonin agonist with the molecular formula c17h25n3o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier qx3kxl1za2, chemically known as 1h-indole-5-ethanesulfonamide, n-methyl-3-(1-methyl-4-piperidinyl)- but generally known as naratriptan, which bears us nih compound identifier 4440. european medicines agency schedules naratriptan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09164mig. the term naratriptan is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). world health organization schedules naratriptan in its anatomical therapeutic chemical (atc) classification. naratriptan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule naratriptan under hs 29350090 and sitc 51580. as of q4 2014, naratriptan remains the us fda preferred term for this commodity. naratriptan bears us nlm identifiers umls id c0540623 and nci concept code c61857. smiles: s(=o)(=o)(nc)ccc1cc2c(c3ccn(cc3)c)c[nh]c2cc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. oxetorone. this classification denotes a serotonin antagonist with the molecular formula c21h21no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t3xos33tiq, chemically known as 3-(12h-benzofuro(3,2-c)(1)benzoxepin-6-yliden)-n,n-dimethylpropylamin but generally known as oxetorone, which bears us nih compound identifier 6436540. european medicines agency schedules oxetorone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09518mig. the term oxetorone is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules oxetorone in its anatomical therapeutic chemical (atc) classification. oxetorone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxetorone under hs 29329985 and sitc 51569. as of q4 2014, oxetorone remains the us fda preferred term for this commodity. oxetorone bears us nlm identifiers umls id c0069760 and nci concept code c84037. smiles: o1c2c(c3c1cccc3)coc1c(c\\2=c\\ccn(c)c)cccc1.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. almotriptan malate. this classification denotes a serotonin agonist with the molecular formula c17h25n3o2s.c4h6o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pjp312605e, chemically known as 1-(((3-(2-(dimethylamino)ethyl)-1h-indol-5-yl)methyl)sulfonyl)pyrrolidine, hydroxybutanedionate (1:1) but more generally known as almotriptan malate, which bears us nih compound identifier 123607. the base compound, almotriptan, comes in base and malate forms. european medicines agency schedules almotriptan malate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20534. most nations, for tariff and trade purposes, schedule almotriptan malate under hs 29350090 and sitc 51580. as of q4 2014, almotriptan malate remains us fdas preferred term for this commodity. almotriptan malate bears us nlm identifiers umls id c0937898 and nci concept code c61628. smiles: cn(c)ccc1c[nh]c2c1cc(cc2)cs(=o)(=o)n3cccc3.c(c(c(=o)o)o)c(=o)o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. dihydroergotamine mesilate or mesylate. this classification denotes a nonnarcotic analgesic and dopamine agonist with the molecular formula c33h37n5o5.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 81axn7r2qt, chemically known as ergotoman-3,6,18-trione,9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5.alpha.)-, monomethanesulfonate (salt), but more generally known as dihydroergotamine mesylate, which bears us nih compound identifier 3066. european medicines agency schedules dihydroergotamine mesylate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07139mig. most nations, for tariff purposes, schedule dihydroergotamine mesylate under hs 29396900. as of q4 2014, dihydroergotamine mesylate remains us fdas preferred term for this commodity. dihydroergotamine mesylate bears us nlm identifiers umls id c0700532 and nci concept code c47491. smiles: c[c@@]1(c(=o)n2[c@h](c(=o)n3ccc[c@h]3[c@@]2(o1)o)cc4ccccc4)nc(=o)[c@@h]5c[c@@h]6c7cccc8c7c(c[nh]8)c[c@h]6n(c5)c.cs(=o)(=o)o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. dihydroergotamine methanesulfonate. this classification denotes a nonnarcotic analgesic and dopamine agonist with the molecular formula c33h37n5o5.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 81axn7r2qt, chemically known as ergotoman-3,6,18-trione,9,10-dihydro-12-hydroxy-2-methyl-5-(phenylmethyl)-, (5.alpha.)-, monomethanesulfonate (salt), but more generally known as dihydroergotamine methanesulfonate, which bears us nih compound identifier 10531. european medicines agency schedules dihydroergotamine methanesulfonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07139mig. most nations, for tariff purposes, schedule dihydroergotamine methanesulfonate under hs 29396900. smiles: c[c@@]1(c(=o)n2[c@h](c(=o)n3ccc[c@h]3[c@@]2(o1)o)cc4ccccc4)nc(=o)[c@@h]5c[c@@h]6c7cccc8c7c(c[nh]8)c[c@h]6n(c5)c.cs(=o)(=o)o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. donitriptan hydrochloride. this classification denotes a serotonin agonist with the molecular formula c23h25n5o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier xtd13t14mr, chemically known as benzonitrile, 4-(4-(2-((3-(2-aminoethyl)-1h-indol-5-yl)oxy)acetyl)-1-piperazinyl)-, hydrochloride (1:1), but more generally known as donitriptan hydrochloride, which bears us nih compound identifier 197705. european medicines agency schedules donitriptan hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01817mig. most nations, for tariff purposes, schedule donitriptan hydrochloride under hs 29335995. smiles: c1cc(ccc1c#n)n2ccn(cc2)c(=o)coc3ccc4c(c3)c(c[nh]4)ccn.cl.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. eletriptan hydrobromide. this classification denotes a serotonin agonist with the molecular formula c22h26n2o2s.brh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m41w832ta3, chemically known as 1h-indole, 3-(((2r)-1-methyl-2-pyrrolidinyl))methyl)-5-(2-(phenylsulfonyl)ethyl)-, monohydrobromide but more generally known as eletriptan hydrobromide, which bears us nih compound identifier 156849. european medicines agency schedules eletriptan hydrobromide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub26382. most nations, for tariff and trade purposes, schedule eletriptan hydrobromide under hs 29339990 and sitc 51577. as of q4 2014, eletriptan hydrobromide remains us fdas preferred term for this commodity. eletriptan hydrobromide bears us nlm identifiers umls id c1178489 and nci concept code c47508. smiles: cn1ccc[c@@h]1cc2c[nh]c3c2cc(cc3)ccs(=o)(=o)c4ccccc4.br.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. ergotamine tartrate. this classification denotes a serotonin agonist and alpha-adrenergic agonist with the molecular formula 2c33h35n5o5.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mru5xh3b48, chemically known as ergotamine, tartrate (2:1) (salt) (8ci) but more generally known as ergotamine tartrate, which bears us nih compound identifier 9787. european medicines agency schedules ergotamine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01934mig. most nations, for tariff and trade purposes, schedule ergotamine tartrate under hs 29396200 and sitc 54146. as of q4 2014, ergotamine tartrate remains us fdas preferred term for this commodity. ergotamine tartrate bears us nlm identifiers umls id c2936189 and nci concept code c47517. smiles: c[c@@]1(c(=o)n2[c@h](c(=o)n3ccc[c@h]3[c@@]2(o1)o)cc4ccccc4)nc(=o)[c@h]5cn([c@@h]6cc7c[nh]c8c7c(ccc8)c6=c5)c.c[c@@]1(c(=o)n2[c@h](c(=o)n3ccc[c@h]3[c@@]2(o1)o)cc4ccccc4)nc(=o)[c@h]5cn([c@@h]6cc7c[nh]c8c7c(ccc8)c6=c5)c.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. frovatriptan succinate. this classification denotes a serotonin agonist with the molecular formula c14h17n3o.c4h6o4.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d28j6w18hy, chemically known as 1h-carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (r)-, butanedioate (1:1) but more generally known as frovatriptan succinate, which bears us nih compound identifier 152944. european medicines agency schedules frovatriptan succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22174. most nations, for tariff and trade purposes, schedule frovatriptan succinate under hs 29339990. as of q4 2014, frovatriptan succinate remains us fdas preferred term for this commodity. frovatriptan succinate bears us nlm identifiers umls id c1099777 and nci concept code c47544. smiles: cn[c@@h]1ccc2c(c3cc(ccc3[nh]2)c(=o)n)c1.c(cc(=o)o)c(=o)o.o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. frovatriptan succinate hydrate. this classification denotes a serotonin agonist with the molecular formula c14h17n3o.c4h6o4.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d28j6w18hy, chemically known as butanedioic acid, compd. with (r)-2,3,4,9-tetrahydro-3-(methylamino)-1h-carbazole-6-carboxamide (1:1), monohydrate, but more generally known as frovatriptan succinate hydrate, which bears us nih compound identifier 152943. european medicines agency schedules frovatriptan succinate hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07817mig. most nations, for tariff purposes, schedule frovatriptan succinate hydrate under hs 29339990. smiles: cn[c@@h]1ccc2c(c3cc(ccc3[nh]2)c(=o)n)c1.c(cc(=o)o)c(=o)o.o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. methysergide maleate. this classification denotes a cns stimulant with the molecular formula c21h27n3o2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2u7h1466gh, chemically known as 9,10-didehydro-n-(1-(hydroxymethyl)propyl)-1,6-dimethylergoline-8beta-carboxamide maleate (1:1) (salt) but more generally known as methysergide maleate, which bears us nih compound identifier 5281073. european medicines agency schedules methysergide maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03263mig. most nations, for tariff and trade purposes, schedule methysergide maleate under hs 29396900 and sitc 54146. as of q4 2014, methysergide maleate remains us fdas preferred term for this commodity. methysergide maleate bears us nlm identifiers umls id c0036177 and nci concept code c61843. smiles: cc[c@@h](co)nc(=o)[c@h]1cn([c@@h]2cc3cn(c4c3c(ccc4)c2=c1)c)c.c(=c\\c(=o)o)\\c(=o)o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. naratriptan hydrochloride. this classification denotes a serotonin agonist with the molecular formula c17h25n3o2s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 10x8x4p12z, chemically known as 1h-indole-5-ethanesulfonamide, n-methyl-3-(1-methyl-4-piperidinyl)-, monohydrochloride but more generally known as naratriptan hydrochloride, which bears us nih compound identifier 60875. european medicines agency schedules naratriptan hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14631mig. most nations, for tariff and trade purposes, schedule naratriptan hydrochloride under hs 29350090 and sitc 51580. as of q4 2014, naratriptan hydrochloride remains us fdas preferred term for this commodity. naratriptan hydrochloride bears us nlm identifiers umls id c0594660 and nci concept code c47633. smiles: cns(=o)(=o)ccc1ccc2c(c1)c(c[nh]2)c3ccn(cc3)c.cl.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. rizatriptan benzoate. this classification denotes a serotonin agonist with the molecular formula c15h19n5.c7h6o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wr978s7qhh, chemically known as 1h-indole-3-ethanamine, n,n-dimethyl-5-(1h-1,2,4-triazol-1-ylmethyl)- but more generally known as rizatriptan benzoate, which bears us nih compound identifier 5078. european medicines agency schedules rizatriptan benzoate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04258mig. most nations, for tariff and trade purposes, schedule rizatriptan benzoate under hs 29339990 and sitc 51577. as of q4 2014, rizatriptan benzoate remains us fdas preferred term for this commodity. rizatriptan benzoate bears us nlm identifiers umls id c0772420 and nci concept code c47708. smiles: cn(c)ccc1c[nh]c2c1cc(cc2)cn3cncn3.c1ccc(cc1)c(=o)o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. rizatriptan sulfate. this classification denotes a serotonin agonist 2c15h19n5.h2o.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 13rrh2218g, chemically known as 1h-indole-3-ethanamine, n,n-dimethyl-5-(1h-1,2,4-triazol-1-ylmethyl)-, sulfate (2:1), monohydrate, but more generally known as rizatriptan sulfate, which bears us nih compound identifier 3038519. most nations, for tariff and trade purposes, schedule rizatriptan sulfate under hs 29339990 and sitc 51577. as of q4 2014, rizatriptan sulfate remains us fdas preferred term for this commodity. rizatriptan sulfate bears us nlm identifiers umls id c1882957 and nci concept code c66520. smiles: cn(c)ccc1c[nh]c2c1cc(cc2)cn3cncn3.cn(c)ccc1c[nh]c2c1cc(cc2)cn3cncn3.o.os(=o)(=o)o.. "
"drugs used for vascular and migraine headaches. this classification denotes products that treat a class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. the two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms).. sumatriptan succinate. this classification denotes a serotonin agonist with the molecular formula c14h21n3o2s.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j8bdz68989, chemically known as 1h-indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-n-methyl- but more generally known as sumatriptan succinate, which bears us nih compound identifier 5358. european medicines agency schedules sumatriptan succinate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15437mig. most nations, for tariff and trade purposes, schedule sumatriptan succinate under hs 29350090 and sitc 51580. as of q4 2014, sumatriptan succinate remains us fdas preferred term for this commodity. sumatriptan succinate bears us nlm identifiers umls id c0206599 and nci concept code c29470. smiles: cns(=o)(=o)cc1ccc2c(c1)c(c[nh]2)ccn(c)c.c(cc(=o)o)c(=o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. . "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. bromocriptine. this classification denotes a neuroprotective agent with the molecular formula c32h40brn5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3a64e3g5zo, chemically known as ergotaman-3,6,18-trione, 2-bromo-12-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-, (5.alpha.)- but generally known as bromocriptine, which bears us nih compound identifier 2443. bromocriptine most often comes in base and mesilate (mesylate) forms. european medicines agency schedules bromocriptine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05918mig. the term bromocriptine is an international non-proprietary name. world health organization schedules bromocriptine in its anatomical therapeutic chemical (atc) classification. bromocriptine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule bromocriptine under hs 29396900 and sitc 54146. as of q4 2014, bromocriptine remains the us fda preferred term for this commodity. bromocriptine bears us nlm identifiers umls id c0006230 and nci concept code c62010. smiles: brc1[nh]c2c3c(c4=cc(c(=o)nc5(oc6(o)n(c(c(=o)n7c6ccc7)cc(c)c)c5=o)c(c)c)cn(c4cc13)c)ccc2.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. carbidopa. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula c10h14n2o4.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier mnx7r8c5vo, chemically known as hydrocinnamic acid, .alpha.-hydrazino-3,4-dihydroxy-.alpha.-methyl-, l- but generally known as carbidopa, which bears us nih compound identifier 2563. carbidopa most often comes in base, anhydrous, and hydrate forms, and is often combined with levodopa. european medicines agency schedules carbidopa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06126mig. carbidopa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule carbidopa under hs 29280090 and sitc 51486. as of q4 2014, carbidopa remains the us fda preferred term for this commodity. carbidopa bears us nlm identifiers umls id c0006982 and nci concept code c47431. smiles: cc(cc1=cc(=c(c=c1)o)o)(c(=o)o)nn.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. levodopa. this classification denotes a dopamine agonist with the molecular formula c9h11no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 46627o600j, chemically known as 3,4-dihydroxyphenyl-l-alanine but generally known as levodopa, which bears us nih compound identifier 836. european medicines agency schedules levodopa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08468mig. the term levodopa is an international non-proprietary name or inn (see who inn reference publication, volume 23, no. 10 1969, list 9). world health organization schedules levodopa in its anatomical therapeutic chemical (atc) classification. levodopa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule levodopa under hs 29225000 and sitc 51467. as of q4 2014, levodopa remains the us fda preferred term for this commodity. levodopa bears us nlm identifiers umls id c0699991 and nci concept code c611. smiles: oc1cc(cc(n)c(=o)o)ccc1o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. selegiline. this classification denotes a monoamine oxidase inhibitor with the molecular formula c13h17n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6w731x367q, chemically known as (-)-(r)-n,alpha-dimethyl-n-2-propynylphenethylamine monohydrochloride but generally known as selegiline hydrochloride, which bears us nih compound identifier 26758. european medicines agency schedules selegiline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04347mig. most nations schedule selegiline under hs 29214980 and sitc 51454. as of q4 2014, selegiline remains the us fda preferred term for this commodity. selegiline bears us nlm identifiers umls id c0036579 and nci concept code c61938. smiles: cl.n(c(cc1ccccc1)c)(cc#c)c.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. pergolide. this classification denotes a dopamine agonist and antiparkinsonian agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 24mj822nz9. european medicines agency schedules pergolide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09725mig. pergolide generally arises in the molecular formula c19h26n2s. the term pergolide is an international non-proprietary name or inn (see who inn reference publication, volume 33, no. 10 1979, list 19.) pergolide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pergolide under hs 29396900 and sitc 54146. as of q4 2014, pergolide remains the us fda preferred term for this commodity. pergolide bears us nlm identifiers umls id c0031007 and nci concept code c61886. smiles: s(cc1cc2c(n(c1)ccc)cc1c3c2cccc3[nh]c1)c.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. pramipexole. this classification denotes an antidepressant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 83619peu5t. european medicines agency schedules pramipexole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09990mig. pramipexole generally arises in the molecular formula c10h17n3s. the term pramipexole is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28.) pramipexole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule pramipexole under hs 29341000 and sitc 51579. as of q4 2014, pramipexole remains the us fda preferred term for this commodity. pramipexole bears us nlm identifiers umls id c0074710 and nci concept code c66456. smiles: cccnc1ccc2=c(c1)sc(=n2)n.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. ropinirole. this classification denotes an antiparkinsonian agent with the molecular formula c16h24n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 030pyr8953, chemically known as 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one but generally known as ropinirole, which bears us nih compound identifier 5095. european medicines agency schedules ropinirole in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10380mig. the term ropinirole is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30). world health organization schedules ropinirole in its anatomical therapeutic chemical (atc) classification. ropinirole is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ropinirole under hs 29337900 and sitc 51561. as of q4 2014, ropinirole remains the us fda preferred term for this commodity. ropinirole bears us nlm identifiers umls id c0244821 and nci concept code c61931. smiles: o=c1nc2c(c(ccn(ccc)ccc)ccc2)c1.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. entacapone. this classification denotes an antiparkinsonian agent with the molecular formula c14h15n3o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4975g9nm6t, chemically known as 2-propenamide, 2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)-n,n-diethyl- but generally known as entacapone, which bears us nih compound identifier 5281081. european medicines agency schedules entacapone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06552mig. the term entacapone is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules entacapone in its anatomical therapeutic chemical (atc) classification. entacapone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule entacapone under hs 29269095 and sitc 51484. as of q4 2014, entacapone remains the us fda preferred term for this commodity. entacapone bears us nlm identifiers umls id c0876730 and nci concept code c61746. smiles: o=c(n(cc)cc)/c(=c/c1cc([n](=o)o)c(o)c(o)c1)c#n.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. tropacine. this classification denotes an antiparkinsonian agent with the molecular formula c22h25no2, chemically known as 2-[3-(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)phenyl]-2-phenylacetic acid but generally known as tropacine, which bears us nih compound identifier 197078. european medicines agency schedules tropacine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15624mig. as of q4 2014, tropacine remains the us fda preferred term for this commodity. smiles: cn1c2ccc1cc(c2)c3=cc(=cc=c3)c(c4=cc=cc=c4)c(=o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. rasagiline. this classification denotes a monoamine oxidase inhibitor and antiparkinsonian agent with the molecular formula c12h13n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 003n66ts6t, chemically known as 2,3-dihydro-n-2-propynyl-1h-inden-1-amine but generally known as rasagiline, which bears us nih compound identifier 122316. european medicines agency schedules rasagiline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10261mig. world health organization schedules rasagiline in its anatomical therapeutic chemical (atc) classification. rasagiline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rasagiline under hs 29214980 and sitc 51454. as of q4 2014, rasagiline remains the us fda preferred term for this commodity. rasagiline bears us nlm identifiers umls id c0525678 and nci concept code c66510. smiles: c#ccnc1ccc2=cc=cc=c12.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. adrogolide. this classification denotes a dopamine agonist with the molecular formula c22h25no4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yc3281g42a, chemically known as (5ar, 11bs) 4,5,5a,6,7,11b-hexahydro-2-propylbenzo(f)thienol(2,3c)quinoline-9,10-diol diacetate (ester) but generally known as adrogolide, which bears us nih compound identifier 176876. adrogolide comes in both base and hydrochloride forms. the term adrogolide is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). most nations schedule adrogolide under hs 29349990 and sitc 51579. as of q4 2014, adrogolide remains the us fda preferred term for this commodity. adrogolide bears us nlm identifiers umls id c0381061 and nci concept code c73308. smiles: cccc1=cc2=c(s1)cnc3c2c4=cc(=c(c=c4cc3)oc(=o)c)oc(=o)c.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. tolcapone. this classification denotes an antiparkinsonian agent with the molecular formula c14h11no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier cif6334oly, chemically known as 3,4-dihydroxy-4-methyl-5-nitrobenzophenone but generally known as tolcapone, which bears us nih compound identifier 4659569. european medicines agency schedules tolcapone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11151mig. the term tolcapone is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules tolcapone in its anatomical therapeutic chemical (atc) classification. tolcapone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule tolcapone under hs 29147000 and sitc 51629. as of q4 2014, tolcapone remains the us fda preferred term for this commodity. tolcapone bears us nlm identifiers umls id c0246330 and nci concept code c47762. smiles: o=c(c1cc([n](=o)o)c(o)c(o)c1)c1ccc(cc1)c.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. amantadine. this classification denotes an antiviral agent and cation channel blocker with the molecular formula c10h17n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bf4c9z1j53, chemically known as 1-aminotricyclo(3.3.1.1(sup 3,7))decane but generally known as amantadine, which bears us nih compound identifier 2130. amantadine most often comes in base and hydrochloride\\tforms and is often combined with ribavirin and interferon (alpha). european medicines agency schedules amantadine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05389mig. the term amantadine is an international non-proprietary name. world health organization schedules amantadine in its anatomical therapeutic chemical (atc) classification. amantadine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule amantadine under hs 29213099 and sitc 51453. as of q4 2014, amantadine remains the us fda preferred term for this commodity. amantadine bears us nlm identifiers umls id c0002403 and nci concept code c61632. smiles: c1c2cc3cc1cc(c2)(c3)n.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. apomorphine or apomorphinum. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula c17h17no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n21far7b4s, chemically known as 6a.beta.-noraporphine-10,11-diol, 6-methyl-, hydrochloride but generally known as apomorphine, which bears us nih compound identifier 2215. apomorphine most often comes in base, chloride, diacetate, hydrochloride, and hydrochloride hemihydrate forms. european medicines agency schedules apomorphine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12923mig. world health organization schedules apomorphine in its anatomical therapeutic chemical (atc) classification. apomorphine or apomorphinum bears us nlm identifiers umls id c0003596 and nci concept code c61639. smiles: oc1c2c3c4c(n(ccc4ccc3)c)cc2ccc1o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. brasofensine. this classification denotes an antiparkinsonian agent with the molecular formula c16h20cl2n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1yp2s94rvh, chemically known as 3-beta-(3,4-dichlorophenyl)-1-alpha-h, 5-alpha-h-tropane-2-alpha-carboxaldehyde (e)-(o-methyloxime). but generally known as brasofensine, which bears us nih compound identifier 9554198. brasofensine most often comes in base, maleate, and sulfate forms. european medicines agency schedules brasofensine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05881mig. the term brasofensine is an international non-proprietary name or inn (see who inn reference publication, volume 11, no. 3 1997, list 38). brasofensine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule brasofensine under hs 29333999 and sitc 51574. as of q4 2014, brasofensine remains the us fda preferred term for this commodity. brasofensine bears us nlm identifiers umls id c0965394 and nci concept code c76391. smiles: clc1cc(c2c(c3n(c(c2)cc3)c)/c=n/oc)ccc1cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. budipine. this classification denotes a cation channel blocker and antiparkinsonian agent with the molecular formula c21h27n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier l9026opi2z, chemically known as 1-tert-butyl-4,4-diphenylpiperidine but generally known as budipine, which bears us nih compound identifier 68778. budipine most often comes in base and hydrochloride forms. european medicines agency schedules budipine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05956mig. the term budipine is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). world health organization schedules budipine in its anatomical therapeutic chemical (atc) classification. budipine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule budipine under hs 29333999 and sitc 51574. as of q4 2014, budipine remains the us fda preferred term for this commodity. budipine bears us nlm identifiers umls id c0054202 and nci concept code c73271. smiles: n1(ccc(cc1)(c1ccccc1)c1ccccc1)c(c)(c)c.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. ciladopa. this classification denotes a dopamine agonist with the molecular formula c21h26n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d09l486r3j, chemically known as 2,4,6-cycloheptatrien-1-one, 2-(4-(2-(3,4-dimethoxyphenyl)-2-hydroxyethyl)-1-piperazinyl)-, (s)- but generally known as ciladopa, which bears us nih compound identifier 133371. european medicines agency schedules ciladopa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06262mig. the term ciladopa is an international non-proprietary name or inn (see who inn reference publication, volume 39, no. 5, 1985, list 25). ciladopa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule ciladopa under hs 29335995 and sitc 51576. as of q4 2014, ciladopa remains the us fda preferred term for this commodity. ciladopa bears us nlm identifiers umls id c0055722 and nci concept code c79568. smiles: oc(cn1ccn(cc1)c1c(=o)ccccc1)c1cc(oc)c(oc)cc1.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. dihydroergocryptine. this classification denotes an antiparkinson drug with the molecular formula c32h43n5o5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 67v3fsl2gl, chemically known as ergotaman-3,6,18-trione, 9,10-dihydro-12-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-, but generally known as dihydroergocryptine, which bears us nih compound identifier 114948. european medicines agency schedules dihydroergocryptine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13588mig. world health organization schedules amantadine in its anatomical therapeutic chemical (atc) classification. as of q4 2014, dihydroergocryptine remains the us fda preferred term for this commodity. smiles: cc(c)cc1c(=o)n2cccc2c3(n1c(=o)c(o3)(c(c)c)nc(=o)c4cc5c(cc6=cnc7=cc=cc5=c67)n(c4)c)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. diprobutine. this classification denotes an antiparkinsonian agent with the molecular formula c10h23n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 5xe7iwd0jx, chemically known as 1,1-dipropylbutylamine but generally known as diprobutine, which bears us nih compound identifier 41701. european medicines agency schedules diprobutine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07221mig. the term diprobutine is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). diprobutine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diprobutine under hs 29211980 and sitc 51451. as of q4 2014, diprobutine remains the us fda preferred term for this commodity. diprobutine bears us nlm identifiers umls id c0058421 and nci concept code c65430. smiles: cccc(ccc)(ccc)n.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. doreptide. this classification denotes an antiparkinsonian agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 51k3u6q5zn. european medicines agency schedules doreptide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06371mig. doreptide generally arises in the molecular formula c17h24n4o3. the term doreptide is an international non-proprietary name or inn (see who inn reference publication, volume 2, no. 3, 1988, list 28.) doreptide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule doreptide under hs 29339990 and sitc 51577. as of q4 2014, doreptide remains the us fda preferred term for this commodity. doreptide bears us nlm identifiers umls id c2699803 and nci concept code c76393. smiles: o=c(nc(cc)(c1ccccc1)c(=o)ncc(=o)n)c1nccc1.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. droxidopa. this classification denotes an antiparkinsonian agent with the molecular formula c9h11no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier j7a92w69l7, chemically known as (-)-threo-3-(3,4-dihydroxyphenyl)-l-serine but generally known as droxidopa, which bears us nih compound identifier 3171. european medicines agency schedules droxidopa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06420mig. the term droxidopa is an international non-proprietary name or inn (see who inn reference publication, volume 1, no. 4, 1987, list 27). droxidopa is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule droxidopa under hs 29225000 and sitc 51467. as of q4 2014, droxidopa remains the us fda preferred term for this commodity. droxidopa bears us nlm identifiers umls id c0000378 and nci concept code c73266. smiles: oc(c(n)c(=o)o)c1cc(o)c(o)cc1.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. ethopropazine or profenamine. this classification denotes an antiparkinsonian agent with the molecular formula c19h24n2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7wi4p02yn1, chemically known as 10h-phenothiazine-10-ethanamine, n,n-diethyl-.alpha.-methyl-, monohydrochloride but generally known as ethopropazine, which bears us nih compound identifier 3290. european medicines agency schedules profenamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10071mig. the term ethopropazine is an international non-proprietary name. world health organization schedules ethopropazine in its anatomical therapeutic chemical (atc) classification. ethopropazine or profenamine bears us nlm identifiers umls id c0015042 and nci concept code c73333. smiles: ccn(cc)c(c)cn1c2=cc=cc=c2sc3=cc=cc=c31.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. etilevodopa. this classification denotes an antiparkinsonian agent with the molecular formula c11h15no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 895x917gye, chemically known as (-)-3,4-dihydroxy-l-phenylalanine, ethyl ester but generally known as etilevodopa, which bears us nih compound identifier 170345. european medicines agency schedules etilevodopa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02042mig. the term etilevodopa is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). most nations schedule etilevodopa under hs 29225000 and sitc 51467. as of q4 2014, etilevodopa remains the us fda preferred term for this commodity. etilevodopa bears us nlm identifiers umls id c1434556 and nci concept code c81562. smiles: ccoc(=o)c(cc1=cc(=c(c=c1)o)o)n.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. ifenprodil. this classification denotes a platelet aggregation inhibitor, antiparkinson agent, and anticonvulsant with the molecular formula 2c21h27no2.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 89ctb4xuf7, chemically known as 4-benzyl-1-(beta,4-dihydroxy-alpha-methylphenethyl)piperidinium hydrogen tartrate but generally known as ifenprodil tartrate, which bears us nih compound identifier 134832. european medicines agency schedules ifenprodil tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02636mig. most nations schedule ifenprodil under hs 29333999 and sitc 51574. as of q4 2014, ifenprodil remains the us fda preferred term for this commodity. ifenprodil bears us nlm identifiers umls id c0063340 and nci concept code c83782. smiles: cc(c(c1=cc=c(c=c1)o)o)n2ccc(cc2)cc3=cc=cc=c3.c(c(c(=o)o)o)(c(=o)o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. lazabemide. this classification denotes a monoamine oxidase inhibitor with the molecular formula c8h10cln3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 420hd787n9, chemically known as 2-pyridinecarboxamide, n-(2-aminoethyl)-5-chloro- but generally known as lazabemide, which bears us nih compound identifier 71307. european medicines agency schedules lazabemide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08418mig. the term lazabemide is an international non-proprietary name. lazabemide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lazabemide under hs 29333999 and sitc 51574. as of q4 2014, lazabemide remains the us fda preferred term for this commodity. lazabemide bears us nlm identifiers umls id c0209106 and nci concept code c80964. smiles: clc1ccc(nc1)c(=o)nccn.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. lisuride. this classification denotes an antiparkinsonian agent with the molecular formula c20h26n4o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e0qn3d755o, chemically known as 3-(9,10-didehydro-6-methylergolin-8alpha-yl)-1,1-diethylurea but generally known as lisuride, which bears us nih compound identifier 28864. european medicines agency schedules lisuride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08535mig. the term lisuride is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). world health organization schedules lisuride in its anatomical therapeutic chemical (atc) classification. lisuride is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lisuride under hs 29396900 and sitc 54146. as of q4 2014, lisuride remains the us fda preferred term for this commodity. lisuride bears us nlm identifiers umls id c0023863 and nci concept code c82247. smiles: o=c(nc1cn(c2c(=c1)c1c3c(c2)c[nh]c3ccc1)c)n(cc)cc.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. mazaticol. this classification denotes an anticholinergic agent with the molecular formula c20h25no3s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i6x824ogwz, chemically known as 6,6,9-trimethyl-9-azabicyclo(3.3.1)non-3beta-yl di-2-thienylglycolate but generally known as mazaticol, which bears us nih compound identifier 68667. european medicines agency schedules mazaticol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08655mig. the term mazaticol is an international non-proprietary name or inn (see who inn reference publication, volume 27, no. 10 1973, list 13). world health organization schedules mazaticol in its anatomical therapeutic chemical (atc) classification. mazaticol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule mazaticol under hs 29349990 and sitc 51579. as of q4 2014, mazaticol remains the us fda preferred term for this commodity. mazaticol bears us nlm identifiers umls id c0065760 and nci concept code c82233. smiles: s1c(c(o)(c(=o)oc2cc3n(c(ccc3(c)c)c2)c)c2sccc2)ccc1.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. melevodopa. this classification denotes a dopamine agonist with the molecular formula c10h13no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m30686u4x4, chemically known as l-tyrosine, 3-hydroxy-, methyl ester (9ci) but generally known as melevodopa, which bears us nih compound identifier 23497. european medicines agency schedules melevodopa in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32447. the term melevodopa is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45). world health organization schedules melevodopa in its anatomical therapeutic chemical (atc) classification. most nations schedule melevodopa under hs 29225000 and sitc 51467. as of q4 2014, melevodopa remains the us fda preferred term for this commodity. melevodopa bears us nlm identifiers umls id c0064871 and nci concept code c83927. smiles: coc(=o)c(cc1=cc(=c(c=c1)o)o)n.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. memantine. this classification denotes a neuroprotective agent and antiparkinsonian agent with the molecular formula c12h21n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w8o17sjf3t, chemically known as 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine but generally known as memantine, which bears us nih compound identifier 4054. european medicines agency schedules memantine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08731mig. the term memantine is an international non-proprietary name or inn (see who inn reference publication, volume 30, no. 10 1976, list 16). world health organization schedules memantine in its anatomical therapeutic chemical (atc) classification. memantine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule memantine under hs 29213099 and sitc 51453. as of q4 2014, memantine remains the us fda preferred term for this commodity. memantine bears us nlm identifiers umls id c0025242 and nci concept code c73269. smiles: nc12cc3(cc(c1)(cc(c3)c2)c)c.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. mofegiline. this classification denotes a monoamine oxidase inhibitor with the molecular formula c11h13f2n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1fmj6d8y1b, chemically known as benzenebutanamine, 4-fluoro-beta-(fluoromethylene)-, (e)- but generally known as mofegiline, which bears us nih compound identifier 6437850. european medicines agency schedules mofegiline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09034mig. the term mofegiline is an international non-proprietary name or inn (see who inn reference publication, volume 8 no. 3 1994, list 34). most nations schedule mofegiline under hs 29214980 and sitc 51454. as of q4 2014, mofegiline remains the us fda preferred term for this commodity. mofegiline bears us nlm identifiers umls id c0208987 and nci concept code c83968. smiles: c1=cc(=cc=c1cc/c(=c\\f)/cn)f.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. phenglutarimide. this classification denotes an anticholinergic agent with the molecular formula c17h24n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 679rc9h8tg, chemically known as 2,6-piperidinedione, 3-(2-(diethylamino)ethyl)-3-phenyl- but generally known as phenglutarimide, which bears us nih compound identifier 92870. european medicines agency schedules phenglutarimide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09762mig. the term phenglutarimide is an international non-proprietary name. world health organization schedules phenglutarimide in its anatomical therapeutic chemical (atc) classification. phenglutarimide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule phenglutarimide under hs 29251995 and sitc 51482. as of q4 2014, phenglutarimide remains the us fda preferred term for this commodity. phenglutarimide bears us nlm identifiers umls id c0070561 and nci concept code c90699. smiles: o=c1nc(=o)cc(c1ccn(cc)cc)c1ccccc1.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. piribedil. this classification denotes a dopamine agonist with the molecular formula c16h18n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier do22k1prdj, chemically known as 2-(4-(3,4-methylenedioxybenzyl)piperazino)pyrimidine but generally known as piribedil, which bears us nih compound identifier 4850. european medicines agency schedules piribedil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09908mig. the term piribedil is an international non-proprietary name or inn (see who inn reference publication, volume 24, no. 11 1970, list 10). world health organization schedules piribedil in its anatomical therapeutic chemical (atc) classification. piribedil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piribedil under hs 29349990 and sitc 51579. as of q4 2014, piribedil remains the us fda preferred term for this commodity. piribedil bears us nlm identifiers umls id c0031979 and nci concept code c81082. smiles: o1c2cc(cn3ccn(cc3)c3ncccn3)ccc2oc1.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. piroheptine. this classification denotes an antiparkinsonian agent with the molecular formula c22h25n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ar6y753arl, chemically known as 3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methylpyrrolidine but generally known as piroheptine, which bears us nih compound identifier 4854. european medicines agency schedules piroheptine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09931mig. the term piroheptine is an international non-proprietary name or inn (see who inn reference publication, volume 25 , no. 10 1971, list 11). piroheptine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule piroheptine under hs 29339990 and sitc 51577. as of q4 2014, piroheptine remains the us fda preferred term for this commodity. piroheptine bears us nlm identifiers umls id c0071147 and nci concept code c66431. smiles: n1(c(/c(=c2/c3c(ccc4c2cccc4)cccc3)cc1)c)cc.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. rotigotine. this classification denotes a dopamine agonist with the molecular formula c19h25nos, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 87t4t8bo2e, chemically known as 6-(propyl(2-(2-thienyl)ethyl)amino)-5,6,7,8-tetrahydro-1-naphthalenol but generally known as rotigotine, which bears us nih compound identifier 57537. european medicines agency schedules rotigotine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21254. the term rotigotine is an international non-proprietary name or inn (see who inn reference publication, volume 15 no. 1, 2001, list 45). world health organization schedules rotigotine in its anatomical therapeutic chemical (atc) classification. most nations schedule rotigotine under hs 29349990 and sitc 51579. as of q4 2014, rotigotine remains the us fda preferred term for this commodity. rotigotine bears us nlm identifiers umls id c1700683 and nci concept code c77566. smiles: s1c(ccn(c2ccc3c(c2)cccc3o)ccc)ccc1.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. adrogolide hydrochloride. this classification denotes a dopamine agonist with the molecular formula c22h25no4s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 69mg3oza0h, chemically known as benzo(f)thieno(2,3-c)quinoline-9,10-diol, 4,5,5a,6,7,11b-hexahydro-2-propyl-, diacetate (ester), hydrochloride, (5ar-trans)- but more generally known as adrogolide hydrochloride, which bears us nih compound identifier 166543. most nations, for tariff and trade purposes, schedule adrogolide hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, adrogolide hydrochloride remains us fdas preferred term for this commodity. adrogolide hydrochloride bears us nlm identifiers umls id c2347538 and nci concept code c72681. smiles: cccc1cc2c(s1)cn[c@h]3[c@h]2c4cc(c(cc4cc3)oc(=o)c)oc(=o)c.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. amantadine hydrochloride. this classification denotes an antiviral agent and cation channel blocker with the molecular formula c10h17n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m6q1eo9td0, chemically known as 1-aminotricyclo(3.3.1.1(sup 3,7))decane but more generally known as amantadine hydrochloride, which bears us nih compound identifier 2130. european medicines agency schedules amantadine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00422mig. most nations, for tariff and trade purposes, schedule amantadine hydrochloride under hs 29213000 and sitc 51453. as of q4 2014, amantadine hydrochloride remains us fdas preferred term for this commodity. amantadine hydrochloride bears us nlm identifiers umls id c0723562 and nci concept code c28818. smiles: c1[c@@h]2cc3c[c@h]1c[c@](c2)(c3)n.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. amantadine sulfate. this classification denotes a miscellaneous antiviral agent and cation channel blocker with the molecular formula 2c10h17n.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9921t5p019. european medicines agency schedules amantadine sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00423mig. the term amantadine sulfate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule amantadine sulfate under hs 29213099 and sitc 51453. as of q4 2014, amantadine sulfate remains us fdas preferred term for this commodity. amantadine sulfate bears us nlm identifiers umls id c0002404 and nci concept code c90781. smiles: c1c2cc3cc1cc(c2)(c3)n.os(=o)(=o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. apomorphine diacetate. this classification denotes a dopamine agonist and antiparkinsonian agent c21h21no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1usw70qzgv, chemically known as (6ar)-5,6,6a,7-tetrahydro-6-methyl-4h-dibenzo(de,g)quinoline-10,11-diol diacetate (ester), but more generally known as apomorphine diacetate, which bears us nih compound identifier 201536. most nations, for tariff and trade purposes, schedule apomorphine diacetate under hs 29391900 and sitc 54141. as of q4 2014, apomorphine diacetate remains us fdas preferred term for this commodity. apomorphine diacetate bears us nlm identifiers umls id c2827080 and nci concept code c83535. smiles: cc(=o)oc1ccc2c(c1oc(=o)c)-c3cccc4c3[c@@h](c2)n(cc4)c.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. apomorphine hydrochloride. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula 2c17h17no2.2clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f39049y068, chemically known as 6a.beta.-noraporphine-10,11-diol, 6-methyl-, hydrochloride but more generally known as apomorphine hydrochloride, which bears us nih compound identifier 2215. european medicines agency schedules apomorphine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12924mig. most nations, for tariff and trade purposes, schedule apomorphine hydrochloride under hs 29391900. as of q4 2014, apomorphine hydrochloride remains us fdas preferred term for this commodity. apomorphine hydrochloride bears us nlm identifiers umls id c0237406 and nci concept code c47400. smiles: cn1ccc2cccc-3c2[c@h]1cc4c3c(c(cc4)o)o.cn1ccc2cccc-3c2[c@h]1cc4c3c(c(cc4)o)o.o.cl.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. apomorphine hydrochloride anhydrous. this classification denotes a dopamine agonist and antiparkinsonian agent c17h17no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9k13md7a0d, chemically known as (6ar)-5,6,6a,7-tetrahydro-6-methyl-4h-dibenzo(de,g)quinoline-10,11-diol hydrochloride, but more generally known as apomorphine hydrochloride anhydrous, which bears us nih compound identifier 9410. most nations, for tariff and trade purposes, schedule apomorphine hydrochloride anhydrous under hs 29391900 and sitc 54141. as of q4 2014, apomorphine hydrochloride anhydrous remains us fdas preferred term for this commodity. apomorphine hydrochloride anhydrous bears us nlm identifiers umls id c0887720 and nci concept code c80572. smiles: cn1ccc2cccc-3c2[c@h]1cc4c3c(c(cc4)o)o.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. brasofensine maleate. this classification denotes the brasofensine form of an antiparkinsonian agent with the molecular formula c16h20cl2n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1yp2s94rvh, chemically known as 3-beta-(3,4-dichlorophenyl)-1-alpha-h, 5-alpha-h-tropane-2-alpha-carboxaldehyde (e)-(o-methyloxime). but more generally known as brasofensine, which bears us nih compound identifier 9554198. brasofensine most often comes in base, maleate, and sulfate forms. european medicines agency schedules brasofensine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05881mig. the term brasofensine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 11, no. 3 1997, list 38). brasofensine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule brasofensine maleate under hs 29333999 and sitc 51574. as of q4 2014, brasofensine maleate remains us fdas preferred term for this commodity. brasofensine maleate bears us nlm identifiers umls id c2698558 and nci concept code c76392. smiles: cn1[c@h]2cc[c@@h]1[c@@h]([c@h](c2)c3ccc(c(c3)cl)cl)/c=n/oc.c(=c\\c(=o)o)\\c(=o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. bromocriptine mesilate or mesylate. this classification denotes a neuroprotective agent with the molecular formula c32h40brn5o5.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ffp983j3od, chemically known as 2-bromo-alpha-ergocryptine, methanesulfonate but more generally known as bromocriptine mesilate, which bears us nih compound identifier 31100. european medicines agency schedules bromocriptine mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00878mig. most nations, for tariff and trade purposes, schedule bromocriptine mesylate under hs 29396900. as of q4 2014, bromocriptine mesylate remains us fdas preferred term for this commodity. bromocriptine mesylate bears us nlm identifiers umls id c0546852 and nci concept code c317. smiles: cc(c)c[c@h]1c(=o)n2ccc[c@h]2[c@]3(n1c(=o)[c@](o3)(c(c)c)nc(=o)[c@h]4cn([c@@h]5cc6c7c(cccc7[nh]c6br)c5=c4)c)o.cs(=o)(=o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. bromocriptine methanesulfonate. this classification denotes a neuroprotective agent with the molecular formula c32h40brn5o5.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ffp983j3od, chemically known as ergotaman-3,6,18-trione, 2-bromo-12-hydroxy-2-(1-methylethyl)-5-(2-methylpropyl)-, monomethanesulfonate (salt), (5.alpha.)-, but more generally known as bromocriptine methanesulfonate, which bears us nih compound identifier 31100. european medicines agency schedules bromocriptine methanesulfonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05918mig. most nations, for tariff purposes, schedule bromocriptine methanesulfonate under hs 29396900. smiles: cc(c)c[c@h]1c(=o)n2ccc[c@h]2[c@]3(n1c(=o)[c@](o3)(c(c)c)nc(=o)[c@h]4cn([c@@h]5cc6c7c(cccc7[nh]c6br)c5=c4)c)o.cs(=o)(=o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. budipine hydrochloride. this classification denotes an antiparkinson agent with the molecular formula c21h27n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nbf4q9307q, chemically known as 1-tert-butyl-4,4-diphenylpiperidine hydrochloride but more generally known as budipine hydrochloride, which bears us nih compound identifier 3030419. european medicines agency schedules budipine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub35026. most nations, for tariff and trade purposes, schedule budipine hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, budipine hydrochloride remains us fdas preferred term for this commodity. smiles: cc(c)(c)n1ccc(cc1)(c2ccccc2)c3ccccc3.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. carbidopa anhydrous. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula c10h14n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier kr87b45rgh, chemically known as benzenepropanoic acid, .alpha.-hydrazino-3,4-dihydroxy-.alpha.-methyl-, (s)-, but more generally known as carbidopa anhydrous, which bears us nih compound identifier 34359. european medicines agency schedules carbidopa anhydrous or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06126mig. most nations, for tariff purposes, schedule carbidopa anhydrous under hs 29280090. carbidopa anhydrous bears us nlm identifiers umls id c1881339 and nci concept code c61803. smiles: c[c@](cc1ccc(c(c1)o)o)(c(=o)o)nn.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. ciladopa hydrochloride. this classification denotes a dopamine agonist with the molecular formula c21h26n2o4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier asr1nr721i. the term ciladopa hydrochloride is a united states adopted name designation. most nations, for tariff and trade purposes, schedule ciladopa hydrochloride under hs 29335995 and sitc 51576. as of q4 2014, ciladopa hydrochloride remains us fdas preferred term for this commodity. smiles: coc1ccc(cc1oc)[c@@h](cn2ccn(cc2)c3cccccc3=o)o.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. ifenprodil tartrate. this classification denotes a platelet aggregation inhibitor, antiparkinson agent, and anticonvulsant with the molecular formula 2c21h27no2.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 89ctb4xuf7, chemically known as 4-benzyl-1-(beta,4-dihydroxy-alpha-methylphenethyl)piperidinium hydrogen tartrate but more generally known as ifenprodil tartrate, which bears us nih compound identifier 134832. european medicines agency schedules ifenprodil tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02636mig. most nations, for tariff and trade purposes, schedule ifenprodil tartrate under hs 29333999 and sitc 51574. as of q4 2014, ifenprodil tartrate remains us fdas preferred term for this commodity. smiles: cc(c(c1ccc(cc1)o)o)n2ccc(cc2)cc3ccccc3.cc(c(c1ccc(cc1)o)o)n2ccc(cc2)cc3ccccc3.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. lazabemide hydrochloride. this classification denotes a monoamine oxidase inhibitor c8h10cln3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pi150j9zx1, chemically known as 2-pyridinecarboxamide, n-(2-aminoethyl)-5-chloro-, monohydrochloride, but more generally known as lazabemide hydrochloride, which bears us nih compound identifier 163727. most nations, for tariff and trade purposes, schedule lazabemide hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, lazabemide hydrochloride remains us fdas preferred term for this commodity. lazabemide hydrochloride bears us nlm identifiers umls id c2825397 and nci concept code c80968. smiles: c1cc(ncc1cl)c(=o)nccn.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. lazabemide monohydrochloride. this classification denotes a monoamine oxidase inhibitor with the molecular formula c8h10cln3o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pi150j9zx1, chemically known as n-(2-aminoethyl)-5-chloro-2-pyridine-carboxamide hydrochloride, but more generally known as lazabemide monohydrochloride, which bears us nih compound identifier 163727. european medicines agency schedules lazabemide monohydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08418mig. most nations, for tariff purposes, schedule lazabemide monohydrochloride under hs 29333999. smiles: c1cc(ncc1cl)c(=o)nccn.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. lisuride maleate. this classification denotes an antiparkinsonian agent with the molecular formula c20h26n4o.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier uv1635n8xw, chemically known as 3-(9,10-didehydro-6-methylergolin-8alpha-yl)-1,1-diethylurea but more generally known as lisuride maleate, which bears us nih compound identifier 28864. european medicines agency schedules lisuride maleate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02940mig. most nations, for tariff and trade purposes, schedule lisuride maleate under hs 29396900 and sitc 54146. as of q4 2014, lisuride maleate remains us fdas preferred term for this commodity. smiles: ccn(cc)c(=o)n[c@@h]1cn([c@@h]2cc3c[nh]c4c3c(ccc4)c2=c1)c.c(=c\\c(=o)o)\\c(=o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. mazaticol hydrochloride. this classification denotes an anticholinergic agent with the molecular formula c20h25no3s2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 44wqi5180q, chemically known as 6,6,9-trimethyl-9-azabicyclo(3.3.1)non-3beta-yl-alpha,alpha-di-(2-thienyl)glycolate hydrochloride but more generally known as mazaticol hydrochloride, which bears us nih compound identifier 135004. european medicines agency schedules mazaticol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03096mig. most nations, for tariff and trade purposes, schedule mazaticol hydrochloride under hs 29349990 and sitc 51579. as of q4 2014, mazaticol hydrochloride remains us fdas preferred term for this commodity. smiles: cc1(ccc2cc(cc1n2c)oc(=o)c(c3cccs3)(c4cccs4)o)c.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. melevodopa hydrochloride. this classification denotes a dopamine agonist with the molecular formula c10h13no4.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jfu1a8866v. european medicines agency schedules melevodopa hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub33439. most nations, for tariff and trade purposes, schedule melevodopa hydrochloride under hs 29225000. as of q4 2014, melevodopa hydrochloride remains us fdas preferred term for this commodity. smiles: coc(=o)[c@h](cc1ccc(c(c1)o)o)n.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. memantine hydrochloride. this classification denotes an antiparkinsonian agent with the molecular formula c12h21n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier jy0wd0ua60, chemically known as 3,5-dimethyltricyclo(3.3.1.1(3,7))decan-1-amine but more generally known as memantine hydrochloride, which bears us nih compound identifier 4054. european medicines agency schedules memantine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03137mig. most nations, for tariff and trade purposes, schedule memantine hydrochloride under hs 29213099 and sitc 51453. as of q4 2014, memantine hydrochloride remains us fdas preferred term for this commodity. memantine hydrochloride bears us nlm identifiers umls id c0771988 and nci concept code c47601. smiles: c[c@@]12cc3c[c@@](c1)(c[c@](c3)(c2)n)c.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. mofegiline hydrochloride. this classification denotes a monoamine oxidase inhibitor c11h13f2n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 08331r10ry, chemically known as benzenebutanamine, 4-fluoro-.beta.-(fluoromethylene)-, hydrochloride, (e)-, but more generally known as mofegiline hydrochloride, which bears us nih compound identifier 3047771. most nations, for tariff and trade purposes, schedule mofegiline hydrochloride under hs 29214980 and sitc 51454. as of q4 2014, mofegiline hydrochloride remains us fdas preferred term for this commodity. mofegiline hydrochloride bears us nlm identifiers umls id c2825395 and nci concept code c80965. smiles: c1cc(ccc1cc/c(=c\\f)/cn)f.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. pergolide mesilate or mesylate. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula c19h26n2s.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 55b9hqy616, chemically known as ergoline, 8-((methylthio)methyl)-6-propyl-, monomethanesulfonate, (8beta)- but more generally known as pergolide mesilate, which bears us nih compound identifier 47812. european medicines agency schedules pergolide mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03709mig. most nations, for tariff and trade purposes, schedule pergolide mesylate under hs 29396900. as of q4 2014, pergolide mesylate remains us fdas preferred term for this commodity. pergolide mesylate bears us nlm identifiers umls id c0701027 and nci concept code c47665. smiles: cccn1c[c@@h](c[c@h]2[c@h]1cc3c[nh]c4c3c2ccc4)csc.cs(=o)(=o)o.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. phenglutarimide hydrochloride. this classification denotes an anticholinergic agent with the molecular formula c17h24n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier b963byq21v, chemically known as 2-(2-diethylaminoethyl)-2-phenylglutarimide hydrochloride, but more generally known as phenglutarimide hydrochloride, which bears us nih compound identifier 102668. european medicines agency schedules phenglutarimide hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09762mig. most nations, for tariff purposes, schedule phenglutarimide hydrochloride under hs 29251995. smiles: ccn(cc)ccc1(ccc(=o)nc1=o)c2ccccc2.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. piribedil mesilate or mesylate. this classification denotes a dopamine agonist with the molecular formula c16h18n4o2.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1u37ngm6kk, chemically known as 2-(4-(1,3-benzodioxol-5-ylmethyl)piperazinyl)pyrimidinium methanesulphonate but more generally known as piribedil mesylate, which bears us nih compound identifier 198284. european medicines agency schedules piribedil mesylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21569. most nations, for tariff and trade purposes, schedule piribedil mesylate under hs 29349990. as of q4 2014, piribedil mesylate remains us fdas preferred term for this commodity. smiles: cs(=o)(=o)o.c1cnc(nc1)n2ccn(cc2)cc3ccc4c(c3)oco4.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. piribedil monomethanesulfonate. this classification denotes a dopamine agonist with the molecular formula c16h18n4o2.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1u37ngm6kk, chemically known as 2-(4-(1,3-benzodioxol-5-ylmethyl)piperazin-1-yl)pyrimidine, methanesulfonic acid, but more generally known as piribedil monomethanesulfonate, which bears us nih compound identifier 198284. european medicines agency schedules piribedil monomethanesulfonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09908mig. most nations, for tariff purposes, schedule piribedil monomethanesulfonate under hs 29349990. smiles: cs(=o)(=o)o.c1cnc(nc1)n2ccn(cc2)cc3ccc4c(c3)oco4.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. piroheptine hydrochloride. this classification denotes an antiparkinsonian agent with the molecular structure c22h25n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 4zm573199n chemically known as 3-(10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-ethyl-2-methyl, hydrochloride, but more commonly known as piroheptine hydrochloride, which bears us nih compound identifier 27844. european medicines agency schedules piroheptine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32954. most nations, for tariff and trade purposes, schedule piroheptine hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, piroheptine hydrochloride remains us fdas preferred term for this commodity. smiles: ccn1ccc(=c2c3ccccc3ccc4c2cccc4)c1c.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. pramipexole dihydrochloride. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula c10h17n3s.2clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3d867np06j, chemically known as 2,6-benzothiazolediamine, 4,5,6,7-tetrahydro-n6-propyl-, dihydrochloride, (s)- but more generally known as pramipexole dihydrochloride, which bears us nih compound identifier 119569. european medicines agency schedules pramipexole dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04004mig. most nations, for tariff and trade purposes, schedule pramipexole dihydrochloride under hs 29341000 and sitc 51579. as of q4 2014, pramipexole dihydrochloride remains us fdas preferred term for this commodity. pramipexole dihydrochloride bears us nlm identifiers umls id c0721754 and nci concept code c29374. smiles: cccn[c@h]1ccc2c(sc(n2)n)c1.o.cl.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. pramipexole dihydrochloride monohydrate. this classification denotes a dopamine agonist and antiparkinsonian agent with the molecular formula c10h17n3s.2clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3d867np06j, chemically known as 2,6-benzothiazolediamine, 4,5,6,7-tetrahydro-n6-propyl-, dihydrochloride, (s)- but more generally known as pramipexole dihydrochloride, which bears us nih compound identifier 119569. european medicines agency schedules pramipexole dihydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04004mig. most nations, for tariff and trade purposes, schedule pramipexole dihydrochloride monohydrate under hs 29341000. smiles: cccn[c@h]1ccc2c(sc(n2)n)c1.o.cl.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. pramipexole hydrochloride hydrate. this classification denotes an antidepressant agent with the molecular formula c10h17n3s.2clh.h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3d867np06j, chemically known as (s)-2-amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole dihydrochloride monohydrate, but more generally known as pramipexole hydrochloride hydrate, which bears us nih compound identifier 166589. european medicines agency schedules pramipexole hydrochloride hydrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09990mig. most nations, for tariff purposes, schedule pramipexole hydrochloride hydrate under hs 29341000. smiles: cccn[c@h]1ccc2c(sc(n2)n)c1.o.cl.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. profenamine hydrochloride. this classification denotes a histamine-1 receptor antagonist with the molecular formula c19h24n2s.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o00t1i1vrn, chemically known as 10h-phenothiazine-10-ethanamine, n,n-diethyl-.alpha.-methyl-, monohydrochloride but more generally known as ethopropazine hydrochloride, which bears us nih compound identifier 3290. european medicines agency schedules profenamine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04056mig. most nations, for tariff and trade purposes, schedule profenamine hydrochloride under hs 29343090. smiles: ccn(cc)c(c)cn1c2ccccc2sc3c1cccc3.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. rasagiline mesilate or mesylate. this classification denotes a monoamine oxidase inhibitor and antiparkinsonian agent with the molecular formula c12h13n.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lh8c2ji290, chemically known as 1h-inden-1-amine, 2,3-dihydro-n-2-propynyl-, (r)-, methanesulfonate but more generally known as rasagiline mesilate, which bears us nih compound identifier 3052775. european medicines agency schedules rasagiline mesilate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21334. most nations, for tariff and trade purposes, schedule rasagiline mesylate under hs 29214980 and sitc 51454. as of q4 2014, rasagiline mesylate remains us fdas preferred term for this commodity. rasagiline mesylate bears us nlm identifiers umls id c1615645 and nci concept code c66511. smiles: cs(=o)(=o)o.c#ccn[c@@h]1ccc2c1cccc2.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. rasagiline methanesulfonate. this classification denotes a monoamine oxidase inhibitor and antiparkinsonian agent with the molecular formula c12h13n.ch4o3s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier lh8c2ji290, chemically known as (r)-n-2-propynyl-1-indanamine methanesulfonate, but more generally known as rasagiline methanesulfonate, which bears us nih compound identifier 3052775. european medicines agency schedules rasagiline methanesulfonate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10261mig. most nations, for tariff purposes, schedule rasagiline methanesulfonate under hs 29214980. smiles: cs(=o)(=o)o.c#ccn[c@@h]1ccc2c1cccc2.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. ropinirole hydrochloride. this classification denotes an antiparkinsonian agent with the molecular formula c16h24n2o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d7zd41rzi9, chemically known as 4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one but more generally known as ropinirole hydrochloride, which bears us nih compound identifier 5095. european medicines agency schedules ropinirole hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15144mig. most nations, for tariff and trade purposes, schedule ropinirole hydrochloride under hs 29337900 and sitc 51561. as of q4 2014, ropinirole hydrochloride remains us fdas preferred term for this commodity. ropinirole hydrochloride bears us nlm identifiers umls id c0771840 and nci concept code c47710. smiles: cccn(ccc)ccc1cccc2c1cc(=o)n2.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. rotigotine hydrochloride. this classification denotes a dopamine agonist with the molecular formula c19h25nos.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6q1w9573l2, chemically known as rotigotine hydrochloride, (-)-, but more generally known as rotigotine hydrochloride, which bears us nih compound identifier 180335. european medicines agency schedules rotigotine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21254. most nations, for tariff purposes, schedule rotigotine hydrochloride under hs 29349990. smiles: cccn(ccc1cccs1)[c@h]2ccc3c(cccc3o)c2.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. selegiline hydrochloride. this classification denotes a monoamine oxidase inhibitor with the molecular formula c13h17n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6w731x367q, chemically known as (-)-(r)-n,alpha-dimethyl-n-2-propynylphenethylamine monohydrochloride but more generally known as selegiline hydrochloride, which bears us nih compound identifier 26758. european medicines agency schedules selegiline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04347mig. most nations, for tariff and trade purposes, schedule selegiline hydrochloride under hs 29214980 and sitc 51454. as of q4 2014, selegiline hydrochloride remains us fdas preferred term for this commodity. selegiline hydrochloride bears us nlm identifiers umls id c0700467 and nci concept code c47714. smiles: c[c@h](cc1ccccc1)n(c)cc#c.cl.. "
"antiparkinson drugs. this classification denotes drugs that treat a progressive, degenerative neurologic disease, called parkinsons disease, characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem.. tropatepine. this classification denotes a tropane and dibenzothiepin with the molecular formula c22h23ns, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier c27hy5rfu5, chemically known as 8-azabicyclo(3.2.1)octane, 3-dibenzo(b,e)thiepin-11(6h)-ylidene-8-methyl- but more generally known as tropatepine, which bears u.s. nih compound identifier 72148. european medicines agency schedules tropatepine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11340mig. world health organization schedules tropatepine in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary. tropatepine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"stimulants and anorexiants. this classification denotes agents that suppress appetite.. . "
"stimulants and anorexiants. this classification denotes agents that suppress appetite.. amfepramone or dexfenfluramine or diethylcathinone or diethylpropion. this classification denotes a serotonin agonist with the molecular formula c12h16f3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e35r3g56ov, chemically known as phenethylamine, n-ethyl-alpha-methyl-m-(trifluoromethyl)-, (s)- but generally known as dexfenfluramine, which bears us nih compound identifier 3337. european medicines agency schedules dexfenfluramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07028mig. the term dexfenfluramine is an international non-proprietary name. world health organization schedules dexfenfluramine in its anatomical therapeutic chemical (atc) classification. dexfenfluramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ccnc(c)cc1=cc(=cc=c1)c(f)(f)f.. "
"stimulants and anorexiants. this classification denotes agents that suppress appetite.. flurothyl. this classification denotes a cns stimulant with the molecular formula c4h4f6o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 9z467fg2yk, chemically known as 2,2,2-trifluoroethyl ether but generally known as flurothyl, which bears us nih compound identifier 9528. european medicines agency schedules flurotyl in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07750mig. the term flurotyl is an international non-proprietary name or inn (see who inn reference publication, volume 31, no10, 1977, list 17). as of q4 2014, flurothyl remains the us fda preferred term for this commodity. flurothyl bears us nlm identifiers umls id c0016380 and nci concept code c76624. smiles: c(c(f)(f)f)occ(f)(f)f.. "
"stimulants and anorexiants. this classification denotes agents that suppress appetite.. fenethylline or fenetylline or phenethylline. this classification denotes a cns stimulant with the molecular formula c18h23n5o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yz0n7vl5r3, chemically known as theophylline, 7-(2-((alpha-methylphenethyl)amino)ethyl)- but generally known as fenethylline, which bears us nih compound identifier 19527. european medicines agency schedules fenetylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07560mig. the term fenetylline is an international non-proprietary name or inn (see who inn reference publication, volume 21 no. 12 1967, list 7). world health organization schedules fenethylline in its anatomical therapeutic chemical (atc) classification. fenethylline or phenethylline bears us nlm identifiers umls id c0060167 and nci concept code c81051. smiles: cc(cc1=cc=cc=c1)nccn2c=nc3=c2c(=o)n(c(=o)n3c)c.. "
"stimulants and anorexiants. this classification denotes agents that suppress appetite.. orlistat. this classification denotes a gastrointestinal lipase inhibitor with the molecular formula c29h53no5, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 95m8r751w8, chemically known as n-formyl-l-leucine, ester with (3s,4s)-3-hexyl-4-((2s)-2-hydroxytridecyl)-2-oxetanone but generally known as orlistat, which bears us nih compound identifier 3034010. european medicines agency schedules orlistat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09460mig. the term orlistat is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). world health organization schedules orlistat in its anatomical therapeutic chemical (atc) classification. orlistat is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, orlistat remains the us fda preferred term for this commodity. orlistat bears us nlm identifiers umls id c0732649 and nci concept code c29303. smiles: o1c(c(cccccc)c1=o)cc(oc(=o)c(nc=o)cc(c)c)ccccccccccc.. "
"stimulants and anorexiants. this classification denotes agents that suppress appetite.. oxiracetam. this classification denotes a nutritional supplement and neuroprotective agent with the molecular formula c6h10n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier p7u817352g, chemically known as 1-pyrrolidineacetamide, 4-hydroxy-2-oxo-, (s)- but generally known as oxiracetam, which bears us nih compound identifier 4626. european medicines agency schedules oxiracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09536mig. the term oxiracetam is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). world health organization schedules oxiracetam in its anatomical therapeutic chemical (atc) classification. oxiracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule oxiracetam under hs 29337900 and sitc 51561. as of q4 2014, oxiracetam remains the us fda preferred term for this commodity. oxiracetam bears us nlm identifiers umls id c0069772 and nci concept code c66271. smiles: oc1cn(c(=o)c1)cc(=o)n.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. . "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. imuracetam. this classification denotes a neuroprotective agent with the molecular formula c11h18n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 972fnv35zm, chemically known as 1,3-bis((2-oxo-1-pyrrolidinyl)methyl)harnstoff but generally known as imuracetam, which bears us nih compound identifier 163319. european medicines agency schedules imuracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08161mig. the term imuracetam is an international non-proprietary name or inn (see who inn reference publication, volume 34, no. 10 1980, list 20). imuracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule imuracetam under hs 29337900 and sitc 51561. as of q4 2014, imuracetam remains the us fda preferred term for this commodity. imuracetam bears us nlm identifiers umls id c1881153 and nci concept code c65904. smiles: c1cc(=o)n(c1)cnc(=o)ncn2cccc2=o.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. aceglutamide. this classification denotes a cns stimulant with the molecular formula c7h12n2o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 01j18g9g97, chemically known as l-glutamine, n2-acetyl- but generally known as aceglutamide, which bears us nih compound identifier 25561. aceglutamide most often arises in forms base and aluminium. european medicines agency schedules aceglutamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05208mig. the term aceglutamide is an international non-proprietary name. aceglutamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aceglutamide under hs 29241900 and sitc 51471. as of q4 2014, aceglutamide remains the us fda preferred term for this commodity. aceglutamide bears us nlm identifiers umls id c0050407 and nci concept code c77843. smiles: oc(=o)c(nc(=o)c)ccc(=o)n.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. aloracetam. this classification denotes a neuroprotective agent with the molecular formula c11h16n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier u0rkz75d0t, chemically known as n-(2-(3-formyl-2,5-dimethylpyrrol-1-yl)ethyl)acetamide but generally known as aloracetam, which bears us nih compound identifier 178134. european medicines agency schedules aloracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05357mig. the term aloracetam is an international non-proprietary name. aloracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule aloracetam under hs 29339990 and sitc 51577. as of q4 2014, aloracetam remains the us fda preferred term for this commodity. aloracetam bears us nlm identifiers umls id c2698059 and nci concept code c74324. smiles: cc1=cc(=c(n1ccnc(=o)c)c)c=o.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. amifampridine. this classification denotes a cation channel blocker with the molecular formula c5h7n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ru4s6e2g0j, chemically known as 3,4 diaminopyridine, but generally known as amifampridine. european medicines agency schedules amifampridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub28846. as of q4 2014, amifampridine remains the us fda preferred term for this commodity. amifampridine bears us nlm identifiers umls id c0046948 and nci concept code c82687. smiles: none.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. brivaracetam. this classification denotes a neuroprotective agent and anticonvulsant agent with the molecular formula c11h20n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, u863jgg2ia chemically known as 1-pyrrolidineacetamide, .alpha.-ethyl-2-oxo-4-propyl (.alpha.s,4r)- but generally known as brivaracetam, which bears us nih compound identifier 9837243. european medicines agency schedules brivaracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25397. the term brivaracetam is an international non-proprietary name or inn (see who inn reference publication, volume 20, no. 1, 2006, list 55). most nations schedule brivaracetam under hs 29337900 and sitc 51561. as of q4 2014, brivaracetam remains the us fda preferred term for this commodity. brivaracetam bears us nlm identifiers umls id c1699861 and nci concept code c65270. smiles: cccc1cc(=o)n(c1)c(cc)c(=o)n.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. choline alfoscerate. this classification denotes a glycerylphosphorylcholine with the molecular formula c8h20no6p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 60m22sgw66, chemically known as ethanaminium, 2-(((2,3-dihydroxypropoxy)hydroxyphosphinyl)oxy)-n,n,n-trimethyl-, hydroxide, inner salt, (r)- but generally known as choline alfoscerate, which bears us nih compound identifier 71920. european medicines agency schedules choline alfoscerate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06216mig. world health organization schedules choline alfoscerate in its anatomical therapeutic chemical (atc) classification. most nations schedule choline alfoscerate under hs 29231000 and sitc 51481. as of q4 2014, choline alfoscerate remains the us fda preferred term for this commodity. smiles: p(=o)(occ[n](c)(c)c)(occ(o)co)o.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. coluracetam. this classification denotes a nootropic with the molecular formula c19h23n3o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier v6fl6o5gr7, chemically known as n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide but generally known as coluracetam, which bears us nih compound identifier 214346. most nations schedule coluracetam under hs 29349990 and sitc 51579. as of q4 2014, coluracetam remains the us fda preferred term for this commodity. coluracetam bears us nlm identifiers umls id c2699411 and nci concept code c77391. smiles: cc1=c(oc2=nc3=c(cccc3)c(=c12)nc(=o)cn4cccc4=o)c.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. dimiracetam. this classification denotes a neuroprotective agent with the molecular formula c6h8n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 4aw7f70mzo chemically known as (+/-)-dihydro-1h-pyrrolo(1,2-a)imidazole-2,5(3h,6h)-dione but generally known as dimiracetam, which bears us nih compound identifier 65955. european medicines agency schedules dimiracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07186mig. the term dimiracetam is an international non-proprietary name or inn (see who inn reference publication, volume 7, no3, 1993, list 33). most nations schedule dimiracetam under hs 29337900 and sitc 51561. as of q4 2014, dimiracetam remains the us fda preferred term for this commodity. dimiracetam bears us nlm identifiers umls id c0250359 and nci concept code c79121. smiles: c1cc(=o)n2c1nc(=o)c2.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. dalfampridine or fampridine. this classification denotes a cation channel blocker with the molecular formula c5h6n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier bh3b64okl9, chemically known as 4-pyridinamine, monohydrochloride but generally known as fampridine, which bears us nih compound identifier 1727. european medicines agency schedules fampridine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07505mig. the term fampridine is an international non-proprietary name or inn (see who inn reference publication, volume 9, no. 3, 1995, list 35). world health organization schedules fampridine in its anatomical therapeutic chemical (atc) classification. dalfampridine or fampridine bears us nlm identifiers umls id c0000477 and nci concept code c76777. smiles: c1=cn=cc=c1n.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. fasoracetam. this classification denotes a nutritional supplement and neuroprotective agent with the molecular formula c10h16n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42o8uf5cjb, chemically known as piperidine, 1-((5-oxo-2-pyrrolidinyl)carbonyl)-, (r)- but generally known as fasoracetam, which bears us nih compound identifier 198695. the term fasoracetam is an international non-proprietary name or inn (see who inn reference publication, volume 12 no. 2 1999, list 40). fasoracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule fasoracetam under hs 29337900 and sitc 51561. as of q4 2014, fasoracetam remains the us fda preferred term for this commodity. fasoracetam bears us nlm identifiers umls id c1880737 and nci concept code c65623. smiles: c1ccn(cc1)c(=o)c2ccc(=o)n2.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. vinconate. this classification denotes a cholinergic agonist with the molecular formula c18h20n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 807mp0mj61, chemically known as 1h-indolo(3,2,1-de)(1,5)naphthyridine-6-carboxylic acid, 3-ethyl-2,3,3a,4-tetrahydro-, methyl ester, (+-)- but generally known as vinconate, which bears us nih compound identifier 68896. european medicines agency schedules vinconate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00058mig. the term vinconate is an international non-proprietary name. vinconate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule vinconate under hs 29339990 and sitc 51577. as of q4 2014, vinconate remains the us fda preferred term for this commodity. vinconate bears us nlm identifiers umls id c0078247 and nci concept code c76615. smiles: o(c(=o)c1=ccc2n(ccc3c2n1c1c3cccc1)cc)c.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. leteprinim. this classification denotes a neuroprotective agent with the molecular formula c15h13n5o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nby3iu407m, chemically known as 4-((3-(1,6-dihydro-6-oxo-9h-purin-9-yl)-1-oxopropyl)amino)benzoic acid but generally known as leteprinim, which bears us nih compound identifier 132123. european medicines agency schedules leteprinim in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02897mig. the term leteprinim is an international non-proprietary name or inn (see who inn reference publication, volume 13 no. 3, 1999, list 42). most nations schedule leteprinim under hs 29335995 and sitc 51576. as of q4 2014, leteprinim remains the us fda preferred term for this commodity. leteprinim bears us nlm identifiers umls id c0252664 and nci concept code c80995. smiles: o=c(nc1ccc(cc1)c(=o)o)ccn1c2[nh]cnc(=o)c2nc1.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. centrophenoxine or meclofenoxate. this classification denotes a neuroprotective agent and nootropic agent with the molecular formula c12h16clno3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier c76qq2i0rg, chemically known as acetic acid, (p-chlorophenoxy)-, 2-(dimethylamino)ethyl ester, hydrochloride but generally known as meclofenoxate, which bears us nih compound identifier 4039. european medicines agency schedules meclofenoxate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08679mig. world health organization schedules meclofenoxate in its anatomical therapeutic chemical (atc) classification. meclofenoxate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cn(c)ccoc(=o)coc1=cc=c(c=c1)cl.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. molracetam. this classification denotes a neuroprotective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r47kmf9589. european medicines agency schedules molracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09043mig. molracetam generally arises in the molecular formula c18h25n3o4. the term molracetam is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26.) molracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule molracetam under hs 29349990 and sitc 51579. as of q4 2014, molracetam remains the us fda preferred term for this commodity. molracetam bears us nlm identifiers umls id c1881887 and nci concept code c66180. smiles: o1ccn(c(=o)cn2ccn(cc2)c(=o)c2ccc(oc)cc2)cc1.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. nebracetam. this classification denotes a neuroprotective agent with the molecular formula c12h16n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier t30038qi8n, chemically known as 2-pyrrolidinone, 4-(aminomethyl)-1-(phenylmethyl)- but generally known as nebracetam, which bears us nih compound identifier 65926. european medicines agency schedules nebracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09176mig. the term nebracetam is an international non-proprietary name or inn (see who inn reference publication, volume 3, no. 3, 1989, list 29). nebracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nebracetam under hs 29337900 and sitc 51561. as of q4 2014, nebracetam remains the us fda preferred term for this commodity. nebracetam bears us nlm identifiers umls id c0078459 and nci concept code c66223. smiles: c1c(cn(c1=o)cc2=cc=cc=c2)cn.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. nefiracetam. this classification denotes a neuroprotective agent with the molecular formula c14h18n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1jk12gx30n, chemically known as 2-oxo-1-pyrrolidineaceto-2,6-xylidide but generally known as nefiracetam, which bears us nih compound identifier 71157. european medicines agency schedules nefiracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09181mig. the term nefiracetam is an international non-proprietary name or inn (see who inn reference publication, volume 6, no, 3 1992, list 32). nefiracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule nefiracetam under hs 29337900 and sitc 51561. as of q4 2014, nefiracetam remains the us fda preferred term for this commodity. nefiracetam bears us nlm identifiers umls id c0165264 and nci concept code c74325. smiles: o=c1n(ccc1)cc(=o)nc1c(cccc1c)c.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. nicoracetam. this classification denotes a neuroprotective agent with the molecular formula c11h12n2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 8u10gc2v6y, chemically known as 2-pyrrolidinone, 1-((6-methoxy-3-pyridinyl)carbonyl)- but generally known as nicoracetam, which bears us nih compound identifier 3047790. european medicines agency schedules nicoracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09243mig. the term nicoracetam is an international non-proprietary name or inn (see who inn reference publication, volume 5, no. 3 1991, list 31). most nations schedule nicoracetam under hs 29337900 and sitc 51561. as of q4 2014, nicoracetam remains the us fda preferred term for this commodity. nicoracetam bears us nlm identifiers umls id c2698464 and nci concept code c76782. smiles: coc1=nc=c(c=c1)c(=o)n2cccc2=o.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. rolziracetam. this classification denotes a neuroprotective agent with the molecular formula c7h9no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier res9i0lgg5, chemically known as 3,5-dioxopyrrolizidine but generally known as rolziracetam, which bears us nih compound identifier 71893. european medicines agency schedules rolziracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10370mig. the term rolziracetam is an international non-proprietary name or inn (see who inn reference publication, volume 40, no. 6, 1986, list 26). rolziracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule rolziracetam under hs 29337900 and sitc 51561. as of q4 2014, rolziracetam remains the us fda preferred term for this commodity. rolziracetam bears us nlm identifiers umls id c0632468 and nci concept code c80998. smiles: o=c1n2c(ccc2=o)cc1.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. sulbutiamine. this classification denotes a thiamine analog, glutamatergic, dopaminergic, and neurotropic agent with the molecular formula c32h46n8o6s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 42ncm1bw43, chemically known as thiamine disulfide o,o-diisobutyrate but generally known as sulbutiamine, which bears us nih compound identifier 3002120. european medicines agency schedules sulbutiamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10679mig. world health organization schedules sulbutiamine in its anatomical therapeutic chemical (atc) classification. sulbutiamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule sulbutiamine under hs 29335995 and sitc 51576. as of q4 2014, sulbutiamine remains the us fda preferred term for this commodity. smiles: cc1=nc=c(c(=n1)n)cn(/c(=c(/ss/c(=c(/n(c=o)cc2=cn=c(n=c2n)c)\\c)/ccoc(=o)c(c)c)\\ccoc(=o)c(c)c)/c)c=o.. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. aceglutamide aluminium. this classification denotes an anti-ulcer agent with the molecular structure 5c7h11n2o4.3al.4ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, r7qtg0pmpx chemically known as aluminium, pentakis(n(sup 2)-acetyl-l-glutaminato)tetrahydroxytri-, but more commonly known as aceglutamide aluminium, which bears us nih compound identifier 25560. european medicines agency schedules aceglutamide aluminium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00244mig. most nations, for tariff and trade purposes, schedule aceglutamide aluminium under hs 29241900 and sitc 51471. smiles: cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].[oh-].[oh-].[oh-].[oh-].[al+3].[al+3].[al+3].. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. aceglutamide aluminum. this classification denotes a cns stimulant with the molecular formula 5c7h11n2o4.3al.4ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r7qtg0pmpx, chemically known as aluminium, pentakis(n(sup 2)-acetyl-l-glutaminato)tetrahydroxytri-, but more generally known as aceglutamide aluminum, which bears us nih compound identifier 25560. european medicines agency schedules aceglutamide aluminum or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05208mig. most nations, for tariff purposes, schedule aceglutamide aluminum under hs 29241900. as of q4 2014, aceglutamide aluminum remains us fdas preferred term for this commodity. aceglutamide aluminum bears us nlm identifiers umls id c0101034 and nci concept code c81602. smiles: cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].cc(=o)n[c@@h](ccc(=o)n)c(=o)[o-].[oh-].[oh-].[oh-].[oh-].[al+3].[al+3].[al+3].. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. leteprinim potassium. this classification denotes a neuroprotective agent c15h12n5o4.k, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier q06wu8jy4f, chemically known as potassium 4-((3-(1,6-dihydro-6-oxo-9h-purin-9-yl)-1-oxopropyl)amino)benzoate, but more generally known as leteprinim potassium, which bears us nih compound identifier 23663995. most nations, for tariff and trade purposes, schedule leteprinim potassium under hs 29335995 and sitc 51576. as of q4 2014, leteprinim potassium remains us fdas preferred term for this commodity. leteprinim potassium bears us nlm identifiers umls id c0967722 and nci concept code c80996. smiles: c1cc(ccc1c(=o)[o-])nc(=o)ccn2cnc3c2nc[nh]c3=o.[k+].. "
"nootropics. drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias.. vinconate hydrochloride. this classification denotes a cholinergic agonist with the molecular formula c18h20n2o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h5mm0uo9n8, chemically known as vinconate hydrochloride, (+/-)-, but more generally known as vinconate hydrochloride, which bears us nih compound identifier 147526. european medicines agency schedules vinconate hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00058mig. most nations, for tariff purposes, schedule vinconate hydrochloride under hs 29339990. smiles: ccn1ccc2c3ccccc3n4c2c1cc=c4c(=o)oc.cl.. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. . "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. salicylic acid. this classification denotes an anti-infective agent with the molecular formula c7h6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier o414pz4lpz, chemically known as silver salicylate, ag (c7h5o3) but generally known as salicylic acid, which bears us nih compound identifier 338. european medicines agency schedules salicylic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15180mig. world health organization schedules salicylic acid in its anatomical therapeutic chemical (atc) classification. most nations schedule salicylic acid under hs 29182100 and sitc 51393. as of q4 2014, salicylic acid remains the us fda preferred term for this commodity. salicylic acid bears us nlm identifiers umls id c0036079 and nci concept code c61934. smiles: c1=cc=c(c(=c1)c(=o)o)o.. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. aloxiprin or aluminium acetylsalicylate. this classification denotes a pharmacologic substance and aluminium acetylsalicylate and unclear, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6qt214x4xu. european medicines agency schedules aloxiprin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00370mig. aloxiprin generally arises in the molecular formula c9h8o4.2al.3o. the term aloxiprin is an international non-proprietary name or inn (see who inn reference publication, volume 19 1975, list 5.) aloxiprin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc(=o)oc1=cc=cc=c1c(=o)[o-].cc(=o)oc1=cc=cc=c1c(=o)[o-].[oh-].[al+3].. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. acetylsalicylic acid or aspirin. this classification denotes a cyclooxygenase inhibitor with the molecular formula c9h8o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r16co5y76e, chemically known as salicylic acid, acetyl- but generally known as acetylsalicylic acid, which bears us nih compound identifier 2244. european medicines agency schedules acetylsalicylic acid in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12730mig. world health organization schedules acetylsalicylic acid in its anatomical therapeutic chemical (atc) classification. smiles: o(c1c(cccc1)c(=o)o)c(=o)c.. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. bismuth subsalicylate. this classification denotes a cytoprotective agent and antidiarrheal agent with the molecular formula c7h4o3.bi.ho, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 62tey51rr1, chemically known as salicylic acid, bismuth(3+) salt (3:1) but generally known as bismuth salicylate, which bears us nih compound identifier 197976. european medicines agency schedules bismuth subsalicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13093mig. as of q4 2014, bismuth subsalicylate remains the us fda preferred term for this commodity. bismuth subsalicylate bears us nlm identifiers umls id c0053792 and nci concept code c1020. smiles: c1=cc=c2c(=c1)c(=o)o[bi]o2.o.. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. diflunisal. this classification denotes a nonsteroidal antiinflammatory drug with the molecular formula c13h8f2o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7c546u4den, chemically known as 5-(2,4-difluorophenyl)salicylic acid but generally known as diflunisal, which bears us nih compound identifier 3059. european medicines agency schedules diflunisal in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07130mig. the term diflunisal is an international non-proprietary name or inn (see who inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules diflunisal in its anatomical therapeutic chemical (atc) classification. diflunisal is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule diflunisal under hs 29182980 and sitc 51394. as of q4 2014, diflunisal remains the us fda preferred term for this commodity. diflunisal bears us nlm identifiers umls id c0012228 and nci concept code c47489. smiles: fc1c(c2cc(c(o)cc2)c(=o)o)ccc(f)c1.. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. salicin. this classification denotes an analgesic agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4649620tbz. european medicines agency schedules salicin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15176mig. salicin generally arises in the molecular formula c13h18o7. the term salicin is an international nomenclature of cosmetic ingredients designation. as of q4 2014, salicin remains the us fda preferred term for this commodity. salicin bears us nlm identifiers umls id c0073969 and nci concept code c90648. smiles: o1c(c(o)c(o)c(o)c1oc1cc(ccc1)co)co.. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. salicylamide. this classification denotes a nonsteroidal antiinflammatory drug, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier em8bm710zc. european medicines agency schedules salicylamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10426mig. salicylamide generally arises in the molecular formula c7h7no2. the term salicylamide is an international non-proprietary name or inn. salicylamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule salicylamide under hs 29242995 and sitc 51479. as of q4 2014, salicylamide remains the us fda preferred term for this commodity. salicylamide bears us nlm identifiers umls id c0036071 and nci concept code c80566. smiles: oc1c(cccc1)c(=o)n.. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. sodium salicylate. this classification denotes a nonsteroidal antiinflammatory drug, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wiq1h85syp. european medicines agency schedules sodium salicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12306mig. sodium salicylate generally arises in the molecular formula c7h5nao3. the term sodium salicylate is a united states homeopathic pharmacopoeia name designation. as of q4 2014, sodium salicylate remains the us fda preferred term for this commodity. sodium salicylate bears us nlm identifiers umls id c0037549 and nci concept code c834. smiles: c1=cc=c(c(=c1)c(=o)[o-])o.[na+].. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. triethanolamine salicylate. this classification denotes a nonsteroidal antiinflammatory drug with the molecular formula c7h6o3.c6h15no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h8o4040bhd, chemically known as 2-hydroxybenzoic acid, compd. with 2,2,2-nitrilotris(ethanol) (1:1) but generally known as tea-salicylate, which bears us nih compound identifier 25213. european medicines agency schedules trolamine salicylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04990mig. most nations schedule triethanolamine salicylate under hs 29221300 and sitc 51461. smiles: c1=cc=c(c(=c1)c(=o)o)o.c(co)n(cco)cco.. "
"salicylates. the salts or esters of salicylic acids, or salicylate esters of an organic acid.. salicylamide sodium. this classification denotes a nonsteroidal antiinflammatory drug with the molecular formula c7h6no2.na, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ozv98v4536, chemically known as benzamide, 2-hydroxy-, monosodium salt, but more generally known as salicylamide sodium, which bears us nih compound identifier 17431. european medicines agency schedules salicylamide sodium or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10426mig. most nations, for tariff purposes, schedule salicylamide sodium under hs 29242995. smiles: c1ccc(c(c1)c(=o)n)[o-].[na+].. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. . "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. disulfiram. this classification denotes a multidrug resistance modulator and angiogenesis inhibitor with the molecular formula c10h20n2s4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tr3mlj1uai, chemically known as 1,1-dithiobis(n,n-diethylthioformamide) but generally known as disulfiram, which bears us nih compound identifier 3117. european medicines agency schedules disulfiram in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06326mig. the term disulfiram is an international non-proprietary name. world health organization schedules disulfiram in its anatomical therapeutic chemical (atc) classification. disulfiram is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule disulfiram under hs 29303000 and sitc 51543. as of q4 2014, disulfiram remains the us fda preferred term for this commodity. disulfiram bears us nlm identifiers umls id c0012772 and nci concept code c447. smiles: ccn(cc)c(=s)ssc(=s)n(cc)cc.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine. this classification denotes a nicotinic agonist and alkaloid with the molecular formula c10h14n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6m3c89zy6r, chemically known as xl all insecti-cide, emo-nib but generally known as nicotine, which bears us nih compound identifier 942. european medicines agency schedules nicotine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14645mig. world health organization schedules nicotine in its anatomical therapeutic chemical (atc) classification. most nations schedule nicotine under hs 29399990 and sitc 54149. as of q4 2014, nicotine remains the us fda preferred term for this commodity. nicotine bears us nlm identifiers umls id c0028040 and nci concept code c691. smiles: cn1cccc1c2=cn=cc=c2.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. varenicline. this classification denotes a nicotinic agonist with the molecular formula c13h13n3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier w6hs99o8zo, chemically known as 7,8,9,10-tetrahydro-6,10-methano-6h-pyrazino(2,3-h)(3)benzazepine but generally known as varenicline, which bears us nih compound identifier 170361. european medicines agency schedules varenicline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub25195. world health organization schedules varenicline in its anatomical therapeutic chemical (atc) classification. most nations schedule varenicline under hs 29333999 and sitc 51574. as of q4 2014, varenicline remains the us fda preferred term for this commodity. varenicline bears us nlm identifiers umls id c1569608 and nci concept code c73609. smiles: n1cc2cc(c3c2cc2nccnc2c3)c1.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. acamprosate. this classification denotes a neuroprotective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier n4k14ygm3j. european medicines agency schedules acamprosate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07366mig. acamprosate generally arises in the molecular formula c5h11no4s. the term acamprosate is an international non-proprietary name or inn (see who inn reference publication, volume 4, no. 3 1990, list 30.) acamprosate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule acamprosate under hs 29241900 and sitc 51471. as of q4 2014, acamprosate remains the us fda preferred term for this commodity. acamprosate bears us nlm identifiers umls id c0284941 and nci concept code c81691. smiles: s(=o)(=o)(o)cccnc(=o)c.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. altinicline. this classification denotes a cholinergic agonist with the molecular formula c12h14n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier rj9v9v09vm, chemically known as pyridine, 3-ethynyl-5-((2s)-1-methyl-2-pyrrolidinyl)- but generally known as altinicline, which bears us nih compound identifier 3036156. altinicline most often comes in base and maleate forms. the term altinicline is an international non-proprietary name or inn (see who inn reference publication, volume 14, no. 3, 2000, list 44). most nations schedule altinicline under hs 29339990 and sitc 51577. as of q4 2014, altinicline remains the us fda preferred term for this commodity. altinicline bears us nlm identifiers umls id c2698073 and nci concept code c77841. smiles: cn1cccc1c2=cn=cc(=c2)c#c.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. calcium carbimide. this classification denotes a cyanide with the molecular formula cn2.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier zlr270912w, chemically known as cyanamide, lead (2+) salt (1:1) but generally known as calcium carbimide, which bears us nih compound identifier 9864. european medicines agency schedules calcium carbimide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06049mig. world health organization schedules calcium carbimide in its anatomical therapeutic chemical (atc) classification. as of q4 2014, calcium carbimide remains the us fda preferred term for this commodity. smiles: c(#n)n.[ca].. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. lobeline. this classification denotes a nicotinic agonist with the molecular formula c22h27no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier d0p25s3p81, chemically known as 8,10-diphenyllobelionol but generally known as lobeline, which bears us nih compound identifier 3945. european medicines agency schedules lobeline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08541mig. the term lobeline is an international non-proprietary name or inn (see who inn reference publication, volume 32, no 10 1978, list 18). lobeline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations schedule lobeline under hs 29399900 and sitc 54149. as of q4 2014, lobeline remains the us fda preferred term for this commodity. lobeline bears us nlm identifiers umls id c0023929 and nci concept code c93261. smiles: oc(cc1n(c(ccc1)cc(=o)c1ccccc1)c)c1ccccc1.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. silver acetate. this classification denotes an acetate used in smoking cessation treatment, with the molecular formula c2h3o2.ag, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19pps85f9h, chemically known as silver;acetate but generally known as silver acetate, which bears us nih compound identifier 11246. the term sparteine is an international non-proprietary name or inn. european medicines agency schedules silver acetate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub15244mig. most nations schedule silver acetate under hs 28432900 and sitc 52432. as of q4 2014, silver acetate remains the us fda preferred term for this commodity. smiles: cc(=o)[o-].[ag+].. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. acamprosate calcium. this classification denotes a neuroprotective agent with the molecular formula 2c5h10no4s.ca, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 59375n1d0u, chemically known as 1-propanesulfonic acid, 3-(acetylamino)-, calcium salt (2:1) but more generally known as acamprosate calcium, which bears us nih compound identifier 155434. european medicines agency schedules acamprosate calcium in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00239mig. most nations, for tariff and trade purposes, schedule acamprosate calcium under hs 29241900 and sitc 51471. as of q4 2014, acamprosate calcium remains us fdas preferred term for this commodity. acamprosate calcium bears us nlm identifiers umls id c0592789 and nci concept code c65209. smiles: cc(=o)ncccs(=o)(=o)[o-].cc(=o)ncccs(=o)(=o)[o-].[ca+2].. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. altinicline maleate. this classification denotes a nicotinic agonist with the molecular formula c12h14n2.c4h4o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier pcl7q9q62q, chemically known as pyridine, 3-ethynyl-5-((2s)-1-methyl-2-pyrrolidinyl)-, (2z)-2-butenedioate(1:1) but more generally known as altinicline maleate, which bears us nih compound identifier 6442277. most nations, for tariff and trade purposes, schedule altinicline maleate under hs 29339990 and sitc 51577. as of q4 2014, altinicline maleate remains us fdas preferred term for this commodity. altinicline maleate bears us nlm identifiers umls id c2983930 and nci concept code c90896. smiles: cn1ccc[c@h]1c2cc(cnc2)c#c.c(=c\\c(=o)o)\\c(=o)o.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. lobeline hydrochloride. this classification denotes a nicotinic agonist with the molecular formula c22h27no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 96j834cb88, chemically known as ethanone, 2-(6-(2-hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenyl-, hydrochloride but more generally known as lobeline hydrochloride, which bears us nih compound identifier 46202. european medicines agency schedules lobeline hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14389mig. most nations, for tariff and trade purposes, schedule lobeline hydrochloride under hs 29399900 and sitc 54149. as of q4 2014, lobeline hydrochloride remains us fdas preferred term for this commodity. smiles: cn1[c@@h](ccc[c@@h]1cc(=o)c2ccccc2)c[c@@h](c3ccccc3)o.cl.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. lobeline sulfate. this classification denotes a nicotinic agonist with the molecular formula 2c22h27no2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4cj480v2hp, chemically known as lobeline, sulfate (2:1) (salt) but more generally known as lobeline sulfate, which bears us nih compound identifier 120636. european medicines agency schedules lobeline sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02962mig. most nations, for tariff and trade purposes, schedule lobeline sulfate under hs 29399900 and sitc 54149. as of q4 2014, lobeline sulfate remains us fdas preferred term for this commodity. smiles: cn1[c@@h](ccc[c@@h]1cc(=o)c2ccccc2)c[c@@h](c3ccccc3)o.cn1[c@@h](ccc[c@@h]1cc(=o)c2ccccc2)c[c@@h](c3ccccc3)o.os(=o)(=o)o.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. lobeline sulphate. this classification denotes a nicotinic agonist with the molecular formula 2c22h27no2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4cj480v2hp, chemically known as 2-((2r,6s)-6-((2s)-2-hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenylethanone sulfate, but more generally known as lobeline sulphate, which bears us nih compound identifier 120636. european medicines agency schedules lobeline sulphate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08541mig. most nations, for tariff purposes, schedule lobeline sulphate under hs 29399900. smiles: cn1[c@@h](ccc[c@@h]1cc(=o)c2ccccc2)c[c@@h](c3ccccc3)o.cn1[c@@h](ccc[c@@h]1cc(=o)c2ccccc2)c[c@@h](c3ccccc3)o.os(=o)(=o)o.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine bitartrate. this classification denotes a nicotinic agonist and alkaloid with the molecular formula c10h14n2.2c4h6o6.2h2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier r7m676m8yv, chemically known as pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (s)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:2) (9ci) but more generally known as nicotine bitartrate, which bears us nih compound identifier 6174. most nations, for tariff and trade purposes, schedule nicotine bitartrate under hs 29399990 and sitc 54149. as of q4 2014, nicotine bitartrate remains us fdas preferred term for this commodity. smiles: cn1ccc[c@h]1c2cccnc2.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.o.o.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine dihydrochloride. this classification denotes a nicotinic agonist and alkaloid with the molecular formula c10h14n2.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier i16i55623s, chemically known as nicotine dihydrochloride, (-)-, but more generally known as nicotine dihydrochloride, which bears us nih compound identifier 80115. european medicines agency schedules nicotine dihydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14645mig. most nations, for tariff purposes, schedule nicotine dihydrochloride under hs 29399990. smiles: cn1ccc[c@h]1c2cccnc2.cl.cl.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine hydrochloride. this classification denotes a nicotinic agonist and alkaloid with the molecular formula c10h14n2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier elz2l53yne, chemically known as nicotine monohydrochloride, (-)-, but more generally known as nicotine hydrochloride, which bears us nih compound identifier 17784. european medicines agency schedules nicotine hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14645mig. most nations, for tariff purposes, schedule nicotine hydrochloride under hs 29399990. smiles: cn1ccc[c@h]1c2cccnc2.cl.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine hydrogen tartrate. this classification denotes a nicotinic agonist and alkaloid with the molecular formula c10h14n2.2c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7892zn5g41, chemically known as nicotine l-(+)-tartrate (1:2), but more generally known as nicotine hydrogen tartrate, which bears us nih compound identifier 6174. european medicines agency schedules nicotine hydrogen tartrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14645mig. most nations, for tariff purposes, schedule nicotine hydrogen tartrate under hs 29399990. smiles: cn1ccc[c@h]1c2cccnc2.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine polacrilex. this classification denotes a nicotinic agonist and alkaloid with the molecular formula c10h14n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6m3c89zy6r, chemically known as xl all insecti-cide, emo-nib but more generally known as nicotine, which bears us nih compound identifier 942. european medicines agency schedules nicotine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14645mig. world health organization schedules nicotine in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule nicotine polacrilex under hs 29399990 and sitc 54149. smiles: cn1ccc[c@h]1c2cccnc2.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine salicylate. this classification denotes a nicotinic agonist and alkaloid with the molecular formula c10h14n2.c7h6o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 744q1cl77h. most nations, for tariff and trade purposes, schedule nicotine salicylate under hs 29399990 and sitc 54149. as of q4 2014, nicotine salicylate remains us fdas preferred term for this commodity. smiles: cn1ccc[c@h]1c2cccnc2.c1ccc(c(c1)c(=o)o)o.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine sulfate. this classification denotes a nicotinic agonist and alkaloid with the molecular formula 2c10h14n2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ux4gth155w, chemically known as (s)-3-(1-methyl-2-pyrrolidinyl)-pyridine sulfate, but more generally known as nicotine sulfate, which bears us nih compound identifier 6173. european medicines agency schedules nicotine sulfate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub14645mig. most nations, for tariff purposes, schedule nicotine sulfate under hs 29399990. smiles: cn1ccc[c@h]1c2cccnc2.cn1ccc[c@h]1c2cccnc2.os(=o)(=o)o.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. nicotine tartrate. this classification denotes a nicotinic agonist and alkaloid with the molecular formula c10h14n2.2c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 7892zn5g41, chemically known as pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (s)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:2) (9ci) but more generally known as nicotine tartrate, which bears us nih compound identifier 6174. european medicines agency schedules nicotine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22391. most nations, for tariff and trade purposes, schedule nicotine tartrate under hs 29399990. smiles: cn1ccc[c@h]1c2cccnc2.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"anti abuse drugs. this classification denotes preparations that combat addiction, usually by neutralizing the affect of alcohol or drugs or otherwise making said affects unpleasant to the patient.. varenicline tartrate. this classification denotes a nicotinic agonist, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 82269asb48. european medicines agency schedules varenicline tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub22601. varenicline tartrate generally arises in the molecular formula c13h13n3.c4h6o6. the term varenicline tartrate is a united states adopted name designation. most nations, for tariff and trade purposes, schedule varenicline tartrate under hs 29333999 and sitc 51574. as of q4 2014, varenicline tartrate remains us fdas preferred term for this commodity. varenicline tartrate bears us nlm identifiers umls id c1711887 and nci concept code c61998. smiles: c1cnc2cc3c(cc2n1)[c@@h]4c[c@h]3cnc4.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"combination anticonvulsants. this classification denotes combination drugs used to prevent seizures or reduce their severity. typical combination anticonvulsant constituients are phenobarbital and phenytoin.. . "
"combination anticonvulsants. this classification denotes combination drugs used to prevent seizures or reduce their severity. typical combination anticonvulsant constituients are phenobarbital and phenytoin.. phenobarbital/phenytoin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn400. this va drug class (cn400) classifies this compound as belonging to the group anticonvulsants.. "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. . "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. acetaminophen/caffeine/isometheptene. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn105. this va drug class (cn105) classifies this compound as belonging to the group antimigraine agents. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a cns stimulant and bioactive food component with the molecular formula c8h10n4o2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 3g6a5w338e, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears u.s. national institutes of health compound identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. the european medicines agency schedules caffeine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13146mig. the third component of this combination drug is an adrenergic agent with the molecular formula c9h19n, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier y7l24thh6t, chemically known as 5-hepten-2-amine, n,6-dimethyl-, hydrochloride but more generally known as isometheptene, which bears u.s. national institutes of health compound identifier 22297. the european medicines agency schedules isometheptene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08324mig. the term isometheptene is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). the world health organization schedules isometheptene in its anatomical therapeutic chemical (atc) classification.. "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. acetaminophen/dichloralphenazone/isometheptene. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class cn105. this va drug class (cn105) classifies this compound as belonging to the group antimigraine agents. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a sedative and hypnotic with the molecular formula c11h12n2o.2c2h3cl3o2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier yyx637r279, chemically known as 1,2-dihydro-1,5-dimethyl-2-phenyl-3h-pyrazol-3-one, compound with 2,2,2-trichloroethane-1,1-diol (1:2) but more generally known as dichloralphenazone, which bears u.s. national institutes of health compound identifier 10188. the european medicines agency schedules dichloralphenazone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13563mig. the world health organization schedules dichloralphenazone in its anatomical therapeutic chemical (atc) classification. the third component of this combination drug is an adrenergic agent with the molecular formula c9h19n, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier y7l24thh6t, chemically known as 5-hepten-2-amine, n,6-dimethyl-, hydrochloride but more generally known as isometheptene, which bears u.s. national institutes of health compound identifier 22297. the european medicines agency schedules isometheptene in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08324mig. the term isometheptene is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). the world health organization schedules isometheptene in its anatomical therapeutic chemical (atc) classification.. "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. belladonna/caffeine/ergotamine/pentobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn105. this va drug class (cn105) classifies this compound as belonging to the group antimigraine agents.. "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. belladonna/caffeine/ergotamine/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn105. this va drug class (cn105) classifies this compound as belonging to the group antimigraine agents.. "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. belladonna/ergotamine/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn105. this va drug class (cn105) classifies this compound as belonging to the group antimigraine agents.. "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. caffeine/ergotamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn105. this va drug class (cn105) classifies this compound as belonging to the group antimigraine agents.. "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. ergotamine/hyoscyamine/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn105. this va drug class (cn105) classifies this compound as belonging to the group antimigraine agents.. "
"combination antimigraine agents. this classification denotes combination drugs that treat primary headache disorders which feature recurrent unilateral pulsatile headaches of types classic (with visible aura neurological symptoms) and type common migraine (without visible aura), headaches commonly called migraines, hence the term antimigraine agents. typical combination antimigraine agent constituents are acetaminophen, belladonna, caffeine, ergotamine, and naproxen.. naproxen/sumatriptan. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn105. this va drug class (cn105) classifies this compound as belonging to the group antimigraine agents.. "
"combination antiparkinson agents. this classification denotes combination drugs used in the treatment of a progressive, degenerative neurologic disease characterized by a tremor that is maximal at rest, retropulsion, rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression, a disorder called parkinson disease, hence the term antiparkinson agents. typical combination antiparkinson agent constituents are carbidopa and levodopa.. . "
"combination antiparkinson agents. this classification denotes combination drugs used in the treatment of a progressive, degenerative neurologic disease characterized by a tremor that is maximal at rest, retropulsion, rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression, a disorder called parkinson disease, hence the term antiparkinson agents. typical combination antiparkinson agent constituents are carbidopa and levodopa.. carbidopa/entacapone/levodopa. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn500. this va drug class (cn500) classifies this compound as belonging to the group antiparkinson agents.. "
"combination antiparkinson agents. this classification denotes combination drugs used in the treatment of a progressive, degenerative neurologic disease characterized by a tremor that is maximal at rest, retropulsion, rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression, a disorder called parkinson disease, hence the term antiparkinson agents. typical combination antiparkinson agent constituents are carbidopa and levodopa.. carbidopa/levodopa. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn500. this va drug class (cn500) classifies this compound as belonging to the group antiparkinson agents.. "
"combination antivertigo agents. this classification denotes combination drugs used in the treatment of an illusion of movement, either of the external world revolving around the individual or of the individual revolving in space, a condition called vertigo, hence the term antivertigo agents. typical combination antivertigo agent constituents are dimenhydrinate and niacin.. . "
"combination antivertigo agents. this classification denotes combination drugs used in the treatment of an illusion of movement, either of the external world revolving around the individual or of the individual revolving in space, a condition called vertigo, hence the term antivertigo agents. typical combination antivertigo agent constituents are dimenhydrinate and niacin.. dimenhydrinate/niacin. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn550. this va drug class (cn550) classifies this compound as belonging to the group antivertigo agents.. "
"combination antivertigo agents. this classification denotes combination drugs used in the treatment of an illusion of movement, either of the external world revolving around the individual or of the individual revolving in space, a condition called vertigo, hence the term antivertigo agents. typical combination antivertigo agent constituents are dimenhydrinate and niacin.. niacin/pheniramine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn550. this va drug class (cn550) classifies this compound as belonging to the group antivertigo agents.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. . "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. liver/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. acetaminophen/diphenhydramine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf) which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other. the first component of this combination drug is an analgesic and antipyretic with the molecular formula c8h9no2, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 362o9itl9d, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears u.s. national institutes of health compound identifier 1983. acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. the european medicines agency schedules acetaminophen in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09611mig. the world health organization schedules acetaminophen in its anatomical therapeutic chemical (atc) classification. the second component of this combination drug is a histamine-1 receptor antagonist and antiemetic agent with the molecular formula c17h21no, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier 8gts82s83m, chemically known as 2-(diphenylmethoxy)-n,n-dimethylethylamine hydrochloride but more generally known as diphenhydramine, which bears u.s. national institutes of health compound identifier 3100. the european medicines agency schedules diphenhydramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07211mig. the term diphenhydramine is an international non-proprietary name. the world health organization schedules diphenhydramine in its anatomical therapeutic chemical (atc) classification.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. amitriptyline/chlordiazepoxide. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. amitriptyline/perphenazine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. benactyzine/meprobamate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. calcium gluconate/niacinamide/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. camphor/hyoscyamus/passion flower/phenobarbital/valerian. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. dextromethorphan/quinidine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. diphenhydramine/ibuprofen. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. fluoxetine/olanzapine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. niacin/niacinamide/phenobarbital. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns medications. this classification denotes combination drugs and preparations that affect the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns medications. typical combination cns medication constituents are acetaminophen, amitriptyline, benactyzine, calcium gluconate, camphor, dextromethorphan, diphenhydramine, fluoxetine, liver, and niacin.. niacin/pentylenetetrazol. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn900. this va drug class (cn900) classifies this compound as belonging to the group cns medications, other.. "
"combination cns stimulants. this classification denotes combination drugs and preparations that stimulate the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns stimulants. typical combination cns stimulant constituents are amphetamine and caffeine.. . "
"combination cns stimulants. this classification denotes combination drugs and preparations that stimulate the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns stimulants. typical combination cns stimulant constituents are amphetamine and caffeine.. amphetamine/dextroamphetamine. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn801. this va drug class (cn801) classifies this compound as belonging to the group amphetamines.. "
"combination cns stimulants. this classification denotes combination drugs and preparations that stimulate the main information-processing organs of the nervous system, consisting of the brain, spinal cord, and meninges, or the central nervous system or cns, hence the term cns stimulants. typical combination cns stimulant constituents are amphetamine and caffeine.. caffeine/sodium benzoate. this classification denotes a combination drug defined by the u.s. department of veterans affairs in its (vas) national drug file (ndf), which falls under va drug class cn809. this va drug class (cn809) classifies this compound as belonging to the group cns stimulants, other.. "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. . "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. cathine hydrochloride. this classification denotes an alkaloid with the molecular formula c9h13no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ix73851j3p, chemically known as s,s-norpseudoephedrine hydrochloride but more generally known as cathine hydrochloride, which bears us nih compound identifier 9065. european medicines agency schedules cathine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub01089mig. most nations, for tariff and trade purposes, schedule cathine hydrochloride under hs 29394300. as of q4 2014, cathine hydrochloride remains us fdas preferred term for this commodity. smiles: c[c@@h]([c@h](c1ccccc1)o)n.cl.. "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. cathine or norpseudoephedrine. this classification denotes an alkaloid with the molecular formula c9h13no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier e1l4zw2f8o, chemically known as (r*,s*)-(1)-alpha-(1-aminoethyl)benzyl alcohol but more generally known as cathine, which bears us nih compound identifier 26934. cathine most often comes in base and hydrochloride forms. european medicines agency schedules cathine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06158mig. the term cathine is an international non-proprietary name. world health organization schedules cathine in its anatomical therapeutic chemical (atc) classification. cathine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. cathine or norpseudoephedrine bears us nlm identifiers umls id c0069021 and nci concept code c79914. smiles: cc(c(c1=cc=cc=c1)o)n.. "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. deanol. this classification denotes an antidepressant agent with the molecular formula c4h11no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2n6k9dra24, chemically known as 2-(n,n-dimethylamino)ethanol but more generally known as deanol, which bears us nih compound identifier 7902. european medicines agency schedules deanol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13534mig. world health organization schedules deanol in its anatomical therapeutic chemical (atc) classification. deanol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, deanol remains us fdas preferred term for this commodity. deanol bears us nlm identifiers umls id c0011064 and nci concept code c72733. smiles: occn(c)c.. "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. deanol aceglumate. this classification denotes a cns stimulant with the molecular formula c7h11no5.c4h11no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2pp737z523, chemically known as glutamic acid, n-acetyl-, compd. with 2-(dimethylamino)ethanol (1:1), l- but more generally known as deanol aceglumate, which bears us nih compound identifier 71125. european medicines agency schedules deanol aceglumate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06926mig. the term deanol aceglumate is an international non-proprietary name. most nations, for tariff and trade purposes, schedule deanol aceglumate under hs 29241900 and sitc 51471. as of q4 2014, deanol aceglumate remains us fdas preferred term for this commodity. deanol aceglumate bears us nlm identifiers umls id c2699566 and nci concept code c76620. smiles: cc(=o)n[c@@h](ccc(=o)o)c(=o)o.cn(c)cco.. "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. hexacyclonate. this classification denotes a cns stimulant with the molecular formula c9h16o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 2k0fp9ub6a, chemically known as 2-[1-(hydroxymethyl)cyclohexyl]acetate but more generally known as hexacyclonate, which bears us nih compound identifier 23675742. european medicines agency schedules hexacyclonate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10564mig. the term hexacyclonate is an international non-proprietary name. smiles: c1ccc(cc1)(cc(=o)[o-])co.. "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. indanorex. this classification denotes an anorexiant with the molecular formula c12h17no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 982loo7dee, chemically known as 1h-inden-2-ol, 2-(1-aminopropyl)-2,3-dihydro- but more generally known as indanorex, which bears us nih compound identifier 65623. european medicines agency schedules indanorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08168mig. the term indanorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14). indanorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule indanorex under hs 29221980 and sitc 51461. as of q4 2014, indanorex remains us fdas preferred term for this commodity. indanorex bears us nlm identifiers umls id c2827198 and nci concept code c83795. smiles: ccc(c1(cc2=cc=cc=c2c1)o)n.. "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. mazindol. this classification denotes a cns stimulant with the molecular formula c16h13cln2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) c56709m5nh, chemically known as 5-(p-chlorophenyl)-2,5-dihydro-3h-imidazo(2,1-a)isoindol-5-ol but more generally known as mazindol, which bears us nih compound identifier 4020. european medicines agency schedules mazindol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08656mig. the term mazindol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 29, no. 10 1975, list 15). world health organization schedules mazindol in its anatomical therapeutic chemical (atc) classification. mazindol is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mazindol under hs 29339190 and sitc 51577. as of q4 2014, mazindol remains us fdas preferred term for this commodity. mazindol bears us nlm identifiers umls id c0024977 and nci concept code c66057. smiles: clc1ccc(c2(o)n3c(=ncc3)c3c2cccc3)cc1.. "
"stimulant or anorexiant alcohols. this classification denotes alkyl compounds containing a hydroxyl group, substances called alcohols, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depressants, thus the term stimulant or anorexiant alcohols.. pyridoxine disulfide or pyrithioxine or pyritinol. this classification denotes a cns stimulant with the molecular formula c16h20n2o4s2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ak5q5fzh2r, chemically known as 3,3-(dithiodimethylene)bis(5-hydroxy-6-methyl-4-pyridinemethanol) but more generally known as pyrithioxine, which bears us nih compound identifier 14190. european medicines agency schedules pyritinol in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10175mig. the term pyritinol is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules pyrithioxine in its anatomical therapeutic chemical (atc) classification. smiles: cc1=nc=c(c(=c1o)co)csscc2=cn=c(c(=c2co)o)c.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. . "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. acridorex. this classification denotes an anorexiant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 7sgv5hqh8b. european medicines agency schedules acridorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05249mig. acridorex generally arises in the molecular formula c24h24n2. the term acridorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 10 1969, list 9.) acridorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule acridorex under hs 29339990 and sitc 51577. as of q4 2014, acridorex remains us fdas preferred term for this commodity. acridorex bears us nlm identifiers umls id c2699762 and nci concept code c77326. smiles: n(c(cc1ccccc1)c)ccc1c2c(nc3c(c2)cccc3)ccc1.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. alfetamine. this classification denotes a cns stimulant with the molecular formula c11h15n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) q3v87119bp, chemically known as 1-phenylpent-4-en-2-amine but more generally known as alfetamine, which bears us nih compound identifier 20254. european medicines agency schedules amfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05318mig. alfetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule alfetamine under hs 29214980 and sitc 51454. smiles: c=ccc(cc1=cc=cc=c1)n.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. azalanstat. this classification denotes an anti-lipidemic agent with the molecular formula c22h24cln3o2s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier, 2nl79ni1ws chemically known as 1-(((2s,4s)-4-(((p-aminophenyl)thio)methyl)-2-(p-chlorophenethyl)-1,3-dioxolan-2-yl)methyl)imidazole, but more commonly known as azalanstat, which bears us nih compound identifier 60876. european medicines agency schedules azalanstat in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05630mig. the term azalanstat is an international non-proprietary name or inn. most nations, for tariff and trade purposes, schedule azalanstat under hs 29349990 and sitc 51579. as of q4 2014, azalanstat remains us fdas preferred term for this commodity. azalanstat bears us nlm identifiers umls id c0218596 and nci concept code c79817. smiles: c1[c@h](o[c@@](o1)(ccc2=cc=c(c=c2)cl)cn3c=cn=c3)csc4=cc=c(c=c4)n.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. azalanstat dihydrochloride. this classification denotes an anti-lipidemic agent with the molecular formula c22h24cln3o2s.2clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier x30j960b4d, chemically known as 1-(((2s,4s)-4-(((p-aminophenyl)thio)methyl)-2-(p-chlorophenethyl)-1,3-dioxolan-2-yl)methyl)imidazole but more generally known as azalanstat dihydrochloride, which bears us nih compound identifier 60876. most nations, for tariff and trade purposes, schedule azalanstat dihydrochloride under hs 29349990 and sitc 51579. as of q4 2014, azalanstat dihydrochloride remains us fdas preferred term for this commodity. azalanstat dihydrochloride bears us nlm identifiers umls id c2698284 and nci concept code c80126. smiles: c1cc(ccc1cc[c@@]2(oc[c@h](o2)csc3ccc(cc3)n)cn4ccnc4)cl.cl.cl.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. clominorex. this classification denotes an anorexiant with the molecular formula c9h9cln2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) o1r2462wa0, chemically known as 5-(4-chlorophenyl)-1,3-oxazolidin-2-imine but more generally known as clominorex, which bears us nih compound identifier 19752. european medicines agency schedules clominorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06724mig. the term clominorex is an international non-proprietary name. clominorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule clominorex under hs 29349990 and sitc 51579. as of q4 2014, clominorex remains us fdas preferred term for this commodity. clominorex bears us nlm identifiers umls id c2347809 and nci concept code c72177. smiles: clc1ccc(c2oc(=nc2)n)cc1.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. dexmethylphenidate. this classification denotes a cns stimulant with the molecular formula c14h19no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) m32rh9mfgp, chemically known as 2-piperidineacetic acid, alpha-phenyl-, methyl ester, threo- but more generally known as dexmethylphenidate, which bears us nih compound identifier 154101. european medicines agency schedules dexmethylphenidate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub30294. the term dexmethylphenidate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 17, no. 4, 2003, list 50). world health organization schedules dexmethylphenidate in its anatomical therapeutic chemical (atc) classification. most nations, for tariff and trade purposes, schedule dexmethylphenidate under hs 29333999 and sitc 51574. as of q4 2014, dexmethylphenidate remains us fdas preferred term for this commodity. dexmethylphenidate bears us nlm identifiers umls id c1169997 and nci concept code c26642. smiles: o(c(=o)c(c1ncccc1)c1ccccc1)c.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. dexmethylphenidate hydrochloride. this classification denotes a cns stimulant with the molecular formula c14h19no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 1678ok0e08, chemically known as 2-piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride, (r-(r*,r*))- but more generally known as dexmethylphenidate hydrochloride, which bears us nih compound identifier 154100. european medicines agency schedules dexmethylphenidate hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub20614. most nations, for tariff and trade purposes, schedule dexmethylphenidate hydrochloride under hs 29333999 and sitc 51574. as of q4 2014, dexmethylphenidate hydrochloride remains us fdas preferred term for this commodity. dexmethylphenidate hydrochloride bears us nlm identifiers umls id c1170743 and nci concept code c47480. smiles: coc(=o)[c@h](c1ccccc1)[c@h]2ccccn2.cl.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. fencamfamin hydrochloride. this classification denotes a dopamine agonist with the molecular formula c15h21n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0m1j60bwex, chemically known as 2-norbornanamine, n-ethyl-3-phenyl-, hydrochloride but more generally known as fencamfamin hydrochloride, which bears us nih compound identifier 14584. european medicines agency schedules fencamfamin hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02110mig. most nations, for tariff and trade purposes, schedule fencamfamin hydrochloride under hs 29214600. as of q4 2014, fencamfamin hydrochloride remains us fdas preferred term for this commodity. fencamfamin hydrochloride bears us nlm identifiers umls id c0140010 and nci concept code c76051. smiles: ccnc1c2ccc(c2)c1c3ccccc3.cl.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. fencamfamin or fencamfamine. this classification denotes a cns stimulant with the molecular formula c15h21n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier nme1i5igbk, chemically known as 2-norbornanamine, n-ethyl-3-phenyl-, hydrochloride but more generally known as fencamfamin, which bears us nih compound identifier 14584. european medicines agency schedules fencamfamin in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07545mig. the term fencamfamin is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules fencamfamin in its anatomical therapeutic chemical (atc) classification. fencamfamin is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. fencamfamin or fencamfamine bears us nlm identifiers umls id c0060157 and nci concept code c87695. smiles: ccnc1c2ccc(c2)c1c3=cc=cc=c3.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. fenfluramine. this classification denotes an anorexiant with the molecular formula c12h16f3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 2ds058h2cf, chemically known as phenethylamine, n-ethyl-alpha-methyl-m-(trifluoromethyl)-, (s)- but more generally known as fenfluramine, which bears us nih compound identifier 3337. european medicines agency schedules fenfluramine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07561mig. the term fenfluramine is an international non-proprietary name. world health organization schedules fenfluramine in its anatomical therapeutic chemical (atc) classification. fenfluramine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fenfluramine under hs 29214980 and sitc 51454. as of q4 2014, fenfluramine remains us fdas preferred term for this commodity. fenfluramine bears us nlm identifiers umls id c0015827 and nci concept code c81418. smiles: ccnc(c)cc1=cc(=cc=c1)c(f)(f)f.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. fenfluramine hydrochloride. this classification denotes an anorexiant with the molecular formula c12h16f3n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3kc089243p, chemically known as phenethylamine, n-ethyl-alpha-methyl-m-(trifluoromethyl)-, (s)- but more generally known as fenfluramine hydrochloride, which bears us nih compound identifier 3337. european medicines agency schedules fenfluramine hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub02115mig. most nations, for tariff and trade purposes, schedule fenfluramine hydrochloride under hs 29214980 and sitc 51454. as of q4 2014, fenfluramine hydrochloride remains us fdas preferred term for this commodity. fenfluramine hydrochloride bears us nlm identifiers umls id c0282179 and nci concept code c75112. smiles: ccnc(c)cc1cccc(c1)c(f)(f)f.cl.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. fenisorex. this classification denotes an anorexiant with the molecular formula c16h16fno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) c0p8mp2sr5, chemically known as 1h-2-benzopyran-3-methanamine, 7-fluoro-3,4-dihydro-1-phenyl-, cis- but more generally known as fenisorex, which bears us nih compound identifier 36983. european medicines agency schedules fenisorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07569mig. the term fenisorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 12 no. 2 1999, list 40). fenisorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fenisorex under hs 29329985 and sitc 51569. as of q4 2014, fenisorex remains us fdas preferred term for this commodity. fenisorex bears us nlm identifiers umls id c0605359 and nci concept code c65654. smiles: fc1cc2c(oc(nc)cc2cc1)c1ccccc1.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. fluminorex. this classification denotes an anorexiant with the molecular formula c10h9f3n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) luo2z7954t, chemically known as 2-oxazolamine, 4,5-dihydro-5-(4-(trifluoromethyl)-phenyl)- but more generally known as fluminorex, which bears us nih compound identifier 24100. european medicines agency schedules fluminorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07703mig. the term fluminorex is an international non-proprietary name. fluminorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fluminorex under hs 29349990 and sitc 51579. as of q4 2014, fluminorex remains us fdas preferred term for this commodity. fluminorex bears us nlm identifiers umls id c2348685 and nci concept code c72179. smiles: c1c(oc(=n1)n)c2=cc=c(c=c2)c(f)(f)f.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. methylphenidate. this classification denotes a cns stimulant with the molecular formula c14h19no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 207zz9qz49, chemically known as 2-piperidineacetic acid, .alpha.-phenyl-, methyl ester, hydrochloride but more generally known as methylphenidate, which bears us nih compound identifier 4158. european medicines agency schedules methylphenidate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08870mig. the term methylphenidate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules methylphenidate in its anatomical therapeutic chemical (atc) classification. methylphenidate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule methylphenidate under hs 29333300 and sitc 51574. as of q4 2014, methylphenidate remains us fdas preferred term for this commodity. methylphenidate bears us nlm identifiers umls id c0025810 and nci concept code c62045. smiles: o(c(=o)c(c1ncccc1)c1ccccc1)c.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. methylphenidate hydrochloride. this classification denotes a central nervous system stimulantt and dopamine uptake inhibitor with the molecular formula c14h19no2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 4b3sc438hi, chemically known as 2-piperidineacetic acid, .alpha.-phenyl-, methyl ester, hydrochloride but more generally known as methylphenidate hydrochloride, which bears us nih compound identifier 4158. european medicines agency schedules methylphenidate hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03254mig. most nations, for tariff and trade purposes, schedule methylphenidate hydrochloride under hs 29333300 and sitc 51574. as of q4 2014, methylphenidate hydrochloride remains us fdas preferred term for this commodity. methylphenidate hydrochloride bears us nlm identifiers umls id c0728759 and nci concept code c646. smiles: coc(=o)[c@h](c1ccccc1)[c@h]2ccccn2.cl.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. morforex. this classification denotes an anorexiant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) o9j6ity8ux. european medicines agency schedules morforex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09066mig. morforex generally arises in the molecular formula c15h24n2o. the term morforex is an international non-proprietary name or inn. morforex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule morforex under hs 29349990 and sitc 51579. as of q4 2014, morforex remains us fdas preferred term for this commodity. morforex bears us nlm identifiers umls id c1881900 and nci concept code c66195. smiles: o1ccn(ccnc(cc2ccccc2)c)cc1.. "
"stimulant or anorexiant amines. this classification denotes compounds derived from ammonia by substituting organic radicals for the hydrogens, substances called amines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amines.. tiflorex. this classification denotes an anorexiant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) eg3b69dfq5. european medicines agency schedules tiflorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub11041mig. tiflorex generally arises in the molecular formula c12h16f3ns. the term tiflorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16.) tiflorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule tiflorex under hs 29309085 and sitc 51549. as of q4 2014, tiflorex remains us fdas preferred term for this commodity. tiflorex bears us nlm identifiers umls id c0145931 and nci concept code c75117. smiles: ccnc(c)cc1=cc(=cc=c1)sc(f)(f)f.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. . "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amfecloral or amphecloral. this classification denotes a cns stimulant and anorexiant with the molecular formula c11h12cl3n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6015xoa0bi, chemically known as 1-phenyl-n-(2,2,2-trichlorethyliden)-2-propylamin but more generally known as amfecloral, which bears us nih compound identifier 21759. european medicines agency schedules amfecloral in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05414mig. the term amfecloral is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). amfecloral is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. amfecloral or amphecloral bears us nlm identifiers umls id c2983798 and nci concept code c90610. smiles: cc(cc1=cc=cc=c1)n=cc(cl)(cl)cl.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amfepentorex. this classification denotes an anorexiant with the molecular formula c15h25n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) ope7bd4aaa, chemically known as phenethylamine, n,alpha-dimethyl-p-pentyl- but more generally known as amfepentorex, which bears us nih compound identifier 71877. european medicines agency schedules amfepentorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05416mig. the term amfepentorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7). amfepentorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule amfepentorex under hs 29214980 and sitc 51454. as of q4 2014, amfepentorex remains us fdas preferred term for this commodity. amfepentorex bears us nlm identifiers umls id c2346735 and nci concept code c72178. smiles: n(c(cc1ccc(ccccc)cc1)c)c.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amfetamine or amphetamine. this classification denotes a cns stimulant with the molecular formula c9h13n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier ck833kgx7e, chemically known as phenethylamine, d-.alpha.-methyl- but more generally known as amfetamine, which bears us nih compound identifier 3007. european medicines agency schedules amfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05418mig. the term amphetamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 13, no. 12, 1959, list 3). world health organization schedules amfetamine in its anatomical therapeutic chemical (atc) classification. amfetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. amfetamine or amphetamine bears us nlm identifiers umls id c0002658 and nci concept code c62006. smiles: nc(cc1ccccc1)c.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amphetamine adipate. this classification denotes a cns stimulant with the molecular formula c9h13n.c6h10o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z58rh02w4m. the term amphetamine adipate is a u.s. fda designation. most nations, for tariff and trade purposes, schedule amphetamine adipate under hs 29214600. as of q4 2014, amphetamine adipate remains us fdas preferred term for this commodity. amphetamine adipate bears us nlm identifiers umls id c0982017 and nci concept code c87425. smiles: cc(cc1ccccc1)n.c(ccc(=o)o)cc(=o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amfepramone hydrochloride. this classification denotes a cns stimulant and anorexiant with the molecular formula c13h19no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19v2pl39ng, chemically known as 1-propanone, 2-(diethylamino)-1-phenyl- but more generally known as amfepramone hydrochloride, which bears us nih compound identifier 7029. european medicines agency schedules amfepramone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00434mig. most nations, for tariff and trade purposes, schedule amfepramone hydrochloride under hs 29223100. smiles: ccn(cc)c(c)c(=o)c1ccccc1.cl.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amfetaminil or amphetaminil. this classification denotes a cns stimulant with the molecular formula c17h18n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0xu0v77jve, chemically known as benzeneacetonitrile, alpha-((1-methyl-2-phenylethyl)amino)- (9ci) but more generally known as amfetaminil, which bears us nih compound identifier 28615. european medicines agency schedules amfetaminil in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05419mig. the term amfetaminil is an international non-proprietary name. amfetaminil is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. amfetaminil or amphetaminil bears us nlm identifiers umls id c2698084 and nci concept code c74237. smiles: cc(cc1=cc=cc=c1)nc(c#n)c2=cc=cc=c2.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amphetamine aspartate. this classification denotes a cns stimulant with the molecular formula 2c9h13n.c4h7no4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier h527kap6l5, chemically known as l-aspartic acid, compd. with alpha-methylbenzeneethanamine (1:2) but more generally known as amphetamine aspartate, which bears us nih compound identifier 32892. european medicines agency schedules amphetamine aspartate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub33384. most nations, for tariff and trade purposes, schedule amphetamine aspartate under hs 29214600. as of q4 2014, amphetamine aspartate remains us fdas preferred term for this commodity. amphetamine aspartate bears us nlm identifiers umls id c0724524 and nci concept code c61636. smiles: cc(cc1ccccc1)n.cc(cc1ccccc1)n.c([c@@h](c(=o)o)n)c(=o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amphetamine hydrochloride. this classification denotes a cns stimulant with the molecular formula c9h13n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 70dmy940zg. most nations, for tariff and trade purposes, schedule amphetamine hydrochloride under hs 29214600. as of q4 2014, amphetamine hydrochloride remains us fdas preferred term for this commodity. amphetamine hydrochloride bears us nlm identifiers umls id c2698101 and nci concept code c77844. smiles: cc(cc1ccccc1)n.cl.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amphetamine phosphate. this classification denotes a cns stimulant with the molecular formula c9h13n.h3o4p, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 163do59r3j. european medicines agency schedules amfetamine phosphate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub36020. most nations, for tariff and trade purposes, schedule amphetamine phosphate under hs 29214600. as of q4 2014, amphetamine phosphate remains us fdas preferred term for this commodity. smiles: cc(cc1ccccc1)n.op(=o)(o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amphetamine sulfate. this classification denotes a cns stimulant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6dpv8nk46s. european medicines agency schedules amfetamine sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00438mig. amphetamine sulfate generally arises in the molecular formula 2c9h13n.h2o4s. the term amphetamine sulfate is a european pharmacopoeia designation. most nations, for tariff and trade purposes, schedule amphetamine sulfate under hs 29214600. as of q4 2014, amphetamine sulfate remains us fdas preferred term for this commodity. amphetamine sulfate bears us nlm identifiers umls id c0282051 and nci concept code c28822. smiles: cc(cc1ccccc1)n.cc(cc1ccccc1)n.os(=o)(=o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. benzphetamine. this classification denotes a cns stimulant and anorexiant with the molecular formula c17h21n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 0m3s43xk27, chemically known as (r,s)-n-benzyl-alpha,n-dimethylphenethylamin but more generally known as benzfetamine, which bears us nih compound identifier 2341. european medicines agency schedules benzfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05748mig. the term benzphetamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). benzfetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, benzphetamine remains us fdas preferred term for this commodity. benzphetamine bears us nlm identifiers umls id c0005096 and nci concept code c61647. smiles: cc(cc1=cc=cc=c1)n(c)cc2=cc=cc=c2.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. chlorphentermine. this classification denotes a cns stimulant with the molecular formula c10h14cln, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) nhw07912o7, chemically known as 4-chloro-.alpha.,.alpha.-dimethylphenethylamine hydrochloride but more generally known as chlorphentermine, which bears us nih compound identifier 10007. european medicines agency schedules chlorphentermine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06205mig. the term chlorphentermine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). chlorphentermine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule chlorphentermine under hs 29214980 and sitc 51454. as of q4 2014, chlorphentermine remains us fdas preferred term for this commodity. chlorphentermine bears us nlm identifiers umls id c0008283 and nci concept code c65323. smiles: cc(c)(cc1=cc=c(c=c1)cl)n.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. clobenzorex. this classification denotes an anorexiant with the molecular formula c16h18cln, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 4a5352xi2a, chemically known as benzeneethanamine, n-((2-chlorophenyl)methyl)-alpha-methyl-, (+)- but more generally known as clobenzorex, which bears us nih compound identifier 71675. european medicines agency schedules clobenzorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06676mig. the term clobenzorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 22, no. 10, 1968, list 8). world health organization schedules clobenzorex in its anatomical therapeutic chemical (atc) classification. clobenzorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule clobenzorex under hs 29214980 and sitc 51454. as of q4 2014, clobenzorex remains us fdas preferred term for this commodity. clobenzorex bears us nlm identifiers umls id c0055894 and nci concept code c77327. smiles: clc1c(cnc(cc2ccccc2)c)cccc1.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. clortermine. this classification denotes a cns stimulant with the molecular formula c10h14cln, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 4fa88hm3ix, chemically known as 2-chloro-alpha,alpha-dimethylbenzeneethanamine but more generally known as clortermine, which bears us nih compound identifier 25223. european medicines agency schedules clortermine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub06768mig. the term clortermine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 24, no. 11 1970, list 10). clortermine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule clortermine under hs 29214980 and sitc 51454. as of q4 2014, clortermine remains us fdas preferred term for this commodity. clortermine bears us nlm identifiers umls id c0771259 and nci concept code c65344. smiles: cc(c)(cc1=cc=cc=c1cl)n.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. dextroamphetamine. this classification denotes a cns stimulant with the molecular formula c9h13n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier tz47u051fi, chemically known as phenethylamine, alpha-methyl-, d- but more generally known as dexamfetamine, which bears us nih compound identifier 5826. european medicines agency schedules dexamfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07019mig. the term dexamfetamine is an international non-proprietary name. world health organization schedules dexamfetamine in its anatomical therapeutic chemical (atc) classification. dexamfetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. as of q4 2014, dextroamphetamine remains us fdas preferred term for this commodity. dextroamphetamine bears us nlm identifiers umls id c0011812 and nci concept code c28981. smiles: nc(cc1ccccc1)c.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. dimethylamphetamine or dimetamfetamine or n,n-dimethylamphetamine. this classification denotes a cns stimulant with the molecular formula c11h17n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 92m4c245d1, chemically known as (s)-n,n,alpha-trimethylphenethylamine but more generally known as dimetamfetamine, which bears us nih compound identifier 65682. european medicines agency schedules dimetamfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07169mig. the term dimetamfetamine is an international non-proprietary name. dimetamfetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: cc(cc1=cc=cc=c1)n(c)c.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. etilamfetamine or ethylamphetamine or n-ethylamphetamine. this classification denotes a cns stimulant with the molecular formula c11h17n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 022yon1xmx, chemically known as phenethylamine, n-ethyl-.alpha.-methyl-, hydrochloride but more generally known as etilamfetamine, which bears us nih compound identifier 9982. european medicines agency schedules etilamfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub12434mig. the term etilamfetamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19). world health organization schedules etilamfetamine in its anatomical therapeutic chemical (atc) classification. etilamfetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. smiles: ccnc(c)cc1=cc=cc=c1.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. amphetamine tartrate. this classification denotes a cns stimulant with the molecular formula c9h13n.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 30g976p30x. european medicines agency schedules amfetamine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00439mig. most nations, for tariff and trade purposes, schedule amphetamine tartrate under hs 29214600. as of q4 2014, amphetamine tartrate remains us fdas preferred term for this commodity. smiles: cc(cc1ccccc1)n.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. etolorex. this classification denotes an anorexiant with the molecular formula c12h18clno, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 449ncx1p03, chemically known as 2-((p-chloro-alpha,alpha-dimethyl-phenethyl)amino)ethanol but more generally known as etolorex, which bears us nih compound identifier 208943. european medicines agency schedules etolorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07327mig. the term etolorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 10 1969, list 9). etolorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule etolorex under hs 29221980 and sitc 51461. as of q4 2014, etolorex remains us fdas preferred term for this commodity. etolorex bears us nlm identifiers umls id c1880586 and nci concept code c65592. smiles: cc(c)(cc1=cc=c(c=c1)cl)ncco.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. fenproporex. this classification denotes an anorexiant with the molecular formula c12h16n2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) w0194s5foa, chemically known as propionitrile, 3-((alpha-methylphenethyl)amino)-, (+-)- but more generally known as fenproporex, which bears us nih compound identifier 61810. european medicines agency schedules fenproporex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07592mig. the term fenproporex is an international non-proprietary name. fenproporex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fenproporex under hs 29263000 and sitc 51484. as of q4 2014, fenproporex remains us fdas preferred term for this commodity. fenproporex bears us nlm identifiers umls id c0060194 and nci concept code c65669. smiles: cc(cc1=cc=cc=c1)nccc#n.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. formetorex. this classification denotes an anorexiant with the molecular formula c10h13no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 30555lm9sq, chemically known as formamide, n-(alpha-methylphenethyl)- (8ci) but more generally known as formetorex, which bears us nih compound identifier 65614. european medicines agency schedules formetorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07785mig. the term formetorex is an international non-proprietary name. formetorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule formetorex under hs 29242995 and sitc 51479. as of q4 2014, formetorex remains us fdas preferred term for this commodity. formetorex bears us nlm identifiers umls id c1880842 and nci concept code c65752. smiles: cc(cc1=cc=cc=c1)nc=o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. furfenorex. this classification denotes an anorexiant with the molecular formula c15h19no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) x83cz0y5tf, chemically known as 2-furanmethanamine, n-methyl-n-(1-methyl-2-phenylethyl)-, (+)- (9ci) but more generally known as furfenorex, which bears us nih compound identifier 26762. european medicines agency schedules furfenorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07840mig. the term furfenorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 21 no. 12 1967, list 7). furfenorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule furfenorex under hs 29321900 and sitc 51569. as of q4 2014, furfenorex remains us fdas preferred term for this commodity. furfenorex bears us nlm identifiers umls id c0060861 and nci concept code c75113. smiles: o1c(cn(c(cc2ccccc2)c)c)ccc1.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. levamfetamine. this classification denotes a cns stimulant with the molecular formula c9h13n.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) stc9o9md79, chemically known as butanedioic acid, compd. with (-)-alpha-methylbenzeneethanamine (1:1) but more generally known as levamfetamine succinate, which bears us nih compound identifier 68638. most nations, for tariff and trade purposes, schedule levamfetamine under hs 29214600 and sitc kg. as of q4 2014, levamfetamine remains us fdas preferred term for this commodity. smiles: cc(cc1=cc=cc=c1)n.c(cc(=o)o)c(=o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. lisdexamfetamine. this classification denotes an anorexiant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) h645gul8kj. european medicines agency schedules lisdexamfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32170. lisdexamfetamine generally arises in the molecular formula c15h25n3o. the term lisdexamfetamine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 20, no. 3, 2006, list 56.) most nations, for tariff and trade purposes, schedule lisdexamfetamine under hs 29242990 and sitc 51479. as of q4 2014, lisdexamfetamine remains us fdas preferred term for this commodity. lisdexamfetamine bears us nlm identifiers umls id c1873633 and nci concept code c75114. smiles: cc(cc1=cc=cc=c1)nc(=o)c(ccccn)n.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. mefenorex. this classification denotes an anorexiant with the molecular formula c12h18cln, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) k98m4n387w, chemically known as phenethylamine, n- (3-chloropropyl)-.alpha.-methyl-, hydrochloride but more generally known as mefenorex, which bears us nih compound identifier 21777. european medicines agency schedules mefenorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08706mig. the term mefenorex is an international non-proprietary name. world health organization schedules mefenorex in its anatomical therapeutic chemical (atc) classification. mefenorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mefenorex under hs 29214600 and sitc kg. as of q4 2014, mefenorex remains us fdas preferred term for this commodity. mefenorex bears us nlm identifiers umls id c0065870 and nci concept code c83915. smiles: cc(cc1=cc=cc=c1)nccccl.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. levamfetamine succinate. this classification denotes a cns stimulant with the molecular formula c9h13n.c4h6o4, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier stc9o9md79, chemically known as butanedioic acid, compd. with (-)-alpha-methylbenzeneethanamine (1:1) but more generally known as levamfetamine succinate, which bears us nih compound identifier 68638. most nations, for tariff and trade purposes, schedule levamfetamine succinate under hs 29214900 and sitc 51454. as of q4 2014, levamfetamine succinate remains us fdas preferred term for this commodity. smiles: c[c@h](cc1ccccc1)n.c(cc(=o)o)c(=o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. lisdexamfetamine dimesylate. this classification denotes a cns stimulant and anorexiant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sjt761gegs. european medicines agency schedules lisdexamfetamine dimesylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32146. lisdexamfetamine dimesylate generally arises in the molecular formula c15h25n3o.2ch4o3s. the term lisdexamfetamine dimesylate is a u.s. fda orange book designation. most nations, for tariff and trade purposes, schedule lisdexamfetamine dimesylate under hs 29242990. as of q4 2014, lisdexamfetamine dimesylate remains us fdas preferred term for this commodity. lisdexamfetamine dimesylate bears us nlm identifiers umls id c1739826 and nci concept code c76628. smiles: c[c@@h](cc1ccccc1)nc(=o)[c@h](ccccn)n.cs(=o)(=o)o.cs(=o)(=o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. metamfetamine or methamphetamine. this classification denotes a cns stimulant with the molecular formula c10h15n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 44ral3456c, chemically known as (s)-(+)-n,alpha,dimethylphenethylamine but more generally known as metamfetamine, which bears us nih compound identifier 10836. european medicines agency schedules metamfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08809mig. the term metamfetamine is an international non-proprietary name. world health organization schedules metamfetamine in its anatomical therapeutic chemical (atc) classification. metamfetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. metamfetamine or methamphetamine bears us nlm identifiers umls id c0025611 and nci concept code c61840. smiles: cc(cc1=cc=cc=c1)nc.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. lisdexamfetamine mesilate or mesylate. this classification denotes a cns stimulant and anorexiant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier sjt761gegs. european medicines agency schedules lisdexamfetamine dimesylate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub32146. lisdexamfetamine mesilate generally arises in the molecular formula c15h25n3o.2ch4o3s. the term lisdexamfetamine mesilate is a u.s. fda orange book designation. most nations, for tariff and trade purposes, schedule lisdexamfetamine mesilate under hs 29242990 and sitc 51479. smiles: c[c@@h](cc1ccccc1)nc(=o)[c@h](ccccn)n.cs(=o)(=o)o.cs(=o)(=o)o.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. phentermine. this classification denotes an anorexiant with the molecular formula c10h15n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) c045tql4wp, chemically known as 1,1-dimethyl-2-phenylethylamine but more generally known as phentermine, which bears us nih compound identifier 4771. european medicines agency schedules phentermine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09784mig. the term phentermine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules phentermine in its anatomical therapeutic chemical (atc) classification. phentermine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule phentermine under hs 29214600 and sitc kg. as of q4 2014, phentermine remains us fdas preferred term for this commodity. phentermine bears us nlm identifiers umls id c0031447 and nci concept code c61890. smiles: cc(c)(cc1=cc=cc=c1)n.. "
"stimulant or anorexiant amphetamines. this classification denotes substances that block adrenergic and dopamine uptake, inhibit monoamine oxidase, and stimulate monamine release, central nervous system stimulators, called amphetamines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amphetamines.. dexamfetamine. this classification denotes a cns stimulant with the molecular formula c9h13n, a preparation that us fda recognizes as an active ingredient or moiety under unique ingredient identifier tz47u051fi, chemically known as phenethylamine, alpha-methyl-, d- but more generally known as dexamfetamine, which bears u.s. national institutes of health compound identifier 5826. european medicines agency schedules dexamfetamine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07019mig. the term dexamfetamine is an international non-proprietary name. world health organization schedules dexamfetamine in its anatomical therapeutic chemical (atc) classification and its who-dd or drug dictionary. dexamfetamine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix.. "
"stimulant or anorexiant azoles. this classification denotes substances composed of five-membered rings that contain a nitrogen atom, substances called azoles, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant azoles.. . "
"stimulant or anorexiant azoles. this classification denotes substances composed of five-membered rings that contain a nitrogen atom, substances called azoles, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant azoles.. aminorex. this classification denotes an anorexiant with the molecular formula c9h10n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 2sh16612i9, chemically known as 4,5-dihydro-5-phenyl-2-oxazolamine but more generally known as aminorex, which bears us nih compound identifier 16630. aminorex most often comes in base and fumarate forms. european medicines agency schedules aminorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05448mig. the term aminorex is an international non-proprietary name. aminorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule aminorex under hs 29349100 and sitc 51579. as of q4 2014, aminorex remains us fdas preferred term for this commodity. aminorex bears us nlm identifiers umls id c0002589 and nci concept code c72180. smiles: o1c(cn=c1n)c1ccccc1.. "
"stimulant or anorexiant azoles. this classification denotes substances composed of five-membered rings that contain a nitrogen atom, substances called azoles, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant azoles.. fenozolone. this classification denotes a cns stimulant with the molecular formula c11h12n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 1nzi4lmu6g, chemically known as 2-oxazolin-4-one, 2-ethylamino-5-phenyl- but more generally known as fenozolone, which bears us nih compound identifier 71682. european medicines agency schedules fenozolone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07584mig. the term fenozolone is an international non-proprietary name. world health organization schedules fenozolone in its anatomical therapeutic chemical (atc) classification. fenozolone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fenozolone under hs 29349990 and sitc 51579. as of q4 2014, fenozolone remains us fdas preferred term for this commodity. fenozolone bears us nlm identifiers umls id c0060187 and nci concept code c65663. smiles: ccnc1=nc(=o)c(o1)c2=cc=cc=c2.. "
"stimulant or anorexiant azoles. this classification denotes substances composed of five-membered rings that contain a nitrogen atom, substances called azoles, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant azoles.. nizofenone. this classification denotes a neuroprotective agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 7a2noc3r88. european medicines agency schedules nizofenone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09336mig. nizofenone generally arises in the molecular formula c21h21cln4o3. the term nizofenone is an international non-proprietary name or inn (see world health organization inn reference publication, volume 35, no. 5 1981, list 21.) nizofenone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nizofenone under hs 29332990 and sitc 51573. as of q4 2014, nizofenone remains us fdas preferred term for this commodity. nizofenone bears us nlm identifiers umls id c0068887 and nci concept code c76783. smiles: clc1c(c(=o)c2c(n3c(ncc3)cn(cc)cc)ccc([n](=o)o)c2)cccc1.. "
"stimulant or anorexiant azoles. this classification denotes substances composed of five-membered rings that contain a nitrogen atom, substances called azoles, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant azoles.. pemoline. this classification denotes a cns stimulant with the molecular formula c9h8n2o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 7gaq2332nk, chemically known as 4-oxazolidinone, 2-imino-5-phenyl- but more generally known as pemoline, which bears us nih compound identifier 4723. european medicines agency schedules pemoline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09657mig. the term pemoline is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules pemoline in its anatomical therapeutic chemical (atc) classification. pemoline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pemoline under hs 29349100 and sitc 51579. as of q4 2014, pemoline remains us fdas preferred term for this commodity. pemoline bears us nlm identifiers umls id c0030800 and nci concept code c47655. smiles: o1c(c2ccccc2)c(=o)n=c1n.. "
"stimulant or anorexiant morpholines. this classification denotes tetrahydro-1,4-oxazines, substances called morpholines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant morpholines.. . "
"stimulant or anorexiant morpholines. this classification denotes tetrahydro-1,4-oxazines, substances called morpholines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant morpholines.. phendimetrazine. this classification denotes a cns stimulant and anorexiant with the molecular formula c12h17no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) ab2794w8kv, chemically known as 3,4-dimethyl-2-phenylmorpholine but more generally known as phendimetrazine, which bears us nih compound identifier 12460. european medicines agency schedules phendimetrazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09756mig. the term phendimetrazine is an international non-proprietary name. phendimetrazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule phendimetrazine under hs 29349100 and sitc 51579. as of q4 2014, phendimetrazine remains us fdas preferred term for this commodity. phendimetrazine bears us nlm identifiers umls id c0070549 and nci concept code c61887. smiles: cc1c(occn1c)c2=cc=cc=c2.. "
"stimulant or anorexiant morpholines. this classification denotes tetrahydro-1,4-oxazines, substances called morpholines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant morpholines.. phendimetrazine bitartrate. this classification denotes a cns stimulant and anorexiant with the molecular formula c12h17no.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6985ip0t80, chemically known as (2s,3s)-3,4-dimethyl-2-phenylmorpholine l-(+)-tartrate, but more generally known as phendimetrazine bitartrate, which bears us nih compound identifier 120608. european medicines agency schedules phendimetrazine bitartrate or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09756mig. most nations, for tariff purposes, schedule phendimetrazine bitartrate under hs 29349100. smiles: c[c@h]1[c@@h](occn1c)c2ccccc2.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"stimulant or anorexiant morpholines. this classification denotes tetrahydro-1,4-oxazines, substances called morpholines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant morpholines.. phendimetrazine tartrate. this classification denotes a cns stimulant and anorexiant with the molecular formula c12h17no.c4h6o6, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 6985ip0t80, chemically known as morpholine, 3,4-dimethyl-2-phenyl-, tartrate, d- but more generally known as phendimetrazine tartrate, which bears us nih compound identifier 120608. european medicines agency schedules phendimetrazine tartrate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03739mig. most nations, for tariff and trade purposes, schedule phendimetrazine tartrate under hs 29349100 and sitc 51579. as of q4 2014, phendimetrazine tartrate remains us fdas preferred term for this commodity. phendimetrazine tartrate bears us nlm identifiers umls id c0148932 and nci concept code c47667. smiles: c[c@h]1[c@@h](occn1c)c2ccccc2.[c@@h]([c@h](c(=o)o)o)(c(=o)o)o.. "
"stimulant or anorexiant morpholines. this classification denotes tetrahydro-1,4-oxazines, substances called morpholines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant morpholines.. phenmetrazine. this classification denotes a cns stimulant and anorexiant with the molecular formula c11h15no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) xa501vl3vr, chemically known as 3-methyl-2-phenyltetrahydro-2h-1,4-oxazine but more generally known as phenmetrazine, which bears us nih compound identifier 4762. european medicines agency schedules phenmetrazine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09769mig. the term phenmetrazine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 32, no 10 1978, list 18). phenmetrazine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule phenmetrazine under hs 29349100 and sitc 51579. as of q4 2014, phenmetrazine remains us fdas preferred term for this commodity. phenmetrazine bears us nlm identifiers umls id c0031411 and nci concept code c66372. smiles: cc1c(occn1)c2=cc=cc=c2.. "
"stimulant or anorexiant piperazines. this classification denotes six-membered ring with two nitrogen atoms positioned opposite to one another, substances called piperazines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant piperazines.. . "
"stimulant or anorexiant piperazines. this classification denotes six-membered ring with two nitrogen atoms positioned opposite to one another, substances called piperazines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant piperazines.. fipexide. this classification denotes an antidepressant agent, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) tg44vme01d. european medicines agency schedules fipexide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07630mig. fipexide generally arises in the molecular formula c20h21cln2o4. the term fipexide is an international non-proprietary name or inn (see world health organization inn reference publication, volume 23, no. 10 1969, list 9.) fipexide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fipexide under hs 29349990 and sitc 51579. as of q4 2014, fipexide remains us fdas preferred term for this commodity. fipexide bears us nlm identifiers umls id c0060394 and nci concept code c65685. smiles: clc1ccc(occ(=o)n2ccn(cc2)cc2cc3ococ3cc2)cc1.. "
"stimulant or anorexiant piperazines. this classification denotes six-membered ring with two nitrogen atoms positioned opposite to one another, substances called piperazines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant piperazines.. pipradrol. this classification denotes a piperidine c18h21no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier f6e46vr9y2, chemically known as .alpha.,.alpha.-diphenyl-2-piperidinemethanol hydrochloride, but more generally known as pipradrol hydrochloride, which bears us nih compound identifier 66008. european medicines agency schedules pipradrol hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub03864mig. most nations, for tariff and trade purposes, schedule pipradrol hydrochloride under hs 29333300 and sitc 51574. as of q4 2014, pipradrol hydrochloride remains us fdas preferred term for this commodity. smiles: c1ccc(cc1)c(c2ccccc2)(c3ccccn3)o.cl.. "
"stimulant or anorexiant piperazines. this classification denotes six-membered ring with two nitrogen atoms positioned opposite to one another, substances called piperazines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant piperazines.. rimonabant. this classification denotes an anxiolytic with the molecular formula c22h21cl3n4o.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier hl0v2lqz09, chemically known as 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-n-1-piperidinyl-1h-pyrazole-3-carboxamide monohydrochloride, but more generally known as rimonabant hydrochloride, which bears us nih compound identifier 104849. european medicines agency schedules rimonabant hydrochloride or its base in its extended eudravigilance medicinal product dictionary or xevmpd under index sub21719. most nations, for tariff purposes, schedule rimonabant hydrochloride under hs 29333999. smiles: cc1c(n(nc1c(=o)nn2ccccc2)c3ccc(cc3cl)cl)c4ccc(cc4)cl.cl.. "
"stimulant or anorexiant pyrrolidines. this classification denotes compounds based on tetrahydropyrrole or c4h9n, substances called pyrrolidines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidines.. . "
"stimulant or anorexiant pyrrolidines. this classification denotes compounds based on tetrahydropyrrole or c4h9n, substances called pyrrolidines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidines.. pramiracetam hydrochloride. this classification denotes a neuroprotective agent with the molecular formula c14h27n3o2.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier wiu553vc0s, chemically known as 1-pyrrolidineacetamide, n-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo-, monohydrochloride; but more generally known as pramiracetam hydrochloride, which bears us nih compound identifier 3050410. european medicines agency schedules pramiracetam hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04005mig. most nations, for tariff and trade purposes, schedule pramiracetam hydrochloride under hs 29337900 and sitc 51561. as of q4 2014, pramiracetam hydrochloride remains us fdas preferred term for this commodity. pramiracetam hydrochloride bears us nlm identifiers umls id c0956068 and nci concept code c72831. smiles: cc(c)n(ccnc(=o)cn1cccc1=o)c(c)c.cl.. "
"stimulant or anorexiant pyrrolidines. this classification denotes compounds based on tetrahydropyrrole or c4h9n, substances called pyrrolidines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidines.. pramiracetam sulfate. this classification denotes a neuroprotective agent with the molecular formula c14h27n3o2.h2o4s, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier op7o7mns9p, chemically known as 1-pyrrolidineacetamide, n-(2-(bis(1-methylethyl)amino)ethyl)-2-oxo, sulfate (1:1) but more generally known as pramiracetam sulfate, which bears us nih compound identifier 51711. european medicines agency schedules pramiracetam sulfate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04006mig. most nations, for tariff and trade purposes, schedule pramiracetam sulfate under hs 29337900 and sitc 51561. as of q4 2014, pramiracetam sulfate remains us fdas preferred term for this commodity. pramiracetam sulfate bears us nlm identifiers umls id c0956067 and nci concept code c84103. smiles: cc(c)n(ccnc(=o)cn1cccc1=o)c(c)c.os(=o)(=o)o.. "
"stimulant or anorexiant pyrrolidines. this classification denotes compounds based on tetrahydropyrrole or c4h9n, substances called pyrrolidines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidines.. prolintane hydrochloride. this classification denotes a central nervous system stimulant c15h23n.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier yeg124534b, chemically known as pyrrolidine, 1-(1-(phenylmethyl)butyl)-, hydrochloride, but more generally known as prolintane hydrochloride, which bears us nih compound identifier 14591. european medicines agency schedules prolintane hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub04064mig. most nations, for tariff and trade purposes, schedule prolintane hydrochloride under hs 29339990 and sitc 51577. as of q4 2014, prolintane hydrochloride remains us fdas preferred term for this commodity. smiles: cccc(cc1ccccc1)n2cccc2.cl.. "
"stimulant or anorexiant pyrrolidines. this classification denotes compounds based on tetrahydropyrrole or c4h9n, substances called pyrrolidines, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidines.. pyrovalerone hydrochloride. this classification denotes a cns stimulant with the molecular formula c16h23no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier z95z9c2201, chemically known as 1-pentanone, 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-, hydrochloride but more generally known as pyrovalerone hydrochloride, which bears us nih compound identifier 14372. most nations, for tariff and trade purposes, schedule pyrovalerone hydrochloride under hs 29339100 and sitc 51577. as of q4 2014, pyrovalerone hydrochloride remains us fdas preferred term for this commodity. pyrovalerone hydrochloride bears us nlm identifiers umls id c0951428 and nci concept code c73830. smiles: cccc(c(=o)c1ccc(cc1)c)n2cccc2.cl.. "
"stimulant or anorexiant alkaloids. this classification denotes organic nitrogenous bases, which chemists usually extract from animal and vegetable sources (and thereafter synthesize the same), substances which called alkaloids, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant alkaloids.. . "
"stimulant or anorexiant alkaloids. this classification denotes organic nitrogenous bases, which chemists usually extract from animal and vegetable sources (and thereafter synthesize the same), substances which called alkaloids, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant alkaloids.. caffeine or trimethylxanthine. this classification denotes a cns stimulant and bioactive food component with the molecular formula c8h10n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3g6a5w338e, chemically known as 1,3,7-trimethylxanthine but more generally known as caffeine, which bears us nih compound identifier 2519. caffeine comes in many forms, including base, benzoate, benzoate sodium, bromide, citrate, hydrobromide, hydrochloride, hydroiodide, monohydrate, salicylate, sodium benzoate, sodium benzoicum, and sodium salicylate. european medicines agency schedules caffeine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub13146mig. world health organization schedules caffeine in its anatomical therapeutic chemical (atc) classification. caffeine or trimethylxanthine bears us nlm identifiers umls id c0006644 and nci concept code c328. smiles: o=c1n(c(=o)n(c2ncn(c12)c)c)c.. "
"stimulant or anorexiant alkaloids. this classification denotes organic nitrogenous bases, which chemists usually extract from animal and vegetable sources (and thereafter synthesize the same), substances which called alkaloids, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant alkaloids.. diethylpropion hydrochloride. this classification denotes a cns stimulant and anorexiant with the molecular formula c13h19no.clh, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 19v2pl39ng, chemically known as 1-propanone, 2-(diethylamino)-1-phenyl- but more generally known as amfepramone hydrochloride, which bears us nih compound identifier 7029. european medicines agency schedules amfepramone hydrochloride in its extended eudravigilance medicinal product dictionary or xevmpd under index sub00434mig. as of q4 2014, diethylpropion hydrochloride remains us fdas preferred term for this commodity. diethylpropion hydrochloride bears us nlm identifiers umls id c0723644 and nci concept code c47486. smiles: o=c(c(n(cc)cc)c)c1ccccc1.. "
"stimulant or anorexiant alkaloids. this classification denotes organic nitrogenous bases, which chemists usually extract from animal and vegetable sources (and thereafter synthesize the same), substances which called alkaloids, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant alkaloids.. propentofylline. this classification denotes a neuroprotective agent with the molecular formula c15h22n4o3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 5rta398u4h, chemically known as 3,7-dihydro-3-methyl-1-(5-oxohexyl)-7-propyl-1h-purine-2,6-dione but more generally known as propentofylline, which bears us nih compound identifier 4938. european medicines agency schedules propentofylline in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10102mig. the term propentofylline is an international non-proprietary name. world health organization schedules propentofylline in its anatomical therapeutic chemical (atc) classification. propentofylline is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule propentofylline under hs 29395900 and sitc 54145. as of q4 2014, propentofylline remains us fdas preferred term for this commodity. propentofylline bears us nlm identifiers umls id c0072171 and nci concept code c81919. smiles: o=c1n(ccccc(=o)c)c(=o)n(c2ncn(c12)ccc)c.. "
"stimulant or anorexiant amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amides.. . "
"stimulant or anorexiant amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amides.. flucetorex. this classification denotes an anorexiant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 0jjt8mq49s. european medicines agency schedules flucetorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07669mig. flucetorex generally arises in the molecular formula c20h21f3n2o3. the term flucetorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 28, no. 10 1974, list 14.) flucetorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule flucetorex under hs 29242995 and sitc 51479. as of q4 2014, flucetorex remains us fdas preferred term for this commodity. flucetorex bears us nlm identifiers umls id c2700198 and nci concept code c75964. smiles: fc(f)(f)c1cc(cc(nc(=o)cc(=o)nc2ccc(oc)cc2)c)ccc1.. "
"stimulant or anorexiant amides. this classification denotes organic compounds containing the -co-nh2 radical, substances called amides, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant amides.. nikethamide. this classification denotes a cns stimulant with the molecular formula c10h14n2o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 368ivd6m32, chemically known as 3-pyridinecarboxamide, n,n-diethyl- but more generally known as nikethamide, which bears us nih compound identifier 5497. european medicines agency schedules nikethamide in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09286mig. the term nikethamide is an international non-proprietary name. world health organization schedules nikethamide in its anatomical therapeutic chemical (atc) classification. nikethamide is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule nikethamide under hs 29333999 and sitc 51574. as of q4 2014, nikethamide remains us fdas preferred term for this commodity. nikethamide bears us nlm identifiers umls id c0028089 and nci concept code c76625. smiles: ccn(cc)c(=o)c1=cn=cc=c1.. "
"stimulant or anorexiant benzene derivatives. this classification denotes organic compounds that chemists extract from a toxic, volatile liquid hydrocarbon byproduct of coal distillation called benzene which bears the molecular formula c6h6 that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant benzene derivatives.. . "
"stimulant or anorexiant benzene derivatives. this classification denotes organic compounds that chemists extract from a toxic, volatile liquid hydrocarbon byproduct of coal distillation called benzene which bears the molecular formula c6h6 that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant benzene derivatives.. etamivan or ethamivan. this classification denotes a cns stimulant with the molecular formula c12h17no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier m44o63ypv9, chemically known as vanillic acid n,n-diethylamide but more generally known as etamivan, which bears us nih compound identifier 9363. european medicines agency schedules etamivan in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07259mig. the term etamivan is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). world health organization schedules etamivan in its anatomical therapeutic chemical (atc) classification. etamivan is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. etamivan or ethamivan bears us nlm identifiers umls id c0059692 and nci concept code c76623. smiles: ccn(cc)c(=o)c1=cc(=c(c=c1)o)oc.. "
"stimulant or anorexiant carboxylic acids. this classification denotes organic compounds containing the carboxy group (-cooh), substances called carboxylic acids, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant carboxylic acids.. . "
"stimulant or anorexiant carboxylic acids. this classification denotes organic compounds containing the carboxy group (-cooh), substances called carboxylic acids, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant carboxylic acids.. fenbutrazate. this classification denotes an anorexiant with the molecular formula c23h29no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) bky8h56395, chemically known as butyric acid, 2-phenyl-, 2-(3-methyl-2-phenylmorpholino)ethyl ester but more generally known as fenbutrazate, which bears us nih compound identifier 20395. european medicines agency schedules fenbutrazate in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07544mig. the term fenbutrazate is an international non-proprietary name or inn (see world health organization inn reference publication, volume 19 1975, list 5). fenbutrazate is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule fenbutrazate under hs 29349990 and sitc 51579. as of q4 2014, fenbutrazate remains us fdas preferred term for this commodity. fenbutrazate bears us nlm identifiers umls id c0605193 and nci concept code c65640. smiles: o1c(c(n(cc1)ccoc(=o)c(cc)c1ccccc1)c)c1ccccc1.. "
"stimulant or anorexiant indoles. this classification denotes substances derived from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, substances called indoles, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant indoles.. . "
"stimulant or anorexiant indoles. this classification denotes substances derived from benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, substances called indoles, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant indoles.. linopirdine. this classification denotes a cation channel blocker with the molecular formula c26h21n3o, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) i5tb3nz94t, chemically known as 1,3-dihydro-1-phenyl-3,3-bis(4-pyridinylmethyl)-2h-indol-2-one but more generally known as linopirdine, which bears us nih compound identifier 3932. european medicines agency schedules linopirdine in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08522mig. the term linopirdine is an international non-proprietary name or inn (see world health organization inn reference publication, volume 7, no3, 1993, list 33). world health organization schedules linopirdine in its anatomical therapeutic chemical (atc) classification. linopirdine is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule linopirdine under hs 29337900 and sitc 51561. as of q4 2014, linopirdine remains us fdas preferred term for this commodity. linopirdine bears us nlm identifiers umls id c0286263 and nci concept code c82306. smiles: o=c1n(c2c(c1(cc1ccncc1)cc1ccncc1)cccc2)c1ccccc1.. "
"stimulant or anorexiant oxadiazoles. this classification denotes aromatic, heterocyclic compounds based on c2h2n2, substances called oxadiazoles, that increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant oxadiazoles.. . "
"stimulant or anorexiant oxadiazoles. this classification denotes aromatic, heterocyclic compounds based on c2h2n2, substances called oxadiazoles, that increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant oxadiazoles.. mesocarb. this classification denotes a dopamine agonist with the molecular formula c18h18n4o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) umt8mp2ndu, chemically known as sydnone imine, 3-(alpha-methylphenethyl)-n-(phenylcarbamoyl)- but more generally known as mesocarb, which bears us nih compound identifier 71932. european medicines agency schedules mesocarb in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08785mig. the term mesocarb is an international non-proprietary name or inn (see world health organization inn reference publication, volume 30, no. 10 1976, list 16). mesocarb is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule mesocarb under hs 29349100 and sitc 51579. as of q4 2014, mesocarb remains us fdas preferred term for this commodity. mesocarb bears us nlm identifiers umls id c0074500 and nci concept code c83937. smiles: o1n[n](c(cc2ccccc2)c)cc1/n=c(\\o)nc1ccccc1.. "
"stimulant or anorexiant piperidines. this classification a family of hexahydropyridines, called piperidines, that increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant piperidines.. . "
"stimulant or anorexiant piperidines. this classification a family of hexahydropyridines, called piperidines, that increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant piperidines.. difemetorex. this classification denotes an anorexiant with the molecular formula c20h25no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) o0417mpf6w, chemically known as 1-piperidineethanol, 2-(diphenylmethyl)- but more generally known as difemetorex, which bears us nih compound identifier 65607. european medicines agency schedules difemetorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub07118mig. the term difemetorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19). difemetorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule difemetorex under hs 29333999 and sitc 51574. as of q4 2014, difemetorex remains us fdas preferred term for this commodity. difemetorex bears us nlm identifiers umls id c2699771 and nci concept code c77328. smiles: occn1c(cccc1)c(c1ccccc1)c1ccccc1.. "
"stimulant or anorexiant piperidines. this classification a family of hexahydropyridines, called piperidines, that increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant piperidines.. levofacetoperane or levophacetoperane. this classification denotes a cns stimulant with the molecular formula c15h21no2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier 3sz9zii529, chemically known as 2-piperidinemethanol, alpha-phenyl-, acetate (ester), (r*,r*)-(-)- but more generally known as levofacetoperane, which bears us nih compound identifier 65715. european medicines agency schedules levofacetoperane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub08469mig. the term levofacetoperane is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19). levofacetoperane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. levofacetoperane or levophacetoperane bears us nlm identifiers umls id c0064875 and nci concept code c81053. smiles: cc(=o)oc(c1ccccn1)c2=cc=cc=c2.. "
"stimulant or anorexiant pyrrolidones. this classification denotes derivatives of oxo-pyrrolidines, substances called pyrrolidones, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidones.. . "
"stimulant or anorexiant pyrrolidones. this classification denotes derivatives of oxo-pyrrolidines, substances called pyrrolidones, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidones.. aniracetam. this classification denotes a neuroprotective agent with the molecular formula c12h13no3, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 5l16lkn964, chemically known as 2-pyrrolidinone, 1-(4-methoxybenzoyl)- but more generally known as aniracetam, which bears us nih compound identifier 2196. european medicines agency schedules aniracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub05517mig. the term aniracetam is an international non-proprietary name or inn (see world health organization inn reference publication, volume 35, no. 5 1981, list 21). world health organization schedules aniracetam in its anatomical therapeutic chemical (atc) classification. aniracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule aniracetam under hs 29337900 and sitc 51561. as of q4 2014, aniracetam remains us fdas preferred term for this commodity. aniracetam bears us nlm identifiers umls id c0051917 and nci concept code c65236. smiles: coc1=cc=c(c=c1)c(=o)n2cccc2=o.. "
"stimulant or anorexiant pyrrolidones. this classification denotes derivatives of oxo-pyrrolidines, substances called pyrrolidones, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidones.. pramiracetam. this classification denotes a neuroprotective agent with the molecular formula c14h27n3o2, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) 4449f8i3le, chemically known as 2,1,3-benzothiadiazole, 5-chloro-4-(2-imidazolin-2-ylamino)- but more generally known as pramiracetam, which bears us nih compound identifier 5487. european medicines agency schedules pramiracetam in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09991mig. the term pramiracetam is an international non-proprietary name. world health organization schedules pramiracetam in its anatomical therapeutic chemical (atc) classification. pramiracetam is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pramiracetam under hs 29337900 and sitc 51561. as of q4 2014, pramiracetam remains us fdas preferred term for this commodity. pramiracetam bears us nlm identifiers umls id c0071809 and nci concept code c84171. smiles: clc1c(nc2=nccn2)c2nsnc2cc1.. "
"stimulant or anorexiant pyrrolidones. this classification denotes derivatives of oxo-pyrrolidines, substances called pyrrolidones, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidones.. prolintane. this classification denotes a central nervous system stimulant with the molecular formula c15h23n, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) em4yzw677h, chemically known as pyrrolidine, 1-(.alpha.-propylphenethyl)-, hydrochloride but more generally known as prolintane, which bears us nih compound identifier 14592. european medicines agency schedules prolintane in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10083mig. world health organization schedules prolintane in its anatomical therapeutic chemical (atc) classification. prolintane is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule prolintane under hs 29339990 and sitc 51577. as of q4 2014, prolintane remains us fdas preferred term for this commodity. smiles: n1(c(ccc)cc2ccccc2)cccc1.. "
"stimulant or anorexiant pyrrolidones. this classification denotes derivatives of oxo-pyrrolidines, substances called pyrrolidones, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidones.. pyrovalerone. this classification denotes a cns stimulant with the molecular formula c16h23no, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) vou69c02jp, chemically known as 1-pentanone, 1-(4-methylphenyl)-2-(1-pyrrolidinyl)- but more generally known as pyrovalerone, which bears us nih compound identifier 14373. european medicines agency schedules pyrovalerone in its extended eudravigilance medicinal product dictionary or xevmpd under index sub10177mig. the term pyrovalerone is an international non-proprietary name. pyrovalerone is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule pyrovalerone under hs 29339190 and sitc 51577. as of q4 2014, pyrovalerone remains us fdas preferred term for this commodity. pyrovalerone bears us nlm identifiers umls id c0072777 and nci concept code c83918. smiles: o=c(c(n1cccc1)ccc)c1ccc(cc1)c.. "
"stimulant or anorexiant pyrrolidones. this classification denotes derivatives of oxo-pyrrolidines, substances called pyrrolidones, that tend to increase behavioral alertness, agitation, or excitation, or otherwise, appetite depression, thus the term stimulant or anorexiant pyrrolidones.. picilorex. this classification denotes an anorexiant, a preparation that us fda regulates as an active ingredient or moiety under unique ingredient identifier (srs unii) s8k2jdr3nz. european medicines agency schedules picilorex in its extended eudravigilance medicinal product dictionary or xevmpd under index sub09809mig. picilorex generally arises in the molecular formula c14h18cln. the term picilorex is an international non-proprietary name or inn (see world health organization inn reference publication, volume 33, no. 10 1979, list 19.) picilorex is scheduled in the u.s. international trade commissions harmonized tariff system (hts) pharmaceutical appendix. most nations, for tariff and trade purposes, schedule picilorex under hs 29339990 and sitc 51577. as of q4 2014, picilorex remains us fdas preferred term for this commodity. picilorex bears us nlm identifiers umls id c2698803 and nci concept code c75116. smiles: clc1ccc(c2cc(nc2c)c2cc2)cc1.. "
